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resumo 
 
 
Os lípidos são considerados alvos importantes das espécies reativas de 
nitrogénio (RNS, do inglês Reactive Nitrogen Species), formadas em 
condições de stresse nitroxidativo. As RNS podem levar à formação de uma 
grande variedade de lípidos modificados, formados através de reações de 
nitração, nitrosação e nitroxidação. Os ácidos gordos nitrados (NO2-FA) têm 
sido descritos como os principais produtos endógenos formados pela reação 
entre ácidos gordos e RNS, e já foram detetados em plasma, urina e tecidos. 
Os NO2-FA são considerados compostos bioativos com um importante papel 
como agentes anti-inflamatórios, anti-hipertensivos e anti-trombóticos, estando 
envolvidos na modulação de complicações metabólicas e inflamatórias. Apesar 
da relevância da nitração de lípidos, maioritariamente descrita para os NO2-FA, 
a nitração de fosfolípidos, que são os principais constituintes das membranas 
celulares, permanece um campo de investigação pouco explorado continuando 
a existir uma falha de conhecimento no que diz respeito ao tipo de produtos 
fosfolipídicos que podem ser formados em condições de stresse nitroxidativo, 
e quais os seus papéis nos sistemas biológicos.  
Para ultrapassar esta questão, os principais objetivos desta tese de 
doutoramento consistiram no desenvolvimento de abordagens baseadas em 
espectrometria de massa (MS) para a) a identificação de diferentes fosfolípidos 
nitrados e nitroxidados, b) a identificação dos padrões de fragmentação 
característicos dos fosfolípidos modificados, c) aplicar as estratégias 
desenvolvidas e baseadas em espectrometria de massa para detetar 
fosfolípidos nitrados e nitroxidados in vivo em modelos de doença, d) avaliar o 
papel dos fosfolípidos nitrados e nitroxidados como agentes anti-inflamatórios 
e antioxidantes e e) avaliar a sua interação com proteínas. De um modo geral, 
pretendemos contribuir para o conhecimento das modificações químicas em 
fosfolípidos induzidas em condições de stresse nitroxidativo e a significância 
biológica desses produtos. 
Para alcançarmos os objetivos propostos, os derivados nitrados dos 
fosfolípidos (NO2-PL), nomeadamente os derivados nitro de fosfatidilcolinas 
(NO2-PC), fosfatidiletanolaminas (NO2-PE) e fosfatidilserinas (NO2-PS), 
contendo diferentes ácidos gordos, foram estudados por MS. Os NO2-PL foram 
sintetizados utilizando nitrónio tetraflouroborato (NO2BF4), mimetizando 
condições de stresse nitroxidativo, e foram posteriormente identificados por MS 
com ionização por electrospray (ESI-MS) e caracterizados por espectrometria 
de massa tandem (ESI-MS/MS). O seu padrão de fragmentação típico foi 
identificado e incluí a perda do grupo nitro (HNO2) e a formação de ácidos 
gordos nitrados. Esta metodologia baseada em MS, permitiu a deteção de oito 
derivados nitrados de fosfolípidos, sete NO2-PCs e uma NO2-PE, em 
mitocôndrias isolados do coração de um modelo animal de diabetes mellitus 
tipo 1 obtido pela administração de streptozotocina (STZ). 
 
 
   
 
 
 
 
 
 
 
 
 
 
  
 
 
Estas descobertas irão contribuir para a compreensão dos mecanismos 
de nitração em ambientes biológicos e para estabelecer a relevância fisiológica 
dos NO2-PLs. Além disso, outros derivados nitrados e nitroxidados das PCs e 
PEs com diferentes combinações de ácidos gordos foram também sintetizados 
utilizando o modelo biomimético de nitroxidação e, posteriormente, foram 
estudados por cromatografia líquida (LC) acoplada à espectrometria de massa 
e MS/MS. Os derivados modificados de fosfolípidos incluíram: derivados 
nitroso e dinitroso, nitro e dinitro, e nitronitroso, em conjunto com derivados 
nitroxidados. A fragmentação típica para cada uma estas modificações foram a 
perda de HNO e HNO2, as perdas combinadas de HNO (HNO2) e a cabeça 
polar dos fosfolípidos, e ainda iões produto correspondentes às cadeias de 
ácido gordo modificadas, nomeadamente iões [NOn-FA+On+H]+ e [NOn-FA+On-
H]- (n=1-2). Estas fragmentações permitiram identificar PCs nitradas, incluindo 
NO2-PC, (NO2)2-PCs, (NO2)(NO)-PC, NO-PC; PEs nitradas, NO2-PEs; e uma 
PC nitroxidada (NO2)(2O)-PC em cardiomioblastos H9c2 em condições de 
starvation, mas não foram detetadas em células em condições de isquémia 
nem no controlo. A relevância fisiológica das PCs e PEs nitradas e 
nitroxidadas observadas exclusivamente em cardiomioblastos H9c2 em 
condições de starvation permanece desconhecida mas estas espécies podem 
ter um papel na cardioproteção que merece ser explorada. 
Para avaliar os possíveis efeitos biológicos dos NO2-PL, os produtos 
nitrados/nitroxidados da POPC, nomeadamente os derivados NO2-POPC, 
foram incubados com macrófagos Raw 264.7, uma linha celular de monócitos 
de ratinho estimulada com LPS, demonstrando ter propriedades anti-
inflamatórias pela diminuição da expressão da forma induzível da óxido nítrico 
sintase (iNOS). Os produtos nitrados/nitroxidados da POPC demonstraram 
ainda ter propriedades antioxidantes, nomeadamente como scavengers, 
demonstrada pela capacidade de reduzir os radicais ABTS●+, DPPH● e 
peroxílo (ensaio ORAC). 
Tendo em conta que os efeitos biológicos dos lípidos nitrados ocorre via 
modificações pós-transducionais de proteínas, também avaliámos a 
capacidade dos produtos nitrados/nitroxidados da POPC em interagir com 
proteínas, especificamente a adição dos derivados NO2-POPC, principais 
produtos formados durante a nitração biomimética da POPC, com a vimentina 
que é um filamento intermediário. Para avaliar o efeito da NO2-POPC foram 
utilizados ensaios de competição in vitro, onde as suas interações foram 
avaliadas utilizando western blotting. A interação dos produtos 
nitrados/nitroxidados da POPC com a vimentina protegeu-a da modificação 
pela iodoacetamida biotinilada. Os produtos nitrados/nitroxidados da POPC 
também induziram alterações na organização da rede de vimentina. Estes 
efeitos foram avaliados, utilizando microscopia confocal, em células de 
carcinoma adrenal SW13, as quais expressam construções específicas de 
vimentina. 
Os resultados obtidos com esta tese de doutoramento fornecem novas 
informações baseadas em abordagens avançadas de MS para a identificação 
de modificações em PLs induzidas pelas RNS nomeadamente em condições 
de stresse nitroxidativo, o que irá ser crucial para a sua identificação em 
amostras biológicas, e ainda para o desvendar dos seus potenciais papéis a 
nível biológico. 
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abstract 
 
Lipids are considered important targets of reactive nitrogen species 
(RNS), under nitroxidative stress conditions. Various RNS can lead to a great 
variety of modified lipids, formed via nitration, nitrosation and nitroxidation 
reactions. Nitro-fatty acids (NO2-FA) have been reported as major endogenous 
products formed between fatty acids (FA) and RNS, and have been detected in 
plasma, urine, and tissues. NO2-FA are considered important bioactive 
molecules with roles as anti-inflammatory, anti-hypertensive, and anti-
thrombotic agents being involved in modulation of metabolic and inflammatory 
complications. In spite of the relevance of lipid nitration, it has been mainly 
focused on NO2-FAs, but in contrast, putative nitration of phospholipids (PL), 
the major constituents of cell membranes, remains an unexplored field of 
research. There are no studies regarding the type of PL products that can be 
formed under nitroxidative stress conditions and their possible roles in 
biological systems.  
To overcome this issue, the main goals of this PhD were the development 
of mass spectrometry (MS)-based approaches a) to identify different PL 
nitrated and nitroxidized products, b) to identify the characteristic fragmentation 
pattern of modified PL, c) to apply the developed MS-based strategies to 
detected nitrated and nitroxidized PL species in in vivo models of disease, d) to 
evaluate the role of nitrated and nitroxidized PLs as anti-inflammatory and as 
antioxidants, and c) to evaluate their adduction to proteins. Overall it is 
expected to contribute for the understanding of the chemical modifications 
induced by nitroxidative stress to PLs and their biological significance. 
To accomplish our goal, first we analyzed nitrated PL species (NO2-PL), 
namely nitro derivatives of phosphatidylcholine (NO2-PC), 
phosphatidylethanolamine (NO2-PE) and phosphatidylserine (NO2-PS), bearing 
different FA by MS. NO2-PL were synthesized using nitronium tetrafluoroborate 
(NO2BF4) in a biomimetic system of nitroxidative stress conditions. NO2PL were 
identified by electrospray (ESI)-MS and characterized by ESI tandem mass 
spectrometry (ESI-MS/MS). The typical fragmentation pattern of NO2-PL was 
determined and included the loss of nitro group (HNO2) and the formation of 
nitrated fatty acids. The MS reported ions allowed us to detect eight nitrated 
derivatives of PLs, seven NO2-PCs and one NO2-PE, in cardiac mitochondria 
isolated from heart of a well-characterized animal model of type 1 diabetes 
mellitus (T1DM) obtained by administration of streptozotocin (STZ). These 
findings will contribute for the understanding of nitration in biological 
environments, and to establish the physiological relevance of NO2-PL species. 
In addition, different nitrated and nitroxidized derivatives of PCs and PEs with 
different combinations of FA were also generated using the biomimetic model 
of nitroxidation and were studied by liquid chromatography (LC)-MS and 
MS/MS approaches. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 Single and multiple nitrated derivatives of PLs such as nitroso and 
dinitroso, nitro and dinitro, nitronitroso derivatives, together with nitroxidized 
derivatives were identified and their specific fragmentation pathways were 
assigned. Typical reporter product ions of these modifications were loss of 
HNO and HNO2, the combined loss of HNO (or HNO2) and polar head groups, 
and [NOn-FA+On+H]+ and [NOn-FA+On-H]- (n=1-2) product ions corresponding 
to the modified fatty acyl chains, depending on each modification. These 
reported fragmentations allowed the identification of nitrated PCs, including 
NO2-PC, (NO2)2-PCs, (NO2)(NO)-PC, NO-PC; nitrated PEs, NO2-PEs; and 
nitroxidized PCs, (NO2)(2O)-PC in cardiomyoblast H9c2 cells under starvation 
conditions, but not in cells under ischemia neither in control. The physiological 
relevance of nitrated and nitroxidized PCs and PEs species observed 
exclusively in cardiomyoblast cells (H9c2) under starvation is still unknown but 
could have a role in cardioprotection that deserves to be explored. 
To evaluate the putative biological effects of NO2-PL, nitrated/nitroxidized 
products of POPC, namely the NO2-POPC derivatives, were incubated with 
Raw 264.7 macrophages, a mouse leukaemic monocyte cell line, stimulated 
with LPS, and revealing anti-inflammatory properties by decreasing the 
expression of the inducible nitric oxide synthase (iNOS). Nitrated/nitroxidized 
products of POPC also showed antioxidant properties, namely as scavenging 
agents, demonstrated by reducing the ABTS●+, DPPH● and peroxyl radicals 
(ORAC assay).  
Considering that the biological effects of nitrated lipid occur via post-
translational modification (PTM) of proteins, we had also evaluated the ability of 
nitrated/nitroxidized products of POPC to interact with proteins. For that it was 
studied the adduction of NO2-POPC derivatives, the major product formed 
during biomimetic nitration of POPC, with vimentin, an intermediate filament 
protein, assessed using in vitro gel-based competition assay, and their 
interactions were evaluated using western blotting. The interaction of 
nitrated/nitroxidized products of POPC with vimentin shielded its modifications 
by biotinylated iodoacetamide. The effects of nitrated/nitroxidized products of 
POPC in the organization of vimentin network was also evaluated in SW13 
adrenal carcinoma cell line expressing defined vimentin constructs using 
confocal microscopy. The results gathered in his study revealed that 
nitrated/nitroxidized products of POPC can interact with vimentin and induced 
changes in the organization of vimentin network. 
Overall, the results gathered in this PhD thesis provide new tool based on 
advanced MS approaches to identify structural modification of phospholipids 
induced by RNS namely under nitroxidative stress, that can be successfully 
used to pinpoint these nitrated species in different systems, and will be crucial 
for their identification in biological samples, and to unveil some of their potential 
roles in biological systems.   
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General Introduction 
 
Phospholipids (PLs) are the most abundant lipids in mammalian, and are associated 
with several biological functions, as the main structural components of cellular membranes 
and lipoproteins, and playing key roles as signaling molecules [1, 2]. Under oxidative 
stress conditions, PLs can be easily modified due to the reaction with reactive oxygen 
species (ROS) generating a huge diversity of oxidized products structurally different from 
the unmodified PL precursors and also with dissimilar properties and functions in 
biological systems [1, 3]. These modified PL has been described to be either pro- or anti-
inflammatory agents playing significant biological roles in the onset, development and 
progression of pathological conditions, such as cancer, neurodegenerative disease, 
cardiovascular diseases, diabetes inflammation and related complications [1-4]. But lipids 
can also be modified by reactive nitrogen species (RNS). Few in vitro studies suggested 
that the reactions of RNS with free fatty acids (FA) may generate a huge diversity of 
oxidized, nitroxidized, nitrated and/or nitrosated derivatives that have been characterized 
mostly using mass spectrometry based approaches [5, 6]. Free nitro-fatty acids (NO2-FA) 
were already detected in biological samples [7-11] and were reported to play a widely 
range of signaling actions, especially as anti-inflammatory, anti-hypertensive and as anti-
thrombotic agents [12-16]. The electrophilic nature of NO2-FA facilitate their interaction 
with key proteins targets leading to the formation of lipid-protein adducts [12, 17, 18] and 
modulating protein function. Nevertheless, the knowledge of the effects of RNS in 
phospholipid itself has been scarcely explored. RNS may freely cross membranes, and 
easily accumulate in this hydrophobic environment, increasing the probability of PLs 
modifications under nitroxidative or nitrative stress conditions, similarly to which was 
observed for free FA, and nitrated/nitroxidized PLs may also have key biological 
properties [6, 11].  
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I.1. Reactive Nitrogen Species and Nitrative, Nitrosative and/or Nitroxidative Stress 
 
Reactive nitrogen species (RNS) are endogenously produced reactive species that can 
be formed either by enzymatic and/or non-enzymatic reactions (Figure I.1), often 
concomitant with ROS, and usually under oxidative stress and inflammation conditions 
[19-21]. RNS are associated with key regulatory functions playing roles as signaling 
molecules [22]. There are also several exogenous sources of RNS (or their precursors), 
such as fruits, vegetables, cured meats, cereals from diet which are rich in the inorganic 
anions nitrite (NO2
-) and nitrate (NO3
-) [23, 24], chemicals and cigarette smoke, polluted 
air (Figure I.1). 
 
 
Figure I.1. Endogenous and exogenous sources of reactive nitrogen species (RNS). 
 
RNS enclose different reactive species, with dissimilar structures and reactivity, 
including radical and non-radicalar species (Table I.1), that can be formed in vivo, namely 
nitric oxide (NO●), peroxynitrite (ONOO-) and nitrogen dioxide (NO2
●), among others. 
Nitric oxide (NO●), or nitrogen monoxide, is a small sized free radical molecule and 
the precursor of the other RNS. NO● is endogenously produced by a wide variety of cells, 
such as neuronal, endothelial and smooth muscle cells, macrophages, neutrophils, platelets 
and fibroblasts. It is formed via oxidation of the amino acid L-arginine to NO● and L-
citrulline, in a reaction catalyzed by the enzyme nitric oxide synthase (NOS) in a tightly 
regulated way. There are three NOS isoforms: the neuronal-NOS (nNOS or NOS-I) [25, 
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26], inducible-NOS (iNOS or NOS-II) [27] and endothelial-NOS (eNOS or NOS-III) [28]. 
The neuronal and endothelial NOS are expressed constitutively and their activity is 
calcium-dependent (via activation by calmodulin). nNOS has been localized in the cytosol 
while eNOS is membrane-bounded [29]. In general, these constitutive isoforms regulate 
normal physiological functions [30]. The iNOS is also predominantly found in the cytosol 
and has a calcium-independent activity [29, 30]. iNOS is expressed in response to 
inflammatory stimuli such as cytokines being usually associated with the immune response 
[31]. In the lung and kidney, iNOS is constitutively expressed and represents a mechanism 
of constitutive generation of NO● that is independent of calcium regulation [30]. 
 In spite of being a free radical, nitric oxide has a short life time, is quite stable and 
thus is not a very reactive molecule [32]. However, it has the ability to react with lipid 
reactive species such as lipid peroxyl radicals (LOO●) to form non-radical end products of 
lipid peroxidation acting as a chain breaking  antioxidant [6, 33]. NO● is a small size, 
neutral and hydrophobic molecule [34, 35]. Due to these characteristics, NO● cross lipid 
membrane bilayers, and easily diffuse through the hydrophilic surface into the hydrophobic 
layer where it is concentrated, triggering both intra and extracellular effects. NO● is an 
important intracellular signaling messenger, and mediates and regulates multiple 
physiological processes, such as blood pressure and vascular relaxation, 
neurotransmission/neuronal communication, signal transduction, platelet aggregation, cell 
cycle regulation, inflammation, host defense, among others [36]. It has also antioxidant 
properties related to its chain breaking activity namely during lipid peroxidation [33, 37]. 
Their physiological effects as signaling molecule or cytoprotective factor are mediated by 
low concentrations. However, during inflammation and oxidative stress-associated 
pathologies, there is an excessive production of NO● by key cells of the immune system, 
promoted by NOS. In fact, upon oxidative and inflammatory conditions where high 
concentration of NO● and ROS are present, NO● can be converted to more reactive RNS 
such as peroxynitrite [20, 29], that can further react with target biomolecules [38-40]. 
Thus, the indirect effects of NO●, transduced by these newly-formed RNS species, are also 
associated with the presence of ROS leading to the occurrence of different types of 
reactions via nitration, nitrosation and/or nitroxidation causing cell damage. Nitrative stress 
can be related to the nitration reactions that lead to the covalent addition of a nitro group 
(NO2) to biomolecules such as lipids, while the nitrosative stress can be related to 
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nitrosation and the covalent addition of a nitroso group (NO). However, because of 
oxidative stress can occurs in simultaneous to nitrative stress and nitration reactions, the 
nitroxidative stress and nitroxidation reactions refers to both nitration and oxidation 
processes mediated by RNS [19, 40]. 
As reported, NO● can be converted into other more reactive RNS. Removal of the 
unpaired electron from NO● leads to the formation of the oxidized species nitrosonium 
cation (NO+) that can be reduced by the addition of electrons leading to the formation of 
the nitroxyl anion (NO-). NO- can interact with NO● yielding dinitrogen monoxide (N2O) 
and hydroxyl radical (●OH). NO● can react with hydrogen peroxide (H2O2) to yield several 
other RNS which include nitrous acid (HNO2), dinitrogen trioxide (N2O3), NO2
- and NO3
- 
[41]. Dietary NO3
- can be converted in NO2
- which can also be obtained directly from diet. 
NO2
- is highly abundant in biological fluids such as saliva. 
 
Table I.1. Reactive nitrogen species grouped in radical and non-radical species. 
Reactive Nitrogen Species 
Radical Non-radical 
NO● Nitric oxide ONOO- Peroxynitrite 
NO2● Nitrogen dioxide O2NOO- Peroxynitrate 
 ONOOH Peroxynitrous acid 
 ONOOCO2- Nitrosoperoxycarbonate anion 
 ROONO Alkyl peroxynitrite 
 NO- Nitroxyl anion 
 NO2- Nitrite 
 NO3- Nitrate 
 NO+ Nitrosonium cation 
 NO2+ Nitronium cation 
 HNO2 Nitrous acid 
 N2O3 Dinitrogen trioxide 
 N2O4 Dinitrogen tetroxide 
 N2O5 Dinitrogen pentoxide 
 NO2Cl Nitryl chloride 
 RO2ONO Alkyl peroxynitrate 
 
Peroxynitrite (ONOO-), a potent oxidant and cytotoxic agent, is the most reactive RNS 
[41]. ONOO- can be formed through the reaction between NO● and superoxide anion (O2
●-) 
[42], two short-living molecules in biological systems, when both are present in the same 
cellular compartment. NO● diffuses through the hydrophobic core of biological 
membranes, where it concentrates and reacts with O2
●-. This reaction occurs at the sites 
spatially associated with the sources of O2
●- due to its restricted ability to diffusion across 
membranes. O2
●- can be generated from peroxysomal fatty acid metabolism, cytochrome P-
450 reactions, NADPH oxidase activity, and from mitochondrial electron transport chain 
CHAPTER I. INTRODUCTION 
 
7 
(complexes I, II and III) that is in fact the cell’s most significant source of this ROS [43]. 
ONOO- can also be formed from the reaction of NO- and O2 [44]. On the other hand, 
reaction of ONOO- with transition metals as ferrous ions (Fe2+) yields nitronium cation 
(NO2
+). While stable at basic pH, at physiological pH (neutral pH), ONOO- is unstable 
undergoing different degradation routes. ONOO- can decompose directly to generate NO2
● 
and NO3
- or it can be protonated to form peroxynitrous acid (ONOOH) [45, 46]. ONOOH 
can undergo homolytic decomposition to yield nitrogen dioxide (NO2
●) and ●OH [45, 46]. 
ONOO- can also react with carbon dioxide (CO2) generating nitrosoperoxycarbonate anion 
(ONOOCO2), which may yields NO2
●
 and carbonate (CO3
●-) by homolysis or NO3
- and 
CO2 [47]. Thus, CO2 plays a role in the decomposition of ONOO
- to NO2
●. NO2
●
 can also 
be formed from the NO
● autoxidation. 
As hydrophobic molecules, NO● and molecular oxygen (O2) can concentrate and 
diffuse in hydrophobic membrane, at similar extent favoring their mutual interaction and 
reaction. Thus, lipid membrane bilayers are the primary site for NO● oxidation reactions to 
take place and be accelerated in vivo [48]. In fact, it was already demonstrated that NO● 
oxidation to NO2
● in aqueous solutions is greatly accelerated by phospholipids [48]. NO2
●
 
can also be generated from NO2
- since, at acidic pH, the latter RNS species can form 
HNO2. The low pH found in gastric compartment and phagocytic lysosomes allows NO2
- 
to generate NO2
● via HNO2 generation. Dimerization of NO2
●
 yields dinitrogen tetraoxide 
(N2O4) that decompose to produce NO2
- and NO3
-. NO2
●
 can react with NO
● to form 
dinitrogen trioxide (N2O3). Both NO2
● and N2O3 are unstable in aqueous phase. N2O3 
rapidly hydrolyzes to form NO2
- in aqueous solutions [38]. This RNS is stabilized in 
hydrophobic environments in which is a weak/mild oxidant agent but a powerful 
nitrosating agent. RNS can also be generated through enzymatic reactions. NO2
● can be 
generated from reaction between NO2
- and H2O2 catalyzed by peroxidases [49-51] 
including myeloperoxidase [52, 53] and lactoperoxidase [51, 54]. NO2
● can also be formed 
from ONOO- in a reaction catalyzed by cytochrome P450 [55].  
In an attempt to mimic biological reactions, there are some laboratorial procedures that 
aim to chemically synthesize some of these RNS naturally occurring in vivo. For example, 
ONOO- can be easily synthesized by mixing sodium nitrite (NaNO2) and H2O2 in acidic 
conditions yielding ONOOH which was further neutralized in the presence of a alkaline 
solution to form the stabilized ONOO-, as described by Robinson and co-authors [56] and 
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Beckman and co-authors [57]. This reaction is widely used in research published in 
scientific literature [6, 8-11, 58]. The decomposition of the NO-generating vasodilator 3-
morpholinosydnonimine (SIN-1) also yields ONOO- continuously from a certain period of 
time after simultaneous generation and combination of NO● and O2
●- [5, 57]. Nitronium 
tetraflouroborate (NO2BF4), a salt of NO2
+ ions [5, 9, 58, 59] and the NO● donors 
(diazeniumdiolates or NONOates) has been also used in biomimetic models of 
nitrative/nitroxidative stress. NO● can be generated from NONOates due to their ability to 
spontaneously release NO● in aqueous media, under physiological conditions. Depending 
on their structure and pH of the solution, their half-life and consequently the rates of NO● 
release are different [60].  
The NO●-derived RNS including ONOO-, NO2
●, NO3
-, NO2
+, in spite of having 
different reactivity, can potentially damage all type of biomolecules [19-21]. Peroxynitrite 
is a powerful nitrating, nitros(yl)aying and oxidizing agent [61, 62] which has been 
associated to  post-translational modifications of biomolecules, such as glutathione (GSH), 
amino acid residues as cysteine and tyrosine, proteins, deoxyribonucleic acid (DNA), lipids 
(polyunsaturated fatty acids) and carbohydrates [19-21, 63]. Protein nitration has been 
widely studied and reported. In fact, the occurrence of protein tyrosine nitration is now a 
well-established footprint of the reaction of RNS, and nitrotyrosine is a well-known marker 
of nitroxidative stress [20, 45, 64]. This stable post-translational modification leads to 
changes in the structure [19] and function of proteins (loss of function or new and different 
function), and has been associated with the onset and progression of several pathologies 
[20] as cardiac, vascular and neurodegenerative diseases, autoimmune diseases, aging, 
asthma, cancer, inflammation, diabetes, and associated complications [20, 38, 46].  
RNS can also react with lipids. The major work concerning the modifications induced 
by RNS to lipids is focused in the study of fatty acid nitration and nitroxidation, namely 
the generation and detection of nitroalkene derivatives of unsaturated FA (or nitro-fatty 
acids, NO2-FA) both in in vivo samples [7, 9-11, 38, 46, 65-70] and in in vitro biomimetic 
model systems. In the following section we will describe how RNS can modify lipids 
based on the mechanisms decribed in the literature. 
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I.2. Nitrated Lipids: Occurrence and Proposed Mechanisms of Formation of Nitrated 
Fatty Acids 
 
To understand lipid nitration, biomimetic systems using pure standards and chemically 
synthetized RNS have been used by several authors. Major work used FA and few RNS 
such as nitrite in acidic conditions [8-10, 71, 72], peroxynitrite and NO2
● [5, 6, 11, 58]. 
These simplistic approaches aiming to mimic the biological conditions have the advantage 
of decreasing the complexity of the sample (in comparison with the more complex 
biological matrices such as urine or plasma) and produce an array of different 
nitrated/nitroxidized products in relatively high yields making easier to develop analytical 
strategies for their identification and characterization. These models can also contribute to 
the knowledge and understanding of the mechanism underlying nitroxidation, nitration 
and/or nitrosation processes and the type of modifications that can occurs in biological 
systems. 
Among the modifications of FA induced by RNS, the nitroalkene derivatives of 
unsaturated fatty acids (nitro-fatty acids, NO2-FA) are the most reported products of lipid 
modifications generated under (patho)physiological conditions associated with 
nitrative/nitroxidative stress,  where oxidative stress and overproduction of NO● occurs 
simultaneously, such as metabolic stress and inflammation [15, 73, 74].  
NO2-FA have been identified in vivo, in samples such as human red blood cells [7, 
75], plasma [7, 9, 69, 75], urine, and in normal and inflamed mammalian tissues, including 
liver, kidney, muscle, adipose tissue [10, 11, 65-70] at concentrations ranging from the 
micromolar [11] to picomolar [69]. Nitro-fatty acids were already identified in cardiac 
tissue following ischemia/reperfusion [76] and ischemia preconditioning [77], oxidative 
stress and hypoxia [78]. More recently, a study of Fazzari and colleagues [23] reported the 
presence of NO2-FAs in plants, specifically in fresh olives, and in extra virgin olive oil 
(EVOO). Moreover, olive oil and fish are rich in unsaturated fatty acids (namely, oleic and 
linoleic acids) while fruits, vegetables and cured meat are rich in inorganic anions nitrite 
and nitrate [23, 24]. The acidic and low oxygen conditions in the stomach provide the 
proper environment for the efficient nitration of unsaturated fatty acids by nitrite [79], 
which became protonated to yield a diversity of reactive intermediaries [80]. In fact, nitro-
fatty acids were identified as major products of the acid-catalyzed reactions in gastric 
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compartment [81] and also from EVOO under acidic conditions which mimic the gastric 
pH and NO2
- concentrations that occur during digestion [23]. Thus, dietary sources may 
also contribute to increase the endogenous presence of NO2-FA [82]. The consumption of 
diets promoting increased NO2-FA levels has recently been proposed to account for a 
significant element of the health benefits linked with Mediterranean diet. In this way, 
generation of nitrated fatty acids can occurs through acid-catalyzed unsaturated fatty acid 
nitration by dietary nitrite coming from vegetables and cured meats during digestion and/or 
free radical-mediated fatty acid nitration reactions during digestion, metabolic stress and 
inflammatory conditions (Figure I.2). 
 
 
Figure I.2. Formation of NO2-FA mediated by reactive nitrogen species occurs during 
digestion and inflammatory conditions. 
 
From the nitroalkene FA derivatives, the nitroalkene derivative of oleic acid (nitro-
oleic acid, NO2-OA) is considered the most predominant derivative in vivo [7, 11] and two 
possible isomers can be formed depending on the position of the nitro group on the fatty 
acyl chain, namely in C9 (9-NO2-OA) and C10 (10-NO2-OA, Figure I.3). These isomers 
were detected in red blood cells and plasma [11], and in in vitro models [5, 83]. 
Nitroalkene derivatives of other fatty acids have been reported namely nitro-linoleic acid 
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(NO2-LA), conjugated nitro linoleic acid (NO2-cLA), and nitroarachidonic acid (NO2-AA) 
[12, 16]. Specific isomers of NO2-LA, namely C10 (10-NO2-LA) and C12 (12-NO2-LA) 
isomers, were detected and characterized in red blood cells and plasma [7]. These two 
isomers, together with C9 (9-NO2-LA) and C13 (13-NO2-LA) were also detected under in 
vitro experiments [5, 83, 84]. The synthesis and characterization of the C9 (9-NO2-AA), 
C12 (12-NO2-AA), C14 (14-NO2-AA) and C15 (15-NO2-AA) isomers of NO2-AA were 
reported by Trostchansky and co-authors [10]. These four isomers plus the 11-NO2-AA 
were also identified by Milic and co-authors [5]. They also identified and characterized the 
isomers of nitro-docosahexaenoic acid (NO2-Dha), namely C10, C11, C13, C14, C16, C17, 
C19 and C20 isomers. The C9 (9-NO2-cLA) and C12 (12-NO2-cLA) isomers of NO2-cLA 
were identified after in vitro nitration of cLA [72]. 
 
 
Figure I.3. Structure of oleic acid and its two nitroalkene isomers: the 9-nitro-oleic acid 
and the 10-nitro-oleic acid isomers.  
 
In addition to the NO2-FA, a wide spectrum of products can be generated from 
reaction of unsaturated fatty acids with RNS, including also different stereo- or positional 
isomers [7, 11]. Nitroso derivatives (NO-FA), multiply nitrated derivatives such as 
dinitroso ((NO)2-FA), di- ((NO2)2-FA) and trinitro derivatives ((NO2)3-FA), and assorted 
nitroxidized products (nitrohydroxy ((NO2)O-FA), nitro-hydroperoxy ((NO2)2O-FA), 
nitro-epoxy, nitro-keto) has been detected and reported for both in vivo (cardiac tissue, 
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human blood and urine) and in vitro studies [6-8, 11, 13, 58, 59, 65, 78, 80, 85-88]. Non-
nitrated  geometrical trans isomers are considered byproducts of nitration reaction, formed 
due to elimination of nitro (NO2) moiety from cis NO2-FA, which decay and originates the 
trans double bond [89, 90]. The huge diversity of products is increased also due to the 
possibility of NO2-FA to undergo β-oxidation, saturation and desaturation [78, 91].  
 The formation of nitrated and/or nitroxidized derivatives of unsaturated fatty acids is 
dependent of the concentration of reactive species (RNS and ROS), of the target species, 
secondary target molecules (scavengers, transition metals and thiols) and oxygen, pH, and 
of the partition between hydrophilic and hydrophobic environment in cellular 
compartments [15]. In membrane hydrophobic environments (and organic solvents in 
model systems), where RNS are soluble and can accumulate thus reaching higher 
concentrations, the lipid nitration products prevail. Otherwise, in aqueous milieu, where 
ROS prevail, the lipid peroxidation products predominate.  
Different pathways have been considered to explain the mechanism of fatty acid 
nitration and nitroxidation (Figure I.4). Formation of NO2-FA can occur through free-
radical-induced nitration mediated by NO2
● [80, 86].  Nitration mediated by NO2
● involves 
a homolytic attack to the double bond of unsaturated fatty acids (or lipid radicals 
previously formed) yielding a β-nitro-alkyl radical (Figure I.4, step 1) that, at low oxygen 
concentrations, reacts with other molecule of NO2
●
 to form nitro-nitrite or dinitro 
intermediates (Figure I.4, step 2). The loss of nitrous acid (HNO2) from this intermediate 
leads to the formation of nitroalkenes (vinyl nitro) derivatives (Figure I.4, step 3), while its 
hydrolysis yields nitro-alcohol (nitrohydroxy) derivatives (Figure I.4, step 4). An 
alternative pathway may involve the abstraction of hydrogen atom from the bis-allylic 
carbon of β-nitro-alkyl radical by other NO2● leading to the formation of nitro-allyl 
derivatives in which both the position and the configuration of the double bond is changed 
(Figure I.4, step 5). Nitration by a free radical mechanism might suggest that all the double 
bonds would be susceptible to nitration, with additional double bond rearrangement and 
conjugation.  Nitroalkene formation can also be achieved by nucleophilic reactions such as 
the electrophilic addition of nitronium cation (NO2
+) at the double bond (Figure I.4, step 6) 
[58, 78, 92]. In this case, no rearrangement of double bond was observed [58]. According 
to the mechanism of nitration and depending on the RNS involved, different species can be 
formed. Addition reactions leads to formation of electrophilic products (also called 
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conjugated nitroalkenes, α,β-unsaturated nitroalkenes or vinyl nitro groups) while the 
hydrogen abstraction leads to non-electrophilic products (non-conjugated nitroalkenes, 
allylic nitro groups, nitroalkane alkene).  
It is important to refer that NO2
● can mediate oxidation, nitration, nitrosation and/or 
nitroxidation of unsaturated fatty acids. The yields of each process depends on the O2 
levels, because at low oxygen concentrations the formation of nitro derivatives will be 
favored, while under aerobic conditions lipid oxidation processes will predominate 
yielding hydroperoxides or trans-isomerized lipids derivatives [86, 88, 92]. At high O2 
concentrations, NO2
●
 can generate a lipid carbon-centered radical (Figure I.4, step 7), 
which can react with O2 to form lipid hydroperoxydes (Figure I.4, step 8), or can also 
produce β-nitro-alkyl radical (Figure I.4, step 9), which may lose HNO2 and regenerate the 
unsaturated fatty acid, with formation of a trans configuration of the double bond (Figure 
I.4, step 10). Generation of trans isomers is a process that is usually mediated by NO2
● [88]  
and peroxynitrite [90]. The β-nitro-alkyl radical can react with O2 to form β-nitro-peroxyl 
radical whose rearrangement leads to the generation of nitrohydroxy derivatives after 
reduction; nitro-keto derivatives after loss of water; nitro-epoxy derivatives after 
deoxydation; nitroalkene (vinyl nitro) derivatives after elimination of O2. Rotation around 
the C-C bond and elimination of O2 and NO2
● from β-nitro-peroxyl radical generated the 
trans derivative due to the isomerization of the double bond [88].  
NO2
●, as well as NO●, can react with lipid radicals derived from peroxidation of 
unsaturated fatty acids such as lipid peroxyl radicals in hydrophobic milieu of membranes 
to terminate the radical chain propagation reactions. This can also lead to the formation of 
nitrated and nitroxidized products [33].  
An additional biologically relevant mechanism for lipid nitroxidative modifications 
can arise from ONOO--derived reactions which may involve both radical (NO2
●) and 
electrophilic (NO2
+) species as described above [73] or by ONOO- direct attack to the 
olefinic group of unsaturated fatty acids [93]. 
A diversity of nitrated and nitroxidized derivatives can be generated by reaction of 
unsaturated fatty acids and RNS. The formation of these new products has been associated 
with several biological activities as we will describe in the following section. 
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Figure I.4. Mechanism proposed for the formation of nitro-fatty acids (adapted from [73]). 
 
I.3. Biological Properties of Nitrated Fatty Acids 
 
Nitro-fatty acids have been recognized, in the last decade, as new signaling molecules 
being key mediators in physiological and pathophysiological processes [11, 13, 94]. The 
concentrations of NO2-FA in biological samples range from the micromolar [11] to the 
picomolar range [69]. In spite of being present in very low concentrations, they have been 
reported to be high enough to mediate their potent biological signaling actions. Moreover, 
the levels of NO2-FAs are increased under some metabolic and inflammatory situations 
CHAPTER I. INTRODUCTION 
 
15 
[71, 76, 77, 95]. Contrary to the initially believed, evidence is emerging that NO2-FA play 
important biological role as anti-inflammatory [11, 13, 15, 70, 78, 91, 94, 96-108], anti-
hypertensive agents [8, 65, 66, 73, 96, 97, 109, 110], and as inhibitors of platelet 
aggregation – anti-thrombotic properties [8, 111], rather than having pro-inflammatory 
potential. Their pleiotropic activities includes the modulation of platelet and macrophage 
activation [10, 99], inhibition of pro-inflammatory cytokine secretion [13, 94], prevention 
of leukocyte and platelet activation [99, 111], promotion of blood vessel relaxation, acting 
as mediators in NO● signaling pathways [65, 109] and metabolism, among others. This 
complex array of signaling actions are mediated through different interdependent 
mechanisms including a) NO2-FA decay reactions and transduction of NO
● signaling 
actions [7, 112], b) electrophilic reactions with cellular nucleophiles, namely proteins, 
inducing post-translational modifications in their structure, function, and localization 
(subcellular distribution) [18]; c) receptor-dependent mediated signaling roles. 
NO2-FAs can spontaneously decay to generate NO
● in aqueous environments acting as 
NO● donors [109, 112, 113] and transducing the cell signaling actions usually mediate by 
NO●. This can explain the ability of NO2-FA to mediate cyclic guanosine monophosphate 
(cGMP)-dependent cell signaling responses [112]. In this way, NO2-FAs are both products 
of oxidative reactions between unsaturated fatty acids and NO● and NO●-derived species, 
and mediators of signaling reactions [6, 99, 111] representing the convergence of lipid and 
NO● signaling actions. One of the biological actions associated to NO● is the ability to 
inhibit lipid peroxidation processes [33, 37] hindering the propagation reactions by chain 
breaking activity [33, 114]. NO● released by nitroalkenes was thought to play an 
antioxidant and protective role on lipid oxidation in membranes and lipoproteins. Besides, 
the capacity to release NO● has been also related to the vasorelaxation properties of NO2-
FA. NO2-AA and nitroxydroxy-AA ((NO2)O-AA) were described to have the ability to 
release NO● and induce cGMP-dependent vasorelaxation in rat aortic ring in an 
endothelium-independent manner [8, 10, 65]. Also, NO2-LA, conjugated nitro linoleic acid 
(NO2-cLA) and (NO2)O-LA promoted vessel relaxation via cGMP-dependent and 
endothelial-independent manner in preconstricted rat aortic rings [97, 109]. However, the 
exact mechanism by which NO2-FAs can decay to release NO
● is controversial and 
remains unknown. Nevertheless, it is known that NO● decay from NO2-FA is regulated via 
hydrophobic reactions, since their organization in micelles and liposomes or incorporation 
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into lipoproteins and lipid membranes protects and stabilizes NO2-FA, thus inhibiting NO
● 
release within the lipophilic milieus [112]. This suggests that NO2-FAs are 
hydrophobically-stabilized NO● reservoirs [112]. In fact, NO2-FA decay has been reported 
to be faster in phosphate buffer, and probably in cytoplasm of cells, than in hydrophobic 
organic solvent [11, 109, 112]. In this way, NO● is most probably released from NO2-FAs 
that are free in the circulation. In spite of the ability of NO2-FA to release NO
● has been 
demonstrated, only low yields of NO● have been detected under aqueous conditions, thus 
NO2-FAs signaling actions and antioxidant effects via NO
● release mechanism are 
considered to be of minor significance in vivo [10, 96, 109, 112, 115], at the endogenous 
concentrations.  
Nitro-fatty acids were detected in human plasma, urine and tissues and in rodent 
models as free, esterified and as reversible nucleophilic-adducted species [71]. In fact, the 
predominant molecular mechanism associated to NO2-FA biological signaling actions is 
based on their electrophilic nature. NO2-FAs interact with key target proteins inducing 
post-translational modifications that alter protein function and modulate the patterns of 
gene expression programs, enzymatic activities, metabolic and inflammatory responses, 
and signaling network activities. The olefinic nitro group added to the double bond of the 
hydrocarbon chain leads to an alkenyl nitro-configuration that makes NO2-FA powerful 
electrophilic species. The conjugation of a strongest electron-withdrawing NO2 group with 
a carbon-carbon double bond of an alkene makes the β-carbon adjacent to the NO2 group 
electron poor and with potential reactivity. The highly electrophilic properties of the 
nitroalkene β-carbon leads to post-translational modification of proteins because enable the 
occurrence of Michael addition reactions with nucleophiles groups of amino acids, such as 
deprotonated thiolate anions of cysteine (S-nitroalkylation) and imidazole moiety of 
histidine, in proteins via kinetically rapid and reversible cross linking adduction (Figure 
I.5) [12, 17, 18, 84, 94, 116]. These post-translational protein modifications can cause 
modulation of protein structure, function and (subcellular) distribution. Addition of a fatty 
acid moiety to protein can significantly influence their catalytic activity and 
hydrophobicity, and represent a new pathway for redox regulation of enzyme function, cell 
signaling, and protein trafficking [14, 18, 91]. NO2FA-protein covalent adducts are 
reversible since β-mercaptoethanol (BME) is able to displace NO2-FA [91, 117]. Hence, 
NO2-FA can mediate signaling actions via covalent, reversible post-translational 
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modifications of target proteins. The reversible nature of these adducts seems to be related 
with a lack of toxicity [118], because irreversible post-translational modifications usually 
leads to protein damage and permanent loss of function, and raises the possibility of 
regulation. This reversible cross-linking adduction also inhibits NO2-FA decay and NO
● 
release, thus manifesting signaling actions via cGMP-independent mechanisms [18]. The 
electrophilic nature of NO2-FA is also related with the occurrence of nitrohydroxy 
derivatives [11, 94] which suggests the addition of hydroxide anion present in aqueous 
medium at physiological pH onto the double bond. 
Examples of molecular targets for NO2-FA electrophilic reactivity include small 
molecules as glutathione (GSH) [17, 18] to large regulatory proteins including 
transcription factors and enzymes. NO2-FA were described to covalently bind to cysteine 
38 (Cys38) of p65 subunit of nuclear factor κB (NF-κB) leading to inhibition of its 
activation controlling the pro-inflammatory process [13, 76]. Nitroalkylation of p65-Cys38 
inhibits NF-κB activation and translocation to the nucleus inhibiting the DNA-binding 
activity and repression of NF-κB-dependent target pro-inflammatory gene expression 
leading to inhibition of secretion of pro-inflammatory cytokines (e.g., IL-6, TNF-α, and 
MCP-1) [13, 108]. NO2-FAs are also irreversible inhibitors of xanthine oxidoreductase 
activity [117]. NO2-FA stimulates the expression of heme oxygenase-1 (HO-1) leading to 
activation of endogenous cytoprotective pathway exerting antioxidant and anti-
inflammatory actions [70, 98, 104, 105, 107, 119]. NO2-FA induces mitogen-activated 
protein kinase (MAPK) phosphatase 1 (MPK-1) expression and activity leading to the 
inactivation and suppression of pro-inflammatory signal transducer and activator of 
transcription (STAT-1) [108] thus having an anti-atherosclerotic effects [120]. MKP-1 
limits pro-inflammatory STAT-1 activity by reducing its phosphorylation. NO2-FA 
interacts with Cys273 and Cys288 in Kelch-like ECH-associated protein 1 (Keap1) [105, 
107, 121, 122]. Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a transcription factor 
that is in its inactive form in cytoplasm due to being binding to Keap1. Activation of Nrf2 
by nitroalkylation of Keap 1 leads to its migration to  the nucleus where it binds to 
antioxidant-response element (ARE) in DNA activating gene expression, namely 
expression of antioxidant and phase II detoxifying enzymes. NO2-FA are also involved in 
the modulation of peroxidase inhibitor of prostaglandin endoperoxide H synthases 1 and 2 
(PGHS)-dependent gene expression [73, 123, 124]. NO2-FA decreases the formation of 
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NO● and inhibits the secretion of pro-inflammatory cytokines  (IL-1β and TNF-α) during 
inflammatory processes, by inhibiting iNOS expression at transcriptional level rather than 
acting on iNOS activity or release of nitric oxide after decay, [10, 13, 71, 107]. NO2-FA 
increased the expression of vascular eNOS [98, 125] limiting vasoconstriction and 
inflammatory cell margination and alleviated vascular injury. NO2-FA covalently binds to 
Angiotensin II (Ang-II) type I receptor (AT1-R) without inhibiting the binding of Ang-II to 
the receptor [96] leading to reduction of blood pressure and vasoconstriction induced by 
Ang II, and reduction of inositol-1,4,5-trisphosphate and calcium mobilization because 
inhibition of AT1-R by NO2-FA uncouples downstream effects of G-protein signaling. The 
human alpha-Synuclein (histidine (His) 50) [126], metalloproteinases (Cys70 for proMMP-
7 and Cys100 for proMMP-9) [127], glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH; Cys 149, Cys153, Cys244, His108, His134, His327) [17, 18] and transient 
receptor potential (TRP) channels [128-131] are also targets of NO2-FAs. 
NO2-FA can display their biological signaling roles by receptor-dependent signaling 
actions and peroxisome proliferator-activated receptor (PPAR) family is one of the main 
targets, and particularly peroxisome proliferator-activated receptor gamma (PPARγ). 
PPARγ regulates glucose uptake and homeostasis, lipid metabolism and homeostasis, 
vascular tone, adipocyte differentiation, and inflammatory signaling being associated with 
anti-inflammatory actions such as modulation of the expression of several pro-
inflammatory cytokines and chemokines. NO2-FAs are potent endogenous ligands and 
activators of PPARγ [11, 13, 15, 94, 100, 107, 132-134] via hydrogen bonding interactions 
and covalent adduction to the Cys285 in the ligand binding domain [132].  
Through these mechanisms, NO2-FA potently control the expression and activity of 
key proteins regulating inflammation [13], metabolism [18, 117], cell proliferation, and 
cell differentiation [11, 94]. They modulate metabolic and inflammatory signaling 
pathways by promoting or inhibiting the expression and/or activity of both anti-
inflammatory and pro-inflammatory proteins, heat shock and phase II antioxidant 
responses. In fact, murine and cell models showed that NO2-FA limit pathologies linked to 
diabetes, metabolic syndrome and obesity [133, 135], ischemic episodes (cardiac and renal 
ischemia/reperfusion injury or ischemic-preconditioned hearts) [76, 77, 101, 136-138], 
cardiovascular disease [96, 99, 104, 111, 120, 123, 139, 140], bacterial LPS [71, 102, 139], 
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renal inflammation and kidney failure [136, 141-145], pulmonary inflammation [98, 102, 
146, 147], chronic inflammatory disorders [100], and neurodegenerative diseases [148].  
 
 
Figure I.5. Electrophilic addition of NO2-FA to a protein/peptide. Michael addition 
between the nitro-oleic acid (the C9 isomer) to a cysteine residue of a protein with 
formation of a nitro-fatty acid-protein adduct. 
 
The formation of NO2-FA is not likely to be isomer specific and a mixture of different 
positional isomers can be randomly produced in biological system. However, some of the 
biological actions of NO2-FA seem to be specific for a particular isomer. Michael addition 
reactions between NO2-FA and peptide/protein seem to be remarkably selective and 
dependent on the nature and structural features of the electrophilic NO2-FA. In fact, there 
is a high level of specificity regarding the structure of NO2-FA with respect to its ability to 
modify proteins. NO2-FA does not act randomly and only specific residues in proteins 
were identified as target sites for adduction. The position of the electrophilic carbon in 
relation to the target nucleophile is known to have a critical effect on the net reactivity and 
extent of formation of lipid-protein adducts [18, 100, 105, 117]. NO2-LA has four possible 
isomers with different positions for the addition of the nitro group, namely in C9, C10, C12 
and C13. The C9 isomer has been reported to be relatively unstable and rapidly degraded. 
The C10 and C12 are the species mostly frequently reported. In fact, the NO2-LA C10 and 
C12 isomers were identified to selectively bind to PPARγ for its activation [132]. The 
major mechanism accounting for activation of PPARγ is the covalent adduction of NO2-FA 
to Cys285 in the ligand binding domain. However, hydrogen bonds between C10 and C12 
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isomers and arginine (Arg) 288 and glutamate (glu) 343, respectively, have been suggested 
for selective and stable activation of PPARγ by NO2-LA binding. Phenylalanine (Phe) 287 
has also important roles for selective and stable activation of PPARγ by NO2-LA [94, 132]. 
For NO2-OA, the C10 isomer is more reactive toward to Cys285 in the ligand binding 
domain of PPARγ than the C9 isomer [133] while Keap1 is activated more readily by the 
C9 isomer via nitroalkylation of Cys273 and Cys288 [105, 122]. Xanthine oxidoreductase 
activity is preferentially inhibited by C9 isomer of NO2-OA or a mixture of both C9 and 
C10 isomers [117]. Prostaglandin endoperoxide H synthases 1 and 2 activity and 
expression are only inhibited by NO2-AA [123]. 
The associated covalent and reversible post-translational modifications that regulate 
protein structure, function and distribution may represent a new process in the redox- and 
NO●-dependent signaling in the resolution of inflammation and other associated 
complications.  
Another important key point is that nitroxidation, nitration and/or nitrosation of fatty 
acids may occur when they are esterified in phospholipids. However, the signaling actions 
of NO2-FA have been only reported for the free forms. This suggests that membrane 
phospholipid-esterified NO2-FA need to be hydrolyzed and mobilized by esterases and 
phospholipase A2 in order to mediate their actions [88, 112]. However, it is important to 
keep in mind that NO2-FA esterified to phospholipid can also be formed and that can have 
different as well as key signaling actions that needs to be exploited in order to have a better 
knowledge of their signaling actions. So, future work is needed to identify and understand 
the chemical modifications induced by nitroxidative or nitrative and/or nitrosative stress to 
PLs and their biological roles such as their reactivity with key proteins and peptides, and 
the structural details and roles of the new adducts formed. Furthermore, the development 
of experimental approaches based on mass spectrometry (MS) and tandem mass 
spectrometry (MS/MS) strategies for the knowledge of the structural details and 
fragmentation patterns of NO2-PL or other nitroxidative derivatives of PL will be crucial 
for their identification and characterization in biological systems and to unveil their 
biological roles as lipid signaling molecules in immune/inflammatory responses.  
In the following section, we will describe the data published concerning the analysis of 
RNS-induced modifications in lipids, with focus on the identification and characterization 
of structural modifications in NO2-FA using MS-based approaches. 
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I.4. Methodologies used for Identification and Characterization of Nitrated Fatty 
Acids 
Mass spectrometry (MS) has been one of the mostly used analytical tool for the analysis 
of nitrated/nitroxidized derivatives of lipids in in vitro studies [112], to understand their 
reactivity, and also for their detection and quantification in biological samples and plants 
[23]. This analytical tool has high sensitivity, specificity and selectivity which allow to 
deal with the complexity and diversity of these products. 
MS can be used alone or coupled with liquid chromatography (LC). Retention times 
for analyte separation and elution are based on the distribution and interaction of the 
components of a mixture with the mobile and stationary phases. Separation of analytes is 
achieved through adsorption of the analyte to the stationary phase due to the different 
affinity of the analytes for the mobile and stationary phases. In normal-phase, the non-
polar (hydrophobic) components have more affinity to non-polar mobile phase and elute 
earlier than the polar components, which have higher affinity to the polar stationary phase 
and are more strongly retained. The retention time increases as the polarity of the mobile 
phase decreases. In reversed-phase occurs the partition of the hydrophobic components in a 
hydrophobic stationary phase while the mobile phase consists of polar solvents. Normal 
phase effectively separates PLs on the basis of class (polar head group) while reversed-
phase separates PLs on the basis of their fatty acids residues. Hydrophilic interaction liquid 
chromatography (HILIC) is a variant of normal phase liquid chromatography. The 
stationary phase is polar like in normal-phase but the mobile phase has also a lower 
amount of water being more similar to the ones used in reversed-phase, but HILIC allows 
separation of lipids based on their polar head structure. Sample components interact with 
the water-rich layer that is formed in the surface of the polar stationary phase [149]. The 
coupling of liquid chromatographic separation technique with MS either online or offline 
can be advantageous in the analysis of complex mixtures, and also provides the separation 
of isomers, i.e. compounds having the same elemental composition, but with different 
structures, and thus not differentiable by direct MS. Additionally, LC-MS approaches 
avoids signal suppression effect caused by the different ionization efficiencies of the 
analytes present in samples. This effect is extremely important concerning the complex 
biological matrices like plasma, urine, and tissue, where nitrated/nitroxidized derivatives of 
lipids are present in low amount.  
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MS, usually coupled to LC, has been used with success for the identification and 
quantification of lipids and to elucidate their interaction with cell metabolism and function 
in biological systems, considering the aims of a lipidomic approach [150, 151]. It has also 
been used to identify chemical modifications of lipids and to pinpoint specific 
fragmentations to develop lipidomics targets analysis for the detection of modified lipids. 
Lipidomics approaches helps in the study of lipid profiles, their alterations in response to 
different stimulus or situations, and their function in biological systems. Typical study of 
lipids from biological samples using lipidomics approaches involve several steps starting 
with lipid extraction from tissues, cells, fluids, and analysis of lipid extracts through MS 
with or without prior chromatographic separation to obtain the lipid profile. This strategy 
has also been used for detection, quantification and characterization of nitroalkene and 
nitroxydroxy derivatives of fatty acids both in biological samples and in in vitro 
biomimetic model systems [5, 7, 9, 11, 23, 65, 75, 81, 91, 119]. 
Analysis of NO2-FA by MS or LC-MS is based on the identification of the mass shifts 
of the products in comparison with the non-modified fatty acids and has been done mostly 
using the electrospray ionization (ESI) technique. Under ESI-MS conditions, NO2-FA are 
usually analyzed in negative-ion mode as deprotonated [M-H]- ions. However, NO2-FA 
can also be identified in positive-ion mode as protonated ions ([M+H]+) [65], and as 
lithium ([M+Li]+) [10], ammonium ([M+NH4]
+) [75, 152] or sodium ([M+Na]+) [75] 
adducts that helps in the fragmentation studies. Reversed-phase LC-MS has been applied 
for analysis of NO2-FA and nitroxidized derivatives since their polarity is changed due to 
the presence of the NO2 group and also oxygen atoms in the case of nitroxidized species. 
Besides, acidic solvents allow a better chromatographic resolution and isomers separation. 
Acetonitrile and formic acid have been used and provided good separation of NO2-FA 
under reversed-phase LC-MS [153]. 
With only one MS analysis and identification of molecular ions, we can acquire 
information on a wide variety of modified products, with different structural features, 
gathered by the reaction of RNS with lipids, namely fatty acids. Accurate mass 
measurements achieved in high resolution mass spectrometry (HRMS), made the 
assignment of elemental composition for the identified ions possible, allowing the 
confirmation of the molecular formula of the lipid species. However, the confirmation of 
the structural details for the species identified by MS analysis can be obtained by tandem 
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mass spectrometry (MS/MS). Several authors reported the typical fragmentation pathways 
of each nitrated/nitroxidized FA by tandem mass spectrometry, because distinct products 
are expected to have different fragmentation pathways. Under MS/MS conditions, tandem 
mass spectrum of NO2-FAs acquired both in positive- and negative-mode, shows several 
product ions that allows the structural characterization of these products [5, 7, 10, 59, 83]. 
The typical fragmentation pattern of NO2-FA includes the neutral loss HNO2 (loss of 47 u) 
which is observed in tandem mass spectra acquired in both ionization modes. The presence 
of product ions of the charged NO2
- (m/z 46) can be also observed in negative-ion mode 
[153]. Additionally, MS/MS data of NO2-FA also shows fragment ions that allow to 
pinpoint the position of the NO2 group on the backbone of the lipid (Table I.2) [153]. 
Cyclization followed by heterolytic carbon chain fragmentation, which generates almost 
exclusively moieties containing an aldehyde and a nitrosamine, allows the correct 
identification of positional isomers [83]. Multiply nitrated products, such as dinitro fatty 
acids, displayed multiple losses of HNO2 molecules [5]. For the polyunsaturated NO2-FA, 
such as NO2-LA and NO2-AA, which have a bis-allylic interrupted diene and an additional 
double bond one or two carbons away from the NO2 moiety already linked to the carbon 
chain, in addition to the previous fragments, were also observed products ions derived 
from cyclization reactions that facilitate the formation of 5- or 6-atom heterocycles [83]. 
Fragmentation pattern obtained after collision-induced dissociation (CID)-MS/MS induced 
fragmentation of (NO2)O-FA allows to identify the specific position of NO2 and hydroxyl 
groups [11]. These well-defined fragmentation pathways are very helpful for structural 
characterization of new and unidentified products, for confirmation of the already 
established products and allow the precise placement of double bonds and sites of nitration, 
predicting the NO2 position. This reporter fragmentation can be used to search these 
modified lipids in biological samples using untargeted and target analysis. 
There are several scan experiments useful for target analyses, which are possible by 
using MS/MS. In product ion scanning (PIS), the most common MS/MS experiment, a 
precursor ion with a specific m/z is selected and isolated in the first mass analyzer; its 
dissociation is induced in collision cell and then all the resulting masses (product ions) are 
separated in terms of m/z values and scanned in the second mass analyzer, reporting the 
fragments of a precursor ion. It allows to identify the fragmentation pattern of different 
nitrated or nitroxidized FA, providing information of their specific fragmentations that can 
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be further used to perform MS-based target analysis. In multiple reaction monitoring 
(MRM) scan mode the precursor ion is selected in the first analyzer, fragmented and the 
second analyzer instead of obtaining a full MS/MS scan with all possible fragments 
derived from the precursor, only a sequence-specific fragment ion is analyzed. MRM is 
applied for MS-based target analysis for scanning of specific transitions allowing to 
perform target detection and quantification of a particular nitrated or nitroxidized FA.  
Therefore, analysis of NO2-FA can be performed by MS alone or coupled to LC, or 
with MRM scan mode for target analysis. MS/MS analysis in negative ion-mode, without 
LC separation or MRM scan mode, was used for direct characterization of NO2-LA 
derivative, synthetized in vitro, based on the presence of fragments formed due to the 
typical neutral loss of HNO2 [84]. RP-LC-MS/MS was also applied for the identification of 
cLA nitrated products generated after in vitro nitration with NO2
- under acidic conditions. 
Based on specific fragmentation, authors confirmed that only C9 and C12 isomers were 
generated [72]. This methodology was also applied in the identification and 
characterization of in vitro synthetized NO2-LA [97].  
RP-LC-MS and MS/MS analysis using MRM scan mode using specific transitions, 
namely the neutral loss of HNO2 (47 u), has been widely used for identification, 
separation, characterization and quantification of nitrated and nitroxidized derivatives of 
unsaturated FAs. Through this RP-LC-MS-based approaches, nitrated and nitroxidized 
fatty acids were already identified and characterized in in vitro biomimetic models [5, 7, 9, 
10, 71, 75, 81, 88] to be applied in their identification in biological samples such as plasma 
samples of healthy and hypercholesterolemic patients (NO2-LA and (NO2)O-LA) [9], in 
human red cells (positional isomers 10-NO2-LA and 12-NO2-LA) [7] and plasma 
(positional isomers 10-NO2-LA and 12-NO2-LA; 9-NO2-OA and 10-NO2-OA) [7, 69]; in 
plasma, red blood cells and urine of healthy humans (9-NO2-OA and 10-NO2-OA, 
nitroalkene derivatives of linoleic, linolenic, palmitic and arachidonic acids, and several 
nitrohydroxy fatty acids, namely 9-(NO2)O-OA, 10-(NO2)O-OA, 10-(NO2)O-LA) [11]; in 
human plasma and lipoproteins, urine and tissues (NO2-cLA) [75, 81]; from colon samples 
and plasma of mice with dextran sulfate sodium (DSS)-induced colitis (NO2-OA and 
(NO2)O-OA) [100]; in rat primary cardiomyocytes (NO2)2-OA, NO2-AA, NO2-Dha, 
(NO2)2-Dha, (NO2)O-Dha) [5]; in endothelial cells (NO2-OA) [98]; in activated 
macrophages (NO2-cLA) [71]; in rat serum and lung tissue [119]. 
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Table I.2. Main specific fragments ions identified in the MS/MS spectra of NO2-FA 
that can be used for pinpoint the position of the NO2 group on hydrocarbon backbone of 
the NO2-FA. 
 
m/z Ionization mode Isomer Specific fragment Reference 
m/z 310 [M-H]- 
9-NO-OA 
m/z 168 (C9H14NO2
-) 
m/z 182 (C10H16NO2
-) 
[5] 
10-NO-OA 
m/z 157 (C8H13O3
-) 
m/z 171 (C9H15O3
-) 
m/z 324 [M-H]- 
9-NO2-LA 
m/z 168 (C9H14NO2
-) 
m/z 210 (C11H16NO3
-) 
m/z 224 (C12H18NO3
-) 
[5] 
[83] 
10-NO2-LA 
m/z 182 (C10H16NO2
-) 
m/z 224 (C12H18NO3
-) 
m/z 238 (C13H20NO3
-) 
[5] 
[83] 
m/z 168 and 228 [7] 
12-NO2-LA 
 
m/z 157 (C8H13O3
-) 
m/z 171 (C9H15O3
-) 
m/z 195 (C11H15O3
-) 
m/z 213 (C11H17O4
-) 
[5] 
[83] 
m/z 196 and 157 [7] 
13-NO2-LA 
m/z 171 (C9H15O3
-) 
m/z 185 (C10H17O3
-) 
m/z 209 (C12H17O3
-) 
m/z 227 (C12H19O4
-) 
[5] 
[83] 
m/z 326 [M-H]- 
9-NO2-OA 
m/z 157 (C8H13O3
-) 
m/z 168 (C9H14NO2
-) 
[5] 
[69] 
[83] 10-NO2-OA 
m/z 169 (C9H12O3
-) 
m/z 198 (C10H16NO2
-) 
m/z 340 [M-H]- 
10,9-(NO2)O-LNA m/z 171 (C9H15O3
-) 
[11] 
9,10-(NO2)O-LNA m/z 202 (C9H16NO4
-) 
13,12-(NO2)O-LNA m/z 211 (C12H19O3
-) 
12,13-(NO2)O-LNA m/z 242 (C12H20NO4
-) 
15,14-(NO2)O-LNA m/z 251 (C15H23O3
-) 
m/z 342* [M-H]- 10,9-(NO2)O-LA m/z 171 (C9H15O3
-) 
m/z 342 [M-H]- 
9-oxo-10-NO2-OA m/z 169 [88] 
10-oxo-9-NO2-OA m/z 202 [88] 
m/z 342 [M-H]- 
9,10-(NO2)O-OA m/z 202 (C9H16NO4
-) 
[5] 
10,9-(NO2)O-OA 
m/z 157 (C8H13O3
-) 
m/z 171 (C9H15O3
-) 
m/z 344* [M-H]- 
9,10-(NO2)O-OA m/z 202 (C9H16NO4
-) 
[88] 
[11] 
10,9-(NO2)O-OA m/z 171 (C9H15O3
-) 
[88] 
[11] 
*
with saturation of the double bond 
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Table I.2. Main specific fragments ions identified in the MS/MS spectra of NO2-FA 
that can be used for pinpoint the position of the NO2 group on hydrocarbon backbone of 
the NO2-FA (continuation). 
 
 
 
 
m/z Ionization mode Isomer Specific fragment Reference 
m/z 
371 
[M-H]- (NO2)2-OA 
m/z 171 (C9H15O3
-) 
m/z 202 (C9H16NO4
-) 
m/z 214 (C10H16NO4
-) 
[5] 
m/z 
356 
 [M+Li]+ 
5-NO2-AA m/z 136 
[10] 
6-NO2-AA m/z 123 
8-NO2-AA m/z 176 
9-NO2-AA 
m/z 163 
m/z 119 (C6H8O2Li
+) [5] 
11-NO2-AA 
m/z 216  
m/z 133 (C8H10O2Li
+) 
m/z 147 (C8H10O2Li
+) 
m/z 149 (C7H10O3Li
+) 
m/z 163 (C8H12O3Li
+) 
[5] 
12-NO2-AA 
m/z 203  [10] 
m/z 147 (C8H10O2Li
+) 
m/z 159 (C9H12O2Li
+) 
m/z 163 (C8H12O3Li
+) 
m/z 175 (C9H12O3Li
+) 
m/z 201 (C11H14O3Li
+) 
[5] 
14-NO2-AA 
m/z 256 [10] 
m/z 173 (C10H14O2Li
+) 
m/z 187 (C11H14O2Li
+) 
[5] 
15-NO2-AA 
m/z 243 [10] 
m/z 187 (C11H14O2Li
+) 
m/z 199 (C12H16O2Li
+) 
 m/z 215 (C12H16O3Li
+) 
m/z 241 (C14H18O3Li
+) 
[5] 
m/z 
366 
[M-H]- 
5,6-(NO2)O-AA m/z 146 (C5H8NO4
-) 
[65] 
6,5-(NO2)O-AA m/z 115 (C5H7O3
-) 
8,9-(NO2)O-AA m/z 186 (C8H12NO4
-) 
9,8-(NO2)O-AA m/z 155 (C8H11O3
-) 
11,12-(NO2)O-AA m/z 226 (C11H16NO4
-) 
12,11-(NO2)O-AA m/z 195 (C11H15O3
-) 
14,15-(NO2)O-AA m/z 266 (C14H20NO4
-) 
15,14-(NO2)O-AA m/z 235 (C14H19O3
-) 
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Table I.2. Main specific fragments ions identified in the MS/MS spectra of NO2-FA 
that can be used for pinpoint the position of the NO2 group on hydrocarbon backbone of 
the NO2-FA (continuation). 
 
 
Target tandem mass spectrometry analysis using MRM scan in positive ion-mode 
([M+H]+ ions), but without LC separation, was used for identification and characterization 
of 6-methyl-NO2-AA allowing to pinpoint the NO2 group to be linked in C6 instead of the 
usual C9, C12, C14 or C15 carbons of fatty acid [65]. RP-LC-MS/MS using MRM scan 
mode also allowed to study the nature and metabolism of NO2-FA in plasma and liver of 
mice after intravenous injection of NO2-OA, and allowed the identification of metabolites 
of β-oxidation, saturation or desaturation of the double bond of NO2-OA [91]. Through this 
advanced analytical approach it was also possible to detect the endogenous presence of 
NO2-FA, namely NO2-cLA, in plants specially in olives and EVOO, and the formation of 
different isomers of NO2-OA (9- and 10-NO2-OA), NO2-LA (9-, 12- and 13-NO2-LA) and 
NO2-cLA (8-, 9-, 11- and 12-NO2-cLA) from EVOO under in vitro conditions that mimic 
gastric pH and NO2
- concentrations during digestion [23]. 
Mass spectrometry coupled to LC has also been used for identification and 
characterization of reversible post-translational modifications of peptides and proteins by 
NO2-FA. LC-ESI-MS and MS/MS was used to detect lipid-protein adducts formed 
m/z Ionization mode Isomer Specific fragment Reference 
m/z 380 [M+Li]+ 
10-NO2-Dha 
m/z 135 (C6H8O3Li
+) 
m/z 149 (C7H10O3Li
+) 
[5] 
11-NO2-Dha 
m/z 149 (C7H10O3Li
+)  
m/z 161 (C8H10O3Li
+) 
13-NO2-Dha 
m/z 175 (C9H12O3Li
+) 
m/z 189 (C10H14O3Li
+) 
14-NO2-Dha 
m/z 189 (C10H14O3Li
+) 
m/z 201 (C11H14O3Li
+) 
16-NO2-Dha 
m/z 215 (C12H16O3Li
+) 
m/z 229 (C13H18O3Li
+) 
17-NO2-Dha 
m/z 229 (C13H18O3Li
+) 
 m/z 241 (C14H18O3Li
+) 
19-NO2-Dha 
m/z 255 (C15H20O3Li
+) 
m/z 269 (C16H22O3Li
+) 
20-NO2-Dha 
m/z 269 (C16H22O3Li
+) 
m/z 281 (C17H22O3Li
+) 
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between NO2-OA and NO2-LA and with proteins and GSH in vivo in human red cells [18]. 
This methodology was also applied to confirm the post-translational modifications of 
matrix metalloproteinase by NO2-OA [127], and identification of reversible Michael 
adducts of NO2-OA and thiols of proteins and GSH in liver and plasma of NO2-OA-treated 
mice, which were further confirmed by exchanged of NO2-OA from proteins to the added 
BME [91]. LC-MS/MS allowed to define the specific sites of adduction since the typical 
fragmentation of NO2-FAs were distinctive, demonstrating the usefulness of the 
assignment of the fragmentation fingerprints that are fundamental for detecting species in 
biological environments [127]. Significant levels of protein cysteine adducts of NO2-OA 
were also observed in fresh olives, especially in the peel [23]. AT1-R adducts with NO2-
OA were quantified by HPLC-MS/MS using MRM scan mode in negative-ion mode as 
BME adducts (BME-NO2-OA adducts) after nucleophilic exchange of NO2-OA from AT1-
R to BME. The presence of exchangeable NO2-OA demonstrated the direct adduction of 
AT1-R by NO2-OA and therefore that AT1-R is a relevant cellular target for NO2-OA 
alkylation [96]. RP-LC-MRM scan in positive-ion mode ([M+H]+ ions) was applied for the 
characterization of NO2-LA-GSH adducts in vitro and their further identification in MCF7 
cells treated with NO2-LA [84]. 
One study also reported the direct analysis by MS and MS/MS, in positive-ion mode, 
of adenine nucleotide translocase 1 (ATN 1) adducts after NO2-LA infusion into intact 
perfused heats allowing to pinpoint that the nitroalkylation of ANT1 by NO2-LA occurred 
on Cys57 [138]. 
The effects of RNS in biological systems,  namely lipid nitration, are reported to occur 
mainly in the hydrophobic environment of biological membranes [59] where phospholipids 
are predominant lipids, rather than free fatty acids, and thus expected to be key target for 
lipid nitration. The possibility of RNS to modified phospholipid-esterified fatty acids is 
very plausible but is still not explored and future work is needed to overcome this issue. 
Having this in mind, the development of sophisticated, robust, sensitive, specific and valid 
tools and technical approaches using MS to help on deciphering the structure and 
biologically relevant roles of phospholipid nitration products in the complex cellular 
network was one of the main aims of this work.  
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I.5. Aim of the work  
 
The identification and structural characterization of the nitroxidative stress-induced 
modifications in PLs, and their possible biological roles, are completely uncharted and can 
be hindered by the diversity, structural complexity and probable lower amount of the 
derived products. 
The aims of this work are to contribute for the understanding of the chemical 
modifications induced by nitroxidative stress to PLs and for the development of MS-based 
approaches that will allow their identification and structural characterization. MS-based 
strategies will be the basis of simple, specific, rapid and sensitive analytical methodologies 
for the in vitro and in vivo detection of nitrated/nitroxidized PL products. 
Nitration/nitroxidation of pure commercial PL standards comprising individual molecular 
species will be induced in controlled reaction conditions mimicking the ones found in 
biological systems. The nitrated/nitroxidized products formed will be analyzed by ESI-MS, 
ESI-MS/MS, LC-ESI-MS and LC-ESI-MS/MS allowing the separation of isomeric 
species, complemented with other analytical procedures. The MS-based approaches 
developed with model systems will be applied in the analysis of phospholipids extracts 
derived from biological samples to screen for the structural modifications and to validate 
the analytical strategy developed. 
We also aim to evaluate the biological roles of nitrated/nitroxidized PLs. Their 
potential as lipid signaling molecules in immune/inflammatory response will be evaluated 
in macrophage immune/inflammatory models. The results obtained will be essential to 
understand their biological roles in diseases associated with oxidative/nitroxidative stress 
and inflammatory processes. Their antioxidant potential will also be assessed using well-
established and reliable assays to determine the antioxidant capacity. The effect of nitrated 
PL in specific proteins will be also accessed. 
All the experimental details are presented in Chapter II of this thesis. The results 
obtained and their discussion are presented in Chapter III. Results will be grouped in three 
subchapters, according to the specific aims of the different studies performed: 
III.1. Understanding the nitroxidative stress-induced modifications of 
phospholipids 
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III.2. Understanding the biological activities of nitrated and nitroxidized 
derivatives of phospholipids 
III.3. Understanding the cross reaction between nitrated and nitroxidized 
derivatives of phospholipids and proteins 
The general concluding remarks are presented in Chapter IV while the references cited 
in the text are presented in Chapter V. In Appendices A-C are presented the supplementary 
material. 
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II.1. Chemicals and Reagents 
 
All chemicals and reagents used in the studies performed during this PhD work and 
presented in Section III were used without further purification.  
 
II.1.1. Chemicals and reagents purchased from Abcam (Cambridge, UK): 
 Primary antibody against inducible Nitric Oxide Synthase (iNOS; rabbit polyclonal 
anti-iNOS).  
 
II.1.2. Chemicals and reagents purchased from Avanti® Polar Lipids, Inc. (Alabaster, 
USA): 
 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC, C16:0/C18:1); 
 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE, C16:0/C18:1); 
 1-Palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine (POPS, C16:0/C18:1); 
 1-Palmitoyl-2-linoleoyl-sn-glycero-3-phosphocholine (PLPC, C16:0/C18:2); 
 1-Palmitoyl-2-linoleoyl-sn-glycero-3-phosphoethanolamine (PLPE, C16:0/C18:2); 
 1-Palmitoyl-2-linoleoyl-sn-glycero-3-phospho-L-serine (PLPS, C16:0/C18:2); 
 1-Palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine (PAPC, C16:0/C20:4);  
 1-Palmitoyl-2-arachidonoyl-sn-glycero-3-phosphoethanolamine (PAPE, 16:0/C20:4);  
 1-Palmitoyl-2-arachidonoyl-sn-glycero-3-phospho-L-serine (PAPS, C16:0/C20:4). 
 
All phospholipid standards used in this PhD work had a purity of >99% and were used 
without further purification. 
 
II.1.3. Chemicals and reagents purchased from Bio-Rad (Hercules, USA): 
 Acrylamide/bis-acrylamide; 
 Ammonium persulfate (APS); 
 Precision plus proteinTM dual color standard (161-0374). 
 
II.1.4. Chemicals and reagents purchased from Chemicon (Madrid, Spain): 
 Mouse monoclonal anti-tubulin antibody. 
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II.1.5. Chemicals and reagents purchased from Cytoskeleton, Inc (Denver, USA): 
 Purified recombinant Syrian hamster vimentin (accession number AH001833). 
 
II.1.6. Chemicals and reagents purchased from Dako (Copenhagen, Denmark): 
 Peroxidase-conjugated anti-mouse immunoglobulins. 
 
II.1.7. Chemicals and reagents purchased from Fisher Scientific Ltd. (Leicestershire, 
UK): 
 Absolute ethanol; 
 Chloroform (HPLC grade); 
 Methanol (HPLC grade). 
 
II.1.8. Chemicals and reagents purchased from Fluka (Buchs, Switzerland): 
 2,2’-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt 
(ABTS●+). 
 
II.1.9. Chemicals and reagents purchased from GE Healthcare (Carnaxide, 
Portugal): 
 Alkaline phosphatase-linked anti-rabbit IgG antibody;  
 
II.1.10. Chemicals and reagents purchased from GE Healthcare (Buckinghamshire, 
UK): 
 Enhanced chemiluminiscence reagents; 
 Horseradish peroxidase (HRP)-streptavidin. 
 
II.1.11. Chemicals and reagents purchased from Gibco Life Technologies (Paisley, 
UK): 
 Fetal bovine serum (for anti-inflammatory assays; Section II.8); 
 Penicillin (for cross adduction with proteins; Section II.9); 
 Streptomycin (for cross adduction with proteins; Section II.9); 
 
II.1.12. Chemicals and reagents purchased from Invitrogen (Carlsbad, USA): 
 4,6-diamidino-2-phenylindole; 
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 Anti-rabbit-Alexa 568; 
 Dulbecco’s Modified Eagle Medium (DMEM) (for cross adduction with proteins, 
Section II.9). 
 
II.1.13. Chemicals and reagents purchased from Life Technologies (Carlsbad, USA): 
 GlutaMAX. 
 
II.1.14. Chemicals and reagents purchased from Lonza Inc. (Walkersville, USA): 
 Fetal bovine serum (FBS; for cross adduction with proteins, Section II.9). 
 
II.1.15. Chemicals and reagents purchased from MatTek Corporation (Ashland, 
USA): 
 Glass bottom dishes. 
 
II.1.16. Chemicals and reagents purchased from Molecular Probes (Oregon, USA): 
 Phalloidin-Alexa568  
 
II.1.17. Chemicals and reagents purchased from Santa Cruz Biotechnology 
(Heidelberg, Germany): 
 Anti-vimentin Alexa 488. 
 
II.1.18.Chemicals and reagents purchased from Sigma-Aldrich (St Louis, MO, USA): 
 (±) 6-Hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid (Trolox); 
 2,2′-Azobis(2-methylpropionamidine) dihydrochloride (AAPH); 
 2,2-Diphenyl-1-picrylhydrazyl (DPPH●); 
 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT); 
 Anti-vimentin antibodies 
 Biotinylated iodoacetamide (Iac-B) 
 Dulbecco’s Modified Eagle Medium (DMEM) (for anti-inflammatory assay, 
Section II.8); 
 Fluorescein sodium salt; 
 Laemmli Buffer 
 Lipopolysaccharide (LPS) from Escherichia coli (serotype 026:B6); 
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 Nitronium tetrafluoroborate (NO2BF4); 
 Penicillin (for anti-inflammatory assays; Section II.8); 
 Potassium phosphate monobasic; 
 Streptomycin (for anti-inflammatory assays; Section II.8); 
 TEMED. 
 
Milli-Q water (Synergy®, Millipore Corporation, Billerica, MA, USA) was also used.  
 
II.2. Samples 
 
II.2.1. Phospholipid Standards  
 
II.2.1.1. Phosphatidylcholines 
 
The commercial phosphatidylcholines (PCs) were used as models because PCs are the 
most abundant phospholipid class present in mammalian cell membranes and plasma 
lipoproteins. POPC is composed by a saturated fatty acyl chain in the sn-1 position 
(palmitic acid, C16:0) and a monounsaturated fatty acyl chain in the sn-2 position (oleic 
acid, C18:1), which mimics mammalian phosphatidylcholine composition. PLPC and 
PAPC are composed by a saturated fatty acyl chain in the sn-1 position (palmitic acid, 
C16:0) and a polyunsaturated fatty acyl chain in the sn-2 position (linoleic acid, C18:2 for 
PLPC; arachidonic acid, C20:4 for PAPC).  
PCs standards (POPC, PLPC and PAPC) were used in the studies presented in Section 
III.1.1 and III.1.2. POPC standard was also used in the studies presented in Section III.2.1 
and Section III.3.1. 
 
II.2.1.2. Phosphatidylethanolamines 
 
 Phosphatidylethanolamines (PEs) commercial standards were used as models, since 
PE is the second most abundant phospholipid class in mammalian cells. POPE, PLPE and 
PAPE are composed by a saturated fatty acyl chain in the sn-1 position (palmitic acid, 
C16:0) and unsaturated fatty acyl chain in the sn-2 position (oleic acid, C18:1 for POPE; 
linoleic acid, C18:2 for PLPE; arachidonic acid, C20:4 for PAPE).  
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PEs standards (POPE, PLPE and PAPE) were used in the studies presented in Section 
III.1.1 and III.1.2.  
 
II.2.1.3. Phosphatidylserines 
 
The commercial phosphatidylserines (PSs) were chosen as models because PSs are the 
most abundant negatively charged phospholipid in eukaryotic cells. POPS, PLPS and 
PAPS are composed by a saturated fatty acyl chain in the sn-1 position (palmitic acid, 
C16:0) and unsaturated fatty acyl chain in the sn-2 position (oleic acid, C18:1 for POPS; 
linoleic acid, C18:2 for PLPS; arachidonic acid, C20:4 for PAPS).  
PSs standards (POPS, PLPS and PAPS) were used in the studies presented in Section 
III.1.1.  
 
II.2.2. Peptides and Proteins Standards 
Vimentin was used as model in the studies of Section III.3.1. 
 
II.2.3. Biological Samples for In Vivo and In Vitro Assays 
 
In order to screen for the structural modification identified by using the phospholipid 
standard models (see Section II.2.1)  in biological samples and to validate the MS and LC-
MS-based experimental methodologies developed (see Section II.4 and II.5), we analyzed 
total lipids extracts from cardiac mitochondria from a well-characterized animal model of 
type 1 diabetes mellitus (T1DM) obtained by administration of streptozotocin (STZ) and 
total lipid extracts from cardiomyoblast cell line (H9c2), a suitable model for cardiac cells, 
with induced starvation and ischemia in order to mimic conditions to which 
cardiomyocytes are exposed during acute myocardial infarction were analyzed. Cardiac 
mitochondria were used in the study presented in Section III.1.1 while cardiomyoblast cell 
line (H9c2) was used in the study presented in Section III.1.2. 
In order to evaluate the biological activity of nitrated POPC, namely its anti-
inflammatory potential, the mouse leukaemic monocyte-macrophage Raw 264.7 cell line 
was used in the studies presented in Section III.2.1.  
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In order to evaluate the ability of nitrated POPC to interact with vimentin and the 
effects on vimentin network organization, the human adrenal tumor cell line SW13 was 
used in the studies of Section III.3.1. 
 
II.3. Preparation of Phospholipid Standard Work Solutions and Biological Samples 
for the Identification and Structural Characterization of Nitrated and 
Nitroxidized derivatives of Phospholipids 
 
II.3.1. Preparation of Phospholipid Standard Model Solutions and Nitration Reaction 
 
Solutions of each PC, PE and PS (1 mg) were dissolved in 1 mL of chloroform and 
well-vortexed. Each solution was prepared immediately before nitration reaction using 
nitronium tetrafluoroborate (NO2BF4) as nitrating agent. 
Nitration of phospholipid standard solutions was carried out with NO2BF4. A solution 
of each PC, PE or PS (1 mg) was prepared in chloroform (1 mL) in an amber vial tube. 
Then, an excess of solid NO2BF4 (≈ 1 mg) was added. NO2BF4 has been previously used as 
nitrating agent in fatty acid nitration studies and was chosen for mimicking the nitration 
occurring on biological membranes with peroxynitrite and nitrite [7, 9, 58, 154]. The 
concentration of NO2BF4 used was high allowing to obtain nitrated derivatives of 
phospholipids in high amount to perform all the mass spectrometry structural 
characterization studies. The reaction mixture was incubated at room temperature for 1 h, 
under orbital shaking at 750 rpm. After incubation, the reaction mixture was transferred to 
a centrifuge glass tube and the reaction was stopped by solvent extraction with Milli-Q 
water. The water is added to hydrolyze unreacted NO2BF4 and to separate water soluble 
contaminants as anions (e.g. nitrite (NO2
-), nitrate (NO3
-), and tetrafluoroborate (BF4
-)) 
from phospholipids [9, 58, 59]. The mixture was vortex for 30 s and then centrifuged at 
2000 rpm for 10 min at room temperature using a Mixtasel Centrifuge (Selecta). The 
organic layer containing the phospholipid products was collected, evaporated under 
nitrogen stream, and stored at -20 °C to be further quantified using phosphorous assay 
[155] (see Section II.3.2.4). 
The extent of nitration reaction and formation of nitrated and nitroxidized products 
were monitored by ESI-MS and MS/MS analysis. The nitrated and nitroxidized products 
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were subsequently separated and identified by reversed phase liquid chromatography (LC) 
coupled to ESI-MS (C5-RP-LC-MS), and characterized by LC-MS/MS.  
 
II.3.2. Preparation of Biological Samples 
 
II.3.2.1. Animal Care Protocol, Induction of Hyperglycemia and Isolation of Cardiac 
Mitochondria  
 
The animal care protocol, the induction and characterization of STZ-induced 
hyperglycemia and the cardiac mitochondria isolation was performed as previously 
described [156]. 
Briefly, Wistar male rats, aged 6–8 weeks, weighing 200 g at the beginning of the 
experiments were randomly divided into two groups: type 1 diabetic group (T1DM) and 
control. Housing and experimental treatment were in accordance with Guide for the Care 
and Use of Laboratory Animals from the Institute for Laboratory Animal Research (ILAR, 
1996). The experimental procedures complied with the current national laws. The T1DM 
group was treated with a single intraperitoneal injection of streptozotocin (STZ; 60 mg/kg), 
after a 16 h fasting period. Control animals were injected with citrate solution. Animals 
were considered hyperglycemic when blood glucose exceeded 250 mg/dL, which was 
veriﬁed after 48 h of STZ injection. After 4 weeks of STZ administration, animals were 
sacriﬁced followed by thoracotomy with heart extraction. The excised hearts were minced 
in an ice-cold isolation medium containing 250 mmol/L sucrose, 0.5 mmol/L EGTA, 10 
mmol/L HEPES-KOH (pH 7.4), and 0.1% defatted BSA. The minced blood-free tissue was 
resuspended in isolation medium containing protease subtilopeptidase A type VIII (1 mg/g 
tissue) and homogenized with tightly ﬁtted Potter–Elvehjen homogenizer and Teﬂon 
pestle. The suspension was incubated for 1 min at 4 °C and re-homogenized. The 
homogenate was centrifuged at 14,500 ×g during 10 min. The supernatant ﬂuid was 
decanted, and the pellet, essentially devoid of protease, was gently resuspended in isolation 
medium. The suspension was centrifuged at 750 ×g for 10 min, and the resulting 
supernatant was centrifuged at 12,000 ×g for 10 min. The pellet was resuspended and 
repelleted at 12,000 ×g for 10 min. The ﬁnal pellet, containing the mitochondrial fraction, 
was resuspended in a washing medium containing 250 mmol/L sucrose, 10 mmol/L 
HEPES-KOH, pH 7.4.  
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II.3.2.2. Cell culture of Cardiomyoblast H9c2 cell line  
 
The cardiomyoblast cell line H9c2 (Sigma-Aldrich, St. Louis, MO) was cultured in 
Dulbecco’s Modified Eagle Medium (DMEM), supplemented with 10% fetal bovine serum 
(FBS), 1% penicillin/streptomycin (100 U/mL: 100 μg/mL) and 1% GlutaMAX, at 37 ºC 
under 5% CO2. Metabolic ischemia was induced by a buffer exchange to an ischemia-
mimetic solution (118 mmol/L NaCl, 4.7 mmol/L KCl, 1.2 mmol/L KH2PO4, 1.2 mmol/L 
MgSO4, 1.2 mmol/L CaCl2, 25 mmol/L NaHCO3, 5 mmol/L calcium lactate, 20 mmol/L 2-
deoxy-D-glucose, 20 mmol/L Na-HEPES, pH 6.6) and by placing the dishes in hypoxic 
pouches with an indicator (GasPakTM EZ, BD Biosciences) for 2 h. As certified by the 
manufacturer, the Anaerobe Gas Generating Pouch System produces an atmosphere 
containing 10% CO2 and 1% O2. Starvation was induced by culturing H9c2 cells in 
DMEM with 1% antibiotics (100 U/ml penicillin, and 100 μg/ml streptomycin), and 1% 
GlutaMAX, but not supplemented with FBS. The cells were maintained at 37 ºC in a 
humidified chamber with 5% CO2.  
 
II.3.2.3. Lipid Extraction of Cardiac Mitochondria and of Cardiomyoblast H9c2 cell 
line 
 
Lipid extraction of either each mitochondrial fraction and each myoblast H9c2 cell 
line condition was performed according to the method of Bligh and Dyer [157]. 
Briefly, 3.75 mL chloroform:methanol 1:2 (v/v) was added to each 1 mL of heart 
mitochondrial fraction and to the cell pellets previously dissolved in 1 mL of Milli-Q H2O. 
Samples were vortexed and incubated on ice for 30 min. An additional volume of 1.25 mL 
of chloroform and 1.25 mL of H2O were added followed by vortex for 1 min between each 
addition. The samples were centrifuged at 1000 rpm for 5 min at room temperature using a 
Mixtasel Centrifuge (Selecta) to obtain a two-phase system: an aqueous top phase and an 
organic bottom phase. The lipid extract was recovered from the organic bottom phase. In 
order to guarantee full extraction of lipid phase, 1.88 mL of chloroform were added to the 
aqueous phase followed by vortex and new centrifugation. The organic phase was 
recovered to the same tube as before and dried under a nitrogen stream. After drying, the 
total lipid extracts were re-suspended in 300 µL of chloroform, transferred to an amber 
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glass vial. The phospholipid amount in each lipid extract was determined by phosphorous 
measurement performed according to Bartlett and Lewis [155] with modifications (see 
Section II.3.2.4). Two different and independent mitochondrial extracts and three different 
and independent myoblast cultures were extracted and analyzed in order to verify the 
reproducibility of the results. 
 
II.3.2.4. Phosphorous Measurement – for Phospholipid Quantification 
 
Total amount of PL was quantiﬁed with the phosphorus assay as previously described 
by Bartlett and Lewis [155].  
For cardiac mitochondria, 650 μL of concentrated perchloric acid (70% m/v) was 
added to an aliquot of 10 μL of each sample (cardiac mitochondria lipid extracts were 
dissolved in 300 μL of CHCl3; the 10 μL of each sample was dried under a nitrogen stream 
before the addition of perchloric acid). Samples were then incubated for 1 h at 180 °C in 
the heating block (Stuart, UK). Afterwards, 3.3 mL of H2O, 500 μL of 1% ammonium 
molybdate (m/v, 1 g of NaMoO4.H2O in 100 mL of Milli-Q H2O) and 4% ascorbic acid 
(m/v, 0.4 g in 10 mL of Milli-Q H2O) were added to all samples. The reaction mixture was 
homogenized in a vortex mixer after each addition followed by incubation for 10 min at 
100 °C in a water bath.  
For myoblast H9c2 cell line and for nitrated and nitroxidized products of PLs 
recovered after extraction (see Section II.3.1), 125 μL of concentrated perchloric acid (70% 
m/v) was added to an aliquot of 10 μL of each sample (myoblast H9c2 cell lipid extracts 
were dissolved in 300 μL of CHCl3 while nitrated and nitroxidized products of PLs were 
dissolved in 1 mL of CHCl3; the 10 μL of each sample was dried under a nitrogen stream 
before the addition of perchloric acid). Samples were then incubated for 1 h at 180 °C in 
the heating block (Stuart, UK). Afterwards, 825 μL of H2O, 125 μL of 2.5% ammonium 
molybdate (m/v; 2.5 g of NaMoO4.H2O in 100 mL of Milli-Q H2O) and 10% ascorbic acid 
(m/v; 0.1 g in 1 mL of Milli-Q H2O) were added to all samples. The reaction mixture was 
homogenized in a vortex mixer after each addition followed by incubation for 10 min at 
100 °C in a water bath. Samples were put on cold water afterward. 
For all samples, standards from 0.1 to 2 μg of phosphate (NaH2PO4.2H2O, 100 μg of 
phosphorus per mL) underwent the same sample treatment with exception of the heating 
block phase. Finally, 200 µL of each standard and sample were added to the 96-multiwell 
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plate and the absorbance was measured at 797 nm in a Multiskan GO Microplate 
Spectrophotometer (Multiskan GO 1.00.38, Thermo Scientiﬁc, Hudson, NH, USA) 
controlled by SkanIT software version 3.2 (Thermo Scientific™). The amount of 
phosphorus present in each sample was calculated by linear regression through the graph 
that relates the amount of phosphorus present in the standards (X-axis) and absorbance 
obtained from the duplicates of the different concentrations (Y-axis). For lipid extracts, the 
amount of phospholipid was directly calculated by multiplying the amount of result 
phosphorus by 25. 
 
II.4. Electrospray Ionization Mass Spectrometry  
 
Mass spectrometry (MS) with electrospray ionization (ESI), combined with tandem 
MS (MS/MS and MSn) is a technique successfully applied in the identification and 
characterization of structural changes of lipids, especially nitro-fatty acids (NO2-FA, see 
Section I.4). Liquid chromatography (LC) coupled online to ESI-MS was also applied. 
The global strategy that was used in this PhD work for the structural characterization 
of nitrated and nitroxidized products of PCs, PEs and PSs was based in the analysis of the 
nitrogen-containing products by mass spectrometry (MS) or by high performance liquid 
chromatoghapy (HPLC) coupled to MS (LC-MS). Different mass spectrometers with 
different mass analyzers but equipped with the same soft ionization source, ESI, were used 
for direct ESI-MS analysis: LXQ linear ion trap (LIT) mass spectrometer 
(ThermoFinnigan, San Jose, CA, USA) and Q-TOF 2 hybrid quadrupole time-of-flight 
mass spectrometer (Micromass, Manchester, UK). The LIT spectrometer allowed to 
perform multistage tandem mass spectrometry (MSn) analysis. The Q-TOF mass 
spectrometer was used to perform the accurate mass measurements and elemental 
composition determination. 
The ESI-MS data were obtained either by direct infusion of sample into the mass 
spectrometer but also by online coupling to LC. The LC was used for separation of the 
diverse products formed including isomeric species.  
 
II.4.1. Linear ion trap (LIT) Mass Spectrometry  
 
An aliquot (4 µg) of each sample in methanol (2:100, v/v) was introduced through 
direct infusion for ESI-MS analysis on the LIT mass spectrometer operated both in 
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positive- and negative-ion modes. For the ESI-MS analysis of PCs in the negative-ion 
mode, 10 µL of 1 mmol/L ammonium acetate in methanol were added and the samples 
were incubated for 5 min before the analysis. The ESI operating conditions used were as 
follows: samples were introduced at a ﬂow rate of 8 µL/ min into the ESI source; 
electrospray voltage was 4.7 kV in the negative-ion mode and 5 kV in the positive-ion 
mode; capillary temperature was 275 ºC and the sheath gas ﬂow of 25 (arbitrary units). 
Nitrogen was used as nebulizing and drying gas. An isolation width of 0.5 Da was used 
with a 30 ms activation time for CID MS/MS experiments using helium as collision gas. 
Full scan MS spectra (acquired over the m/z range 200-2000) and MS/MS spectra were 
acquired with a 50 ms and 200 ms maximum ion injection time, respectively. For MS/MS 
experiments, a normalized collision energyTM (CE) between 20 and 30 (arbitrary units) was 
used. Data acquisition and analysis were performed using Xcalibur Data System (version 
2.0, ThermoFinnigan, San Jose, CA, USA). 
 
II.4.2. Quadrupole Time-of-Flight (Q-TOF) Mass Spectrometry  
 
ESI-MS and MS/MS analysis of the nitrated and nitroxidized products of PCs, PEs 
and PSs standards were carried out in positive-ion using a Q-TOF mass spectrometer. 
Samples (4 µg of each sample in methanol (2:100, v/v)) were introduced through direct 
infusion into ESI source conditions at a flow rate of 10 µL/ min. The cone voltage was set 
at 30 V; capillary voltage was maintained at 3 kV, source temperature was 80 °C; 
desolvation temperature was 150 °C. Mass spectra were acquired for 1 min scanning the 
mass range from m/z 100 to 2000. MS/MS spectra were accumulated for 1 min and 
acquired by CID using argon as the collision gas. The collision energy used was set 
between 20 and 40 eV. Data acquisition and analysis were performed using MassLynx 4.0 
data system.  
The identification of the new product ions resulting from nitration/nitroxidation of PL 
standards were confirmed by the accurate mass measurements and elemental composition 
determination using ESI-MS spectra acquired and processed using MassLynx 4.0 data 
system after locking the mass correction for the calculated monoisotopic mass of the 
[M+H]+ ions of each native phospholipid (non-modified phospholipid). 
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II.5. High-Performance Liquid Chromatography Online Coupled with Electrospray 
Ionization Mass Spectrometry 
 
Electrospray ionization sources can be easily coupled online to a high performance 
liquid chromatography (HPLC) system because of the production of gas-phase ions 
directly from a liquid solution. This allows the separation of components in complex 
mixtures. 
In this PhD work, nitrated phospholipid standards mixtures were analyzed by 
reversed-phase LC-ESI-MS using a C5 column. For biological samples, Hydrophilic 
Interaction Liquid Chromatography Mass Spectrometry (HILIC-ESI-MS) was used. 
 
II.5.1. Reversed- Phase HPLC-ESI-MS Analysis with a C5 column 
 
The nitrated and nitroxidized products obtained after nitration reactions between 
phospholipid standards (PCs, PEs and PSs) and NO2BF4 were separated and identified by 
LC-ESI-MS and characterized by LC-ESI-MS/MS. These experiments were performed on 
a Waters Alliance 2690 HPLC system (Mildford, MA, USA) coupled online to the LXQ 
linear ion trap (LIT) mass spectrometer (ThermoFinnigan, San Jose, CA, USA). An aliquot 
of 60 μg of each nitrated mixture (previously dissolved in chloroform, transferred to an 
Eppendorf tube and dried under a nitrogen stream) was diluted in 60% of mobile phase A 
(30 μL), and then filtered using a PVDF Millex-GV syringe filter with a 0.22 µm pore size 
(Millipore, Billerica, MA, USA). Volumes of 5 μL of each diluted and filtered nitrated 
mixture (60 μg in 30 µL of mobile phase A) were introduced into a Discovery Bio Wide 
Pore C5 column (15 cm × 0.5 mm, 5 μm particle size; Supelco, Bellefonte, PA, USA), 
using a flow rate of 16 μL/min. The mobile phase A consisted of water with 5% 
acetonitrile and 0.1% formic acid. The mobile phase B consisted of acetonitrile, with 0.1% 
formic acid. Prior to use, the mobile phases were filtered with Supelco Nylon 66 
membranes (0.45 µm pore size and 47 mm diameter; Sigma-Aldrich, St Louis, MO, USA), 
and degassed by ultrasonication for 15 min. The mobile phase gradient was programmed as 
follows: initial conditions were 60% of A; 0-35 min, linear increase gradient to 60% of B; 
35–45 min linear increase gradient to 100% of B held in isocratic mode for 10 min; 55-60 
min linear gradient to 60% of A in order to bring back to the mobile phase composition to 
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the initial conditions and held in isocratic mode for 5 min, allowing to equilibrate the 
column until the next injection. The LIT mass spectrometer was operated both in positive- 
and negative-ion mode. Typical ESI conditions were as follows: electrospray voltage of 4.7 
kV in the negative-ion mode and 5 kV in the positive-ion mode; capillary temperature, 275 
°C; and sheath gas (nitrogen) ﬂow of 25 (arbitrary units). To obtain the product-ion spectra 
of the major components during LC experiments, cycles consisting of one full scan mass 
spectrum (m/z 100-1700) and three data-dependent MS/MS scans were repeated 
continuously throughout the experiments with the following dynamic exclusion settings: 
repeat count 3; repeat duration 30 s; exclusion duration 45 s. An isolation with of 0.5 Da 
was used with a 30 ms activation time for MS/MS experiments using helium as collision 
gas. Normalized collision energy was 27 (arbitrary units). Data acquisition and processing 
was carried out on an Xcalibur data system (version 2.0). 
 
II.5.2. Hydrophilic Interaction Liquid Chromatography (HILIC)-ESI-MS  
 
Phospholipid either from cardiac mitochondrial extracts from control and T1DM heart, 
and from cardiomyoblast H9c2 cells from control, starvation and ischemic groups were 
separated and identified by hydrophilic interaction liquid chromatography (HILIC)-ESI-
MS and characterized by HILIC-ESI-MS/MS performed on a Waters Alliance 2690 HPLC 
system (Mildford, MA, USA) coupled online to the LXQ linear ion trap (LIT) mass 
spectrometer (ThermoFinnigan, San Jose, CA, USA). Aliquots of 25 µg from the total lipid 
extracts (previously dissolved in chloroform, transferred to an Eppendorf tube and dried 
under a nitrogen stream) were diluted in 90 µL of the mobile phase B (acetonitrile 60%, 
methanol 40% with 10 mmol/L ammonium acetate) and then filtered using a PVDF 
Millex-GV syringe filter with a 0.22 µm pore size (Millipore, Billerica, MA, USA).  
Volume of 5 µL of each diluted and filtered reaction mixture was introduced into an 
Ascentis Si HPLC Pore column (15 cm × 1.0 mm, 3 µm; Sigma–Aldrich). Prior to use, the 
mobile phases were filtered with Supelco Nylon 66 membranes (0.45 µm pore size and 47 
mm diameter; Sigma-Aldrich, St Louis, MO, USA), and degassed by ultrasonication for 15 
min. The solvent gradient for phospholipid class separation from cardiac mitochondrial 
extracts was programmed as follows: gradient started with 0% of A (acetonitrile 55%, 
methanol 35% and water 10% (v/v) with 10 mmol/L of ammonium acetate) and linear 
increase to 100% of A during 20 min, and held isocratically for 30 min, returning to the 
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initial conditions in 10 min. The solvent gradient for phospholipid class separation from 
cardiomyoblast H9c2 cells was programmed as follows: gradient started with 0% of A 
(acetonitrile 50%, methanol 25% and water 25% with 10 mmol/L of ammonium acetate) 
and 100% of B, and held isocratically for 8 min. It linearly increased to 60% of A and 
decreased to 40% of B during 7 min, and held isocratically for 22 min, returning, to the 
initial conditions in 5 min. The ﬂow rate through the column was 60 µL/ min. The LXQ 
linear ion trap mass spectrometer was operated in positive-ion mode. Typical ESI 
conditions were as follows: electrospray voltage, 5 kV; capillary temperature, 275 ºC; and 
the sheath gas flow of 8 (arbitrary unis). To obtain the product-ion spectra of the major 
components during LC experiments, cycles consisting of one full scan mass spectrum and 
three data-dependent MS/MS scans were repeated continuously throughout the 
experiments with the following dynamic exclusion settings: repeat count 3; repeat duration 
30 s; exclusion duration 45 s. For the identification and characterization of the nitrated and 
nitroxidized species of cardiomyoblast H9c2 cells under MS/MS, an inclusion list with the 
m/z values of the major plausible products was created. HILIC-LC-MS was performed 
with an internal standard to confirm the retention time (RT) for elution of each PL class. 
Internal standards were added to the lipid extracts aliquots (prior being dried under a 
nitrogen stream), and the amount added was adjusted to the percentage of each PL class in 
the total PL extract. For cardiac mitochondria, 7 µg of PC (dMPC 14:0/14:0) and 5 µg PE 
(dMPE 14:0/14:0) were used. The results obtained for T1DM and for control group are 
presented as mean±SD of two experiments that were measured independently in different 
days for each experimental group (Control and T1DM). For cardiomyoblast H9c2 cell line, 
PL standards used were 2 µg of PC (dMPC 14:0/14:0) and 3 µg of PE (dMPE 14:0/14:0). 
The results obtained for cardiomyoblast H9c2 cell line (control, starvation and ischemia 
groups) are presented as mean±SD of three experiments that were measured independently 
in different days for each experimental group. Data acquisition was carried out on an 
Xcalibur data system (V2.0). Relative quantification of each individual phospholipid 
species was obtained by the ratio between the area of reconstructed ion chromatogram of a 
given m/z value against the area of the reconstructed ion chromatogram of the respective 
standard. 
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II.6. Theoretical Calculations 
 
All calculations were performed with Gaussian09 [158] at the DFT level using the 
B3LYP functional and the 6-31++G** basis set. Wiberg bond indices were obtained from 
a Natural Bond Orbital [159] analysis as implemented in Gaussian software, at the same 
level of theory, using previously geometry optimized conformations.  
 
II.7. Antioxidant Assays 
 
The role of the nitrated/nitroxidized products of POPC, namely the nitrated derivative 
(NO2-POPC), generated as described in Section II.3.1 as potential antioxidant candidates 
was evaluated using the radical scavenging capacity assays against 2,2-diphenyl-1-
picrylhydrazyl radical (DPPH●) and 2,2’-azinobis-3-ethylbenzothiazoline-6-sulfonic acid 
radical cation (ABTS●+), and also the oxygen radical absorbance capacity (ORAC) assay.  
The DPPH● assay is based on the reduction of the purple chromogen DPPH● radical to 
the corresponding pale yellow hydrazine through electron transfer by antioxidant 
compound(s). The scavenging capacity was evaluated by monitoring the absorbance 
decrease at 517 nm. The blue-green ABTS●+ radical can be reduced either by antioxidant 
compound(s) by electron transfer or by hydrogen atom transfer. The scavenging capacity 
was assessed by monitoring of the absorbance decrease at 734 nm. The ORAC assay is 
based on the inhibition of the peroxyl radical (ROO●)-induced oxidation of a fluorescent 
probe (usually fluorescein) through hydrogen atom donation. The fluorescence intensity is 
monitored at λexc 485 nm, λem 535 nm.  
Stock solutions for antioxidant assays were prepared from the dried non-modified 
POPC standard and nitrated POPC (1 mg), recovered after extraction and properly 
quantified (see Section II.3.1), which were dissolved in 1 mL of ethanol and well-vortexed. 
Work solutions of 7.5, 25 and 100 µg/mL for ORAC assay, and 250, 300 and 500 µg/mL 
for DPPH● and ABTS●+ assays of each POPC (non-modified and nitrated) were prepared 
by dissolving the correct volume of stock solution (3.75, 12.5, 50, 125, 150 and 250 µL) in 
ethanol (final volume of 500 µL). 
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II.7.1. DPPH● Assay 
 
The microplate DPPH● method previously described [160] was applied with some 
modifications. A stock solution of DPPH● in ethanol (250 µmol/L) was prepared and kept 
in dark at room temperature. On the day of analysis, different concentrations of DPPH● 
(between 10 and 300 µmol/L) were prepared in ethanol. Then, 150 µL of each dilution of 
DPPH● and 150 µL of ethanol were placed in each well of the 96-well flat-bottom UV 
transparent microplates and absorbance measurements at 517 nm were performed at room 
temperature, 2 min after incubation, using an UV-Vis spectrophotometer (Multiskan GO 
1.00.38, Thermo Scientiﬁc, Hudson, NH, USA) controlled by SkanIT software version 3.2 
(Thermo Scientific™).  The DPPH● calibration curve was established, allowing to 
determine the necessary dilution of DPPH● stock solution to obtain absorbance values of 
0.9. This solution was used for further experiments. 
For evaluation of radical species scavenging, 150 µL of Trolox standard solutions 
(between 5 and 75 µmol/L in ethanol), non-modified POPC and nitrated POPC (250, 300 
and 500 µg/mL in ethanol) were placed in each well, followed by addition of 150 µL of 
DPPH● in ethanol. The DPPH● scavenging activity of standards and samples was 
monitored at 517 nm every 5 min after the beginning of reaction during 120 min at room 
temperature. The microplate was automatically shaken for 5 s prior to each reading. For 
each sample, the experiment was performed in triplicate in three different days. In order to 
evaluate the stability of the radical upon reaction time, the absorbance of DPPH● in the 
absence of antioxidant species (blank) was monitored at 517 nm every 5 min after the 
beginning of reaction at room temperature, providing an absorbance decrease of 5% after 
120 min. The percentage of DPPH● radical remaining was calculated using the equation:  
 
% DPPH● Remaining = (Abssample after incubation time/Abssample at the beginning of reaction) x 100. 
 
The antioxidant activity of the tested samples expressed as percentage of inhibition of 
DPPH● radical was calculated (60 and 120 min) using the following equation:  
 
% inhibition = ((AbsDPPH
●-Abssample)/AbsDPPH
●) x 100. 
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The IC20 values (concentration of sample that induces a reduction of 20% in the initial 
DPPH● radical) after 120 min of reaction were calculated by linear regression from the 
concentration of sample versus percentage of inhibition. The results were also expressed as 
Trolox equivalent (TE, µmol Trolox/ g of sample). The equation used was: 
 
TE  = IC20 Trolox (µmol/L) x 1000/ IC20 of sample (µg/mL). 
 
II.7.2. ABTS●+ Assay 
 
The microplate ABTS●+ method previously described [161] was applied. 96-Well flat-
bottom UV transparent microplates and microplate reader equipment were the same as 
described for DPPH● assay. The ABTS●+ radical cation solution was prepared by mixing 
equal volumes of an ABTS stock solution (7 mmol/L in water) with potassium persulfate 
(2.45 mmol/L in water) [161, 162]. This mixture was kept for 12–16 h at room temperature 
in the dark. On the day of analysis, five different concentrations of the ABTS●+ solution 
(between 25 and 350 µmol/L) were prepared in acetate buffer (pH 4.6, 50 mmol/L). A 
linear relationship between the radical concentration and absorbance at 734 nm was 
established in order to determine the dilution of the ABTS●+ stock solution necessary to 
obtain an ABTS●+ concentration that provided an absorbance value of 0.9. Hence, 150 µL 
of each ABTS●+ dilution in acetate buffer (pH 4.6, 50 mmol/L) and 150 µL of ethanol were 
placed in each well. The absorbance measurements were performed at room temperature, 
after 2 min of incubation. In order to evaluate the stability of the radical upon reaction 
time, the absorbance of ABTS●+ in the absence of antioxidant species (blank) was 
monitored, and the absorbance decrease observed was 5% after 120 min of reaction. 
For evaluation of radical species scavenging, 150 µL of Trolox standard solutions 
(between 5 and 75 µmol/L in ethanol), non-modified POPC and nitrated POPC (250, 300 
and 500 µg/mL in ethanol) and 150 µL of ABTS●+ solution were placed in each well. The 
ABTS●+ scavenging activity of standards and samples was monitored at 734 nm every 5 
min after the beginning of reaction during 120 min at room temperature. The microplate 
was automatically shaken for 5 s prior to each reading. The experiments were performed in 
triplicate and in three different days. The percentage of ABTS●+ radical remaining was 
calculated using the equation:  
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% ABTS●+ Remaining = (Abssample after incubation time/Abssample at the beginning of reaction) x 100. 
 
The antioxidant activity of the tested samples expressed as percentage of inhibition of 
ABTS●+ radical was calculated at specific time-points (60 and 120 min) using the 
following equation:  
 
% inhibition = ((AbsABTS
●+-Abssample)/AbsABTS
●+) x 100. 
 
The IC50 values (concentration of sample that induces the reduction of ABTS●+ 
radical to 50%) after 120 min of reaction were calculated by linear regression from 
concentration of sample versus percentage of inhibition. The results were also expressed as 
Trolox equivalent (TE, µmol Trolox/ g of sample). The equation used was: 
 
TE  = IC50 Trolox (µmol/L) x 1000/ IC50 of sample (µg/mL). 
 
II.7.3. ORAC Assay 
 
ORAC assay was carried out in black-walled 96-well plates, using a volume of 200 µL 
per well. Potassium phosphate buffer (75 mmol/L, pH 7.4) was used for the preparation of 
fluorescein and AAPH solutions. Control experiments were performed using 60 µL of 
potassium phosphate buffer and 20 µL of ethanol, ensuring 10% (v/v) ethanol per well. For 
the blank experiment (fluorescein + AAPH), 20 µL of ethanol were used instead of sample. 
Trolox standard solutions (10, 25, 50, 100, 150, 200, 250 µmol/L), non-modified POPC 
and nitrated POPC samples (7.5, 25 and 100 µg/mL) were prepared in ethanol. Twenty µL 
of each standard/sample were placed in the calibration or sample wells, respectively, 
providing a final concentration corresponding to the one-tenth value. 
Then, 120 µL of fluorescein (117 nmol/L; 70 nmol/L per well) were added to all wells, 
after which the microplate was pre-incubated at 37°C for 15 min in the microplate reader 
(Cytation3 Cell Imaging Microplate Reader, Bio-Tek Instruments, Inc., Winooski, VT, 
USA). This pre-incubation step was followed by the addition of 60 μL of AAPH solution 
(40 mmol/L; 12 mmol/L per well), with the exception of control experiments, to initiate the 
reaction. The fluorescence intensity (λexc 485 nm, λem 528 nm) was recorded every min 
during 240 min.  
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The ORAC curves (fluorescence vs time) were normalized (relative fluorescence, %) 
and the reaction endpoint was fixed at 5 % of the initial fluorescence intensity. The area 
under the curve (AUC) was calculated by integrating the curve defined by the relative 
fluorescence curve as a function of the reaction time. The lag time was also determined as 
the initial period of constant fluorescence intensity, prior to signal decay. Trolox equivalent 
(TE) values for ORAC assay were determined by interpolation of the determined AUC 
values in the trolox calibration curve and expressed as mmol Trolox/g lipid. 
 
II.8. Anti-Inflammatory Assays 
 
The role of the nitrated products of POPC generated as described in Section II.3.1 in 
the inflammatory response, and consequently their potential anti-inflammatory properties 
were assessed using the murine-leukaemic monocyte-macrophage Raw 264.7 cell line. 
Macrophages are key players in immune system and the Raw 264.7 cell line has been 
widely used as a very useful model to assess the effects of compounds, both as pro- or anti-
inflammatory agents, in inflammatory processes. The bacterial lipopolysaccharide (LPS) 
was used as pro-inflammatory stimuli, acting on macrophages and triggering a cascade of 
inflammatory processes which leads to the production of several inflammatory modulators 
(such as NO● and cytokines) and activation of enzymes such as iNOS. 
 
II.8.1. Cell culture of Raw 264.7 Macrophage cell line 
 
Raw 264.7, a mouse leukaemic monocyte-macrophage cell line from American Type 
Culture Collection (ATCC number: TIB-71), was cultured in DMEM supplemented with 
10% non-inactivated fetal bovine serum, 100 U/mL penicillin, and 100 μg/mL 
streptomycin at 37 °C in a humidified atmosphere of 95% air and 5% CO2. Along the 
experiments, cells were monitored by microscope observation in order to detect any 
morphological change. 
 
II.8.2. Cell viability by MTT Assay 
 
Assessment of metabolically active cells was performed using 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyl tetrazolium bromide (MTT) reduction colorimetric assay, as previously 
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reported [163]. Raw 264.7 cells (0.3 × 106 cells/well) were plated and allowed to stabilize 
overnight. Afterwards, cells were either maintained in culture medium (control) or pre-
incubated with different concentrations of non-modified POPC and nitrated POPC in PBS 
(7.5 µg/mL, 15 µg/mL and 30 µg/mL) for 1 h, and later activated with 1 μg/mL LPS (from 
E. coli-serotype 026:B6) for 24 h. After treatments, a solution of MTT (5 mg/mL in 
phosphate buffered saline) was added and cells were further incubated at 37 °C for 15 min 
[163]. Supernatants were removed and dark blue crystals of formazan solubilized with 
300 μL of acid isopropanol (0.04N HCl in isopropanol). Quantification of formazan was 
performed using an ELISA automatic microplate reader (SLT, Austria) at 570 nm, with a 
reference wavelength of 620 nm. 
 
II.8.3. Western Blot for Immunodetection of iNOS 
 
Raw 264.6 cells were plated at 0.6 x 106 cells per well in 24 well culture plates and 
allowed to stabilize overnight. Afterwards, cells were either maintained in culture medium 
(control) or pre-incubated with non-cytotoxic concentrations of  non-modified POPC and 
nitrated POPC for 1 h, and later activated with 1 μg/mL LPS for 24 h. Cells were then 
lysed with RIPA buffer (50 mmol/L Tris–HCl, pH 8.0, 1% Nonidet P-40, 150 mmol/L 
NaCl, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate and 2 mmol/L 
ethylenediamine tetraacetic acid) freshly supplemented with 1 mmol/L dithiothreitol, 
protease and phosphatase inhibitor cocktails, during 30 min in ice. The nuclei and the 
insoluble cell debris were removed by centrifugation at (12,000 g for 10 min, at 4 °C). The 
postnuclear extracts were collected and used as total cell lysates. Protein concentration was 
determined using the bicinchoninic acid method and cell lysates denatured at 95 ºC, for 5 
min in sample buffer (0.125 mmol/L Tris pH 6.8, 2% (w/v) sodium dodecyl sulfate, 100 
mmol/L dithiothreitol, 10% glycerol and bromophenol blue). Briefly, equivalent amounts 
of protein were electrophoretically separated on a 10% (v/v) sodium dodecyl sulfate – 
polyacrylamide gel and transferred to a PVDF membrane. The membranes were blocked 
with 5% (w/v) fat-free dry milk in Tris- buffered saline containing 0.1% (v/v) Tween 20 
(T-TBS), for 1 h, at room temperature. Blots were then incubated overnight at 4 ºC with 
the primary antibody against iNOS (1:500). The membranes were then washed for 30 min 
with T-TBS and incubated for 1 h at room temperature with alkaline phosphatase-
conjugated anti-rabbit antibody (1:20,000). The immune complexes were detected by 
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membrane exposure to the enhanced chemifluorescence reagent for 5 min, followed by 
scanning for blue excited fluorescence on the Typhoon FLA 9000 imager (GE Healthcare). 
The generated signals were analyzed using Image-Quant TL software. To ensure that 
equivalent amounts of protein were loaded for each sample, the membranes were stripped 
and reprobed with a monoclonal anti-tubulin antibody (1:20,000). 
 
II.9. Cross Adduction with Proteins 
 
II.9.1. In vitro Competition Assay for Vimentin Modification 
 
For modification of vimentin and evaluation of non-modified POPC or nitrated POPC 
as potential electrophiles a competition assay was performed. Stock solutions (3.67 
mmol/L) were prepared by dissolving the dried non-modified POPC standard and nitrated 
POPC (1 mg), recovered after extraction and properly quantified (see Section II.3.1) in 339 
µL of dimethylsulfoxide (DMSO). Three work solutions of 100 µmol/L, 500 µmol/L and 1 
mmol/L were prepared by dissolving the correct volume of stock solution (2.7, 13.6 and 
27 µL) in DMSO (final volume of 100 µL). Stock solution of 28.3 µmol/L soluble 
vimentin (1.5 mg/mL) in 5 mmol/L PIPES (pH 7.0) and 0.1 mmol/L dithiothreitol (DTT) 
was used without further dilution. Vimentin at 2.8 μmol/L (1μL of 28.3 µmol/L vimentin 
stock solution in 5 mmol/L PIPES (pH 7.0)) was pre-incubated in the absence or presence 
of the previous designated compounds at 10, 50 and 100 μmol/L final concentration (1 μL 
of each PL work solution in DMSO; final volume of reaction mixture of 10 µL in 
5 mmol/L PIPES (pH 7.0)). The assay was carried out at room temperature during 4 h. A 
work solution of 200 µmol/L of biotinylated iodoacetamide (Iac-B) was prepared in 
5 mmol/L PIPES (pH 7.0) buffer (10 µL of Iac-B in a final volume of 500 µL) from the 
10 mmol/L stock solution (in water). Subsequently, 20 μmol/L of Iac-B (1 μL of 200 
μmol/L work solution of Iac-B in 5 mmol/L PIPES (pH 7.0)) was added to the samples and 
incubated for additional 30 min. Incorporation of Iac-B was assessed through biotin 
detection after the separation of aliquots from the incubations on 10% SDS–
polyacrylamide gels (SDS–PAGE) followed by transfer to PVDF membranes (0.45 µm 
pore size; Sigma-Aldrich, St Louis, MO, USA). Blots were incubated with horseradish 
peroxidase (HRP)-streptavidin and enhanced chemiluminiscence (ECL). Western blot with 
specific antibodies was used for detection and to determine the vimentin amount. 
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II.9.2. Western blot and Immunoprecipitation for Vimentin Modification 
 
Aliquots from the competition assays (final volume 10 µL) were separated on 10% 
SDS–polyacrylamide gels. A volume of 2.5 µL of Laemmli sample buffer (4% SDS, 20% 
glycerol, 10% β-mercaptoethanol, 0.004% bromophenol blue and 0.125 mol/L Tris-HCl, 
pH 6.8) was added and samples were incubated for 5 min at 95 °C for protein denaturation. 
After cooling, 6 µL of each sample and 4 µL aliquot of a protein marker were loaded on 
top of a 4% SDS–polyacrylamide stacking gel polymerized over a 10% SDS–
polyacrylamide gels. Samples were separate by running the gel at 100 V until samples got 
into the running gel and then at 120 V until the end of the run using the running buffer 125 
mmol/L Tris, 0.96 mol/L glycine, 20% SDS, pH 8.3. Gels were further transferred to 
PVDF membranes on a semidry trans-blot system from Bio-Rad set at 22 V, for 50 min. A 
three buffer system (anode buffer I, 0.3 mol/L Tris pH 10.4, 10% (v/v) MeOH; anode 
buffer II, 25 mmol/L Tris pH 10.4, 10% (v/v) MeOH; catode buffer, 25 mmol/L Tris pH 
9.4, 40 mmol/L 6-aminohexanoic acid, 20% MeOH, pH 9.4) was used according to the 
instructions of the manufacturer. Membranes were then blocked by incubation with 2% 
defatted milk for 1 h at room temperature with shaking followed by three times washes of 
5 min with  Tween-Tris Buffer Saline (T-TBS; 20 mmol/L Tris-HCl pH 7.5, 500 mmol/L 
NaCl, 0.05% Tween 20). Then, membranes were incubated for 45 min with HRP-
conjugated streptavidin diluted 1:1000 in 1% BSA prepared in T-TBS. A new step of three 
times washes of 5 min with T-TBS was performed. For detection, membranes were 
incubated with ECL reagents for 1 min as specified in the manufacturer instructions. Signal 
is obtained by exposing membranes to Hyperfilm (GE Healthcare, Buckinghamshire, UK) 
for various time periods to ensure non-saturated signals (1, 5, 15 and 30 seconds). Then, 
the stripping of membrane was performed. For that, membranes were washed three times 
for 5 min with water to remove the salts followed by a quick step of incubation with 
8 mol/L guanidinium chloride pH 3 (only few seconds; membrane should become 
transparent). Membranes were washed three times for 5 min with water and three times for 
5 min with T-TBS. In order to guarantee that protein was loaded and transferred, the 
membranes were incubated with anti-vimentin antibody (1:500) in 1% BSA prepared in T-
TBS for 1 h, followed by three washes of 5 min with T-TBS. Then, incubation with an 
HRP-conjugated secondary antibody (anti-mouse (1:2000) for vimentin for 1h was 
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executed, and immunoreactive bands were detected with ECL according to standard 
western blot procedures. Levels of the proteins of interest were estimated by image 
scanning after exposing membranes to Hyperfilm for various time periods (1, 5, 15 and 
30 s) to ensure non-saturated ECL signals. Afga Arcus 1200 scanner with the Fotolook 
software (version 32 v3.60.0) was used for scanning the gel images. Gel-imaging software 
(Scion Image from Scion Corporation, Inc.) was used for signal quantification. 
 
II.9.3. Cell culture and Treatments of Adrenal Carcinoma SW13 cell line 
 
The cell line SW13/cl.2 (SW13), which is a vimentin-deficient cell line devoid of 
cytosolic intermediate filaments, was stably transfected as previously described by Peréz-
Sala and co-authors [225]. In RFP//vimentin, cells were co-transfected with a bicistronic 
expression plasmid coding for vimentin wild type (wt) or C328S mutant (vimentin wt or 
C328S and the red fluorescent protein RFP (DsRed-Express2 protein) as a marker of 
transfection were expressed as separated products). In these cells, both vimentin constructs 
form an extended radial network. SW13 cells were also stably transfected with constructs 
expressing the green fluorescent protein fused to vimentin wt or C328S mutant (GFP-
vimentin wt or C328S). These cells are characterized by the formation of filamentous 
structures with two free ends consistent with vimentin squiggles or short vimentin 
filaments in the case of wt, but only bright vimentin dots in the case of GFP-vimentin 
C328S, which is not competent for the formation of squiggles. 
RFP//vimentin wt and RFP//vimentin C238S SW13 cells were cultured on p-60 plates 
with glass bottom dishes in Dulbecco’s Modified Eagle Medium (DMEM) supplemented 
with 10% (v/v) fetal bovine serum (FBS) and 1% antibiotics (100 U/mL penicillin and 100 
µg/mL streptomycin) at 37 ºC under 5% CO2. For experiments cells were plated on p-35 
plates. Experiments were performed on confluent monolayers. Medium with FBS was 
removed, plates were washed with medium without FBS and then cells were treated in 
fresh medium without FBS. Treatments with 10 µmol/L non-modified POPC and nitrated 
POPC (from 3.67 mmol/L stock solution) were carried out at 37 ºC under 5% CO2 for 6h. 
At the time point, cells were fixed, processed for immunofluorescence and observed by 
confocal microscopy. 
GFP-vimentin wt stable transfectants were plated on 12-multiwell plate on glass 
bottom dishes in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% 
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(v/v) fetal bovine serum (FBS) and 1% antibiotics (100 U/mL penicillin and 100 µg/mL 
streptomycin) at 37 ºC under 5% CO2. Confluent monolayers were plated in DMEM 
medium deprived of FBS and were observed by confocal microscopy before and after 
treatments with 10 µmol/L and 30 µmol/L non-modified POPC and nitrated POPC (from 
3.67 mmol/L stock solution), and 10 µmol/L and 30 µmol/L GSNO (from stock solution of 
10 mmol/L) for imaging of live cells. Controls cells received an equivalent volume of 
DMSO. After treatments, cells were fixed, processed for immunofluorescence and 
observed by confocal microscopy. 
 
II.9.4. Immunofluorescence 
 
After the 6h treatment with 10 µmol/L non-modified and nitrated POPC, SW13 cells 
were washed twice with 1 mL 1x PBS, fixed with 4% paraformaldehyde for 20 min at 
room temperature, and washed again twice with 1 mL 1x PBS. Cells were permeabilized 
with 1 mL 0.1% Triton X-100 in PBS for 15 min, washed twice with 1 mL 1x PBS, 
blocked by incubation in 1% bovine serum albumin in PBS (blocking solution) for 1h, 
washed again twice with 1 mL 1x PBS and incubated with 500 µL anti-vimentin-Alexa 
488 at 1:200 dilution in blocking solution for 1h. Cells were further washed three times for 
5 min with 1 mL 1x PBS. For actin visualization, cells were counterstained with 100 µL of 
Phalloidin-Alexa 568 (5:200 dilution in blocking solution) for 30 min, and further washed 
three times for 5 min with 1 mL 1x PBS. The position of the nuclei was obtained by 
staining cells with 100 µL of 4,6-diamidino-2-phenylindole (DAPI) at 1:1500 dilution in 
PBS was added to cells and allowed to incubate for 20 min. Cells were washed twice with 
1 mL 1x PBS and kept in 1 mL 1x PBS with 4 µL of 10% sodium azide solution (final 
concentration of 0.04%) for confocal microscopy. 
 
II.9.5. Confocal Microscopy 
 
Cells were visualized on confocal microscopes Leica SP2 (LEICA DMRE2, 
Heidelberg, Germany) or LEICA SP5 (Leica microsystem LAS AF6000 modular system, 
Heidelberg, Germany). Individual sections were taken every 0.5 µm with a numerical 
aperture of x63. 
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RFP//vimentin wt and C238S SW13 cells were observed after 6 hours of treatment on 
a LEICA SP2. Cross-sections of single confocal microscopy planes of SW13 cells stained 
for vimentin by immunofluorescence were plotted to obtain profiles using Fiji ImageJ 
software. The pattern of the vimentin network was assessed to evaluate the proportion of 
cells with vimentin filaments circumscribed to the perinuclear area or extending towards 
the periphery of the cells. A minimum of 100 cells per assay were monitored.  
The Leica SP5 confocal microscope equipped with a thermostatic chamber at 37 °C 
was used for imaging of GFP-vimentin wt SW13 live cells after being treated with non-
modified POPC, nitrated POPC, GSNO (10 and 30 µmol/L), and DSMO. Briefly, a pre-
incubation image was taken, before the addition of the previous designated compounds.  
Further, cells underwent the treatments with 10 µmol/L and 30 µmol/L non-modified 
POPC and nitrated POPC (from 3.67 mmol/L stock solution), and 10 µmol/L and 
30 µmol/L GSNO (from stock solution of 10 mmol/L). Prompt observations of post-treated 
cells were performed. Then, cells were monitored for the 75 min of incubation. After the 
immunofluorescence protocol, GFP-vimentin wt SW13 cells were observed on LEICA 
SP2.  
 
II.10. Statistical Analysis 
 
Statistical analysis was performed using PRISM® GraphPad Software, Inc (GraphPad 
Prism 5.0, La Jolla, CA, USA). 
One-way analysis of variance (ANOVA) with the Bonferroni post-hoc test was used to 
determine significant differences (p<0.05) among phospholipid molecular species (non-
modified and nitrated phospholipid (NO2-PL) molecular species) for each experimental 
group in cardiac mitochondria from type 1 diabetes mellitus model (see Section II.5.2). 
The two-sided paired t-test was used to compare the conversion of phospholipid molecular 
species with formation of NO2-PLs. The results were expressed as mean ± SD of two 
different and independent experiments. 
One-way analysis of variance (ANOVA) with the Bonferroni post-hoc test was used to 
determine significant differences (p<0.05) among phospholipid molecular species (non-
modified and nitrated phospholipid (NO2-PL) molecular species) and to compare the 
conversion of phospholipid molecular species with formation of NO2-PLs for each control 
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and starvation group in cardiomyoblast H9c2 cell line model (see Section II.5.2). The 
results were expressed as mean ± SD of three different and independent experiments. 
In DPPH● (see Section II.7.1) and ABTS●+ (see Section II.7.2) assays, the experiments 
were performed in triplicate and in three different days both for non-modified and nitrated 
POPC. The results were expressed as mean ± SD. One-way analysis of variance (ANOVA) 
with the Bonferroni post-hoc test was used to determine signiﬁcant differences among 
samples. A P value <0.05 was considered signiﬁcant. For ORAC assay (see Section II.7.3), 
the experiments were performed in triplicate and in two different days both for non-
modified and nitrated POPC. The results were expressed as mean ± SD using two-sided 
unpaired t-test for a P value <0.05.  
For cell viability (see Section II.8.2), the results were analyzed with one-way ANOVA 
followed by Dunnett's multiple comparison test. For iNOS protein expression (see Section 
II.8.3) the comparison was made between the treatment condition and control using the 
two-sided unpaired t-test. A P value <0.05 was considered statistically significant. For each 
experimental condition, the results were expressed as the mean ± SD of at least three 
independent experiments.  
For in vitro gel-based competition method (see Section II.9.1), the results were 
analyzed with one-way ANOVA followed by Dunnett's multiple comparison test. The 
results were expressed as mean ± SD of three different and independent experiments. For 
SW13 cells treated with non-modified or nitrated POPC (see Section II.9.3), the results 
were analyzed with one-way ANOVA followed by Bonferroni post-hoc test. A P value 
<0.05 was considered statistically significant. For each experimental condition, the results 
were expressed as the mean ± SD of two independent experiments.  
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III.1. UNDERSTANDING THE NITROXIDATIVE STRESS-INDUCED 
MODIFICATIONS OF PHOSPHOLIPIDS 
 
Reactive nitrogen species (RNS) has the ability to react with lipids, generating nitro-
fatty acids that have been identified in vitro and in vivo. Considering that RNS can freely 
cross membranes, where it accumulates in higher concentrations, thus it is plausible that 
phospholipid nitration/nitroxidation can also occur. However, the identification and 
detailed structural characterization of nitrated and nitroxidized derivatives of phospholipids 
have been overlooked.  
In order to better understand the nitrative/nitroxidative-induced modifications in 
phospholipids, phospholipid standards from distinct classes, including 
phosphatidylcholine, phosphatidylethanolamine, and phosphatidylserine, the most 
abundant phospholipids in membranes, bearing different fatty acyl chains with distinct 
unsaturation degrees, were submitted to nitration by nitronium tetraflouroborate (NO2BF4), 
in a biomimetic model of nitroxidation (Section III.1.1 and Section III.1.2). The products 
formed in in vitro model system were characterized by liquid chromatography (LC)-mass 
spectrometry (MS) and tandem mass spectrometry (MS/MS) and identified in biological 
samples using the developed MS-based approaches. 
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III.1.1.1. Background and Aim of the Study 
 
In recent years, there has been an increasing interest in nitro-fatty acids (NO2-FA) as 
signaling molecules formed under nitroxidative stress. NO2-FA were detected in vivo in a 
free form, although it is assumed that they may also be esterified to phospholipids (PL). 
Nevertheless, insufficient discussion about the nature, origin or role of nitro phospholipids 
(NO2-PL) was reported up to now.  
The aim of this study was to develop a mass spectrometry (MS)-based approach which 
allows identifying nitroalkenes derivatives of three major PL classes found in living 
systems: phosphatidylcholines (PCs), phosphatidylethanolamines (PEs) and 
phosphatidylserines (PSs). NO2-PLs were generated by nitronium tetrafluoroborate 
(NO2BF4) in hydrophobic environment, mimicking biological systems. The NO2-PLs were 
then detected by electrospray ionization (ESI-MS) and ESI-MS coupled to hydrophilic 
interaction liquid chromatography (HILIC). Identified NO2-PLs were further analyzed by 
tandem MS in positive (as [M+H]+ ions for all PL classes) and negative-ion mode (as [M-
H]- ions for PEs and PSs and [M+OAc]-ions for PCs) for characterization of their 
fragmentation patterns. The developed MS method was further validated by screening the 
identified NO2-PL in cardiac mitochondria from a well-characterized animal model of type 
1 diabetes mellitus.  
 
III.1.1.2. Results and Discussion 
 
In this study, we have induced the nitration of PC, PE and PS phospholipids, differing 
in degree of unsaturation of the hydrocarbon chains (oleic acid (OA), linoleic acid (LA) 
and arachidonic acid (AA)) (Supplementary Table S-1 and Figure S-1, Appendix A), by 
incubation with nitronium tetrafluoroborate (NO2BF4). NO2BF4 is a nitronium cation salt 
(NO2
+) that has been previously used as nitrating agent in fatty acid nitration studies and 
was chosen for mimicking the nitration occurring on biological membranes with 
peroxynitrite and nitrite [7, 9, 58, 154] by allowing nitration to occur in hydrophobic 
environments [9, 58, 59]. 
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Tandem Mass Spectrometry Characterization of NO2-PLs 
 
Nitro phospholipids, NO2-PLs, were observed in the positive mass spectra as [M+H]
+ 
molecular ions and, in the negative mode mass spectra, as [M-H]- for PE and PS, and as 
[M+OAc]- molecular ions for PC. MS/MS spectra were acquired for both positive and 
negative precursor ions, to obtain complementary information, which could further be used 
for lipidomic studies on cell, tissues and biofluids [164, 165]. In the mass spectra, the nitro 
phospholipids (NO2-PL) were observed with a mass increment of 45 u relative to the non-
modified PL (Supplementary Table S-1, Appendix A). In order to confirm the formation of 
NO2-PLs, accurate mass measurement and elemental composition determination were 
performed in a Q-TOF mass spectrometer. Based on the accuracy of the measurements, the 
structural assignments could be made with a high degree of confidence (Supplementary 
Table S-2, Appendix A). 
Further, MS/MS spectra were acquired for the PC, PE and PS nitro derivatives both in 
positive- and negative-ion mode (Figure III.1) using collision induced dissociation (CID) 
conditions. All MS/MS spectra showed four main fragmentation pathways involving: a) 
the elimination of the nitro (NO2) group, as neutral loss of HNO2; b) formation of ionized 
nitrated fatty acids as [NO2-FA+H]
+ and [NO2-FA-H]
-; c) the fragmentation of the fatty 
acyl chain in the vicinity of the NO2 group and; d) combined fragmentation of the NO2 
group and the polar head groups of each PL. The fragmentation pathways identified for 
NO2-PLs are illustrated in Figure III.2 using NO2-OA-PLs as model. The product ions 
arising from observed fragmentation pathways can be used for identifying nitrated PLs. 
These include product ions formed due to neutral loss of nitro group as HNO2 (loss of 47 
u), observed both in positive and negative mode MS/MS spectra of all NO2-PL, as can be 
seen in Figure III.1 and Supplementary Figure S-2 to S-4 (Appendix A). Product ions 
arising from the neutral loss of H2O and 2H2O (loss of 18 u or 36 u) and combined loss of 
water and HNO2 (65 u and 83 u) were also observed. Such product ions were already 
reported for NO2-FA and thus can be used to unequivocally confirm the presence of a NO2 
group [7, 9, 10, 58, 69, 83, 100, 153, 154]. Other typical product ions that were observed in 
the MS/MS spectra are the protonated molecules of nitro-fatty acids, [NO2-FA+H]
+, that 
occur due to cleavage between the fatty acid and the glycerol backbone, and which 
observation in MS2 is favored due to charge retention in the nitro group [166, 167]. These 
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product ions were found at m/z 328.3 ([NO2-OA+H]
+), m/z 326.3 ([NO2-LA+H]
+) and m/z 
350.4 ([NO2-AA+H]
+) (Figure III.1 A to C, Figure III.2 and Supplementary Table S-3, 
Appendix A). When NO2-PL were analyzed in the negative mode, we observed in all the 
MS/MS spectra peaks corresponding to the carboxylate anions of NO2-FA ([NO2-FA-H]
-) 
(Supplementary Table S-3, Appendix A). These ions allowed unequivocal identification of 
NO2-FA esterified to the particular PL. Furthermore, MS
3 spectra of the nitro-fatty acids 
product ions, both in positive ([NO2-FA+H]
+) and negative ion modes (NO2-FA-H]
-), 
showed product ions confirming the presence of the NO2 group (neutral loss of HNO2), as 
reported previously for [NO2-FA-H]
- (Supplementary Figure S-5 and Table S-3, Appendix 
A) [5, 59, 83]. 
As previously indicated, the third identified fragmentation pathway produces typical 
fragment ions arising from cleavage of fatty acyl chain in the vicinity of the NO2 group, as 
shown in Figure III.2. This fragmentation pathway is observed in the MS/MS spectra of 
both positive and negative NO2-PLs precursor ions. Formed product ions are common for 
the NO2-PLs with the same fatty acyl chain (OA, LA and AA), independently of the polar 
head group. However, the fragment ions, that were observed for each fatty acyl chain were 
different and thus, the nature of the NO2-PLs was also different. In the case of NO2-OA-
PL, we have assigned the 9-NO2-OA-PL and 10-NO2-OA-PL species, which is in 
accordance with previously reported results for oleic acid nitration [5, 83]. The location of 
the nitro group at C9 or C10 was inferred by the observed cleavage between C8-C9 or 
C10-C11 occurring with a neutral loss of 169 u (C10H19ON) or 128 u (C8H16O), 
respectively [5, 83]. For NO2-LA-PL, we have assigned three major isomers, with the nitro 
group attached at C9, C10, or C13, inferred by product ions formed by cleavages between 
C9-C10, C13-C14, C10-C11 and C12-C13, respectively. These backbone cleavages 
promote neutral losses of 156 u (C9H16O2), 86 u (C5H10O), 139 u (C8H13ON) and 115 u 
(C6H13ON), respectively. For NO2-AA-PLs, we assigned four major isomers, with the nitro 
group attached in C11, C12, C14 or C15. The location of the NO2 group at C14 and C15 
were inferred by the observation of cleavages between C10-C11 and C13-C14 with the 
correspondent neutral loss of 183 u (C10H17O2N) or 143 u (C7H13O2N). The 11- or 12-NO2-
AA-PLs were assigned due to neutral loss of 193 u (C12H19ON). Other minor product ions 
were observed, as reported in Figures S-5 and S-6 (Appendix A), which are well described 
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in literature [5, 83]. These product ions can be used to locate the position of the NO2 group 
along the fatty acyl chain.  
 
 
 
Figure III.1. ESI-MS/MS spectra of: A) [M+NO2+H]
+ and [M+NO2+OAc]
- POPC 
molecular ions ([POPC+NO2+H]
+; A1, [POPC+NO2+OAc]
-); B) [M+NO2+H]
+ and 
[M+NO2-H]
- POPE molecular ions ([POPE+NO2+H]
+; B1, [POPE+NO2-H]
-) and; C) 
POPS molecular ions ([POPS+NO2+H]
+; C1, [POPS+NO2-H]
-). Product ions indicating 
the presence of a NO2 group were labeled with (♦). 
 
Phospholipids usually show a typical MS/MS fragmentation pattern depending on the 
polar head, including the observation of a product ion at m/z 184 for [PCs+H]+ ions, and 
neutral losses of 141 u for [PEs+H]+ ions and of 185 u for [PSs+H]+ precursor quasi-
molecular ions. However, the MS/MS spectra of the [M+H]+ ions of NO2-PLs (Figure III.1 
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A to C) show fragmentations usually observed in the MS/MS spectra of cationized ions 
([M+X, X= Na, K, Li]+) of non-modified PLs [3, 164, 168-171]. These fragmentations 
involve the polar head group and are the neutral losses of 59 u (C3H9N, trimethylamine) 
and 183 u (C5H14PO4N, phosphocholine) in the case of NO2-PCs. The decomposition of 
NO2-PEs and of NO2-PSs showed, respectively, the neutral loss of 43 u (aziridine, C2H5N) 
and the neutral loss of 87 u (Supplementary Table S-3, Appendix A). The occurrence of 
these fragmentation pathways in NO2-PL MS/MS spectra can lead to misassignment of the 
peaks in lipidomics studies. This behavior can be caused by proton retention in the NO2 
group, which modifies the lability of the chemical bonds, favoring different fragmentation 
pathways. Losses of 59 u, 43 u and 87 u involves cleavages of the O-C bond, namely 
between phosphate and PL-head group. The presence of the charge in the NO2 group, 
rather than exclusively in the polar head, could to favor the cleavage between the 
phosphate and the polar head, which only occurs in cationized non-nitrated PL. In fact, 
sodium ions have been reported to randomly associate with several regions of the PL 
molecule and the free negatively charged phosphate oxygen, in the sodium adduct of PL, 
can undergo fragmentation via neutral loss of trimethylamine (loss of 59 u) [172].   
 
 
 
Figure III.2. Major fragmentation pathways identified for NO2-PLs in positive- and 
negative-ion mode; NO2-OA-PLs derivatives were used as examples. Common 
fragmentations observed both in positive and negative modes are the loss of HNO2 and 
cleavages in the vicinity of the NO2 group. Fragmentations observed only in negative-ion 
mode ([M-H]- ions) corresponding to the carboxylate anions of NO2-FAs. Typical 
fragmentations observed in positive-ion mode ([M+H]+ ions) involve the presence of 
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protonated NO2-FA and loss of polar head group typically observed for the cationized ions 
of PLs. 
 
Bond Energy Theoretical Studies 
 
In order to gain atomistic insights into the mechanisms governing the different 
fragmentation patterns of the several compounds, namely the distinct fragments observed 
upon CID fragmentation of nitrated lipids, we have performed bond energy theoretical 
calculations. Since the distinct fragmentation was observed independently of the polar head 
and the fatty acyl chain, the theoretical calculations were performed considering the NO2-
PLPE system as a representative example of the common behavior of the remaining NO2-
PLs studied. The PE was chosen since it has the simplest polar head in terms of chemical 
structure and is more prone to theoretical calculation. The strategy involved analysis of the 
Wiberg bond indices obtained through Natural Bonding Orbital (NBO) analysis at the 
B3LYP/ 6-31++G** level using geometry optimized molecules (at the same level and 
theory). To decrease the conformational freedom and the total number of atoms, the 
saturated aliphatic chain was truncated to a simple methyl substitute. The lowest energy 
conformations of the PLPE models protonated at the -NO2 and terminal -NH2 groups (top 
and bottom, respectively) alongside the calculated Wiberg bond indices of the relevant 
bonds are shown in Supplementary Figure S-7 (Appendix A). 
The lowest energy conformation for the -NO2 protonated model presents the phosphate 
OH hydrogen bonded to the ester carbonyl (dNH--O=1.88 Å) whereas the ethanolamine 
terminal chain is stretched and not involved in any intramolecular interaction. In contrast, 
the -NH2 protonated structure shows an intramolecular hydrogen bond between one -NH3
+ 
hydrogen and the ester carbonyl (dNH--O=1.59 Å), resulting from the curling of the 
phosphoethanolamine fragment into itself. The protonation of the terminal NH2 originates 
a significantly more stable isomer, suggesting that this species are the most abundant. 
Comparing the Wiberg bond indices between both species, depicted in Supplementary 
Figure S-7 (Appendix A), the C—O bond near the ester is slightly weaker (lower bond 
index) in the NH2 protonated model (0.8674) than in the NO2 one (0.8768), suggesting that 
the former is more likely to be cleaved during MS/MS experiments. In contrast, the C—O 
bond close to the terminal NH2 is weaker in NO2 model than in the NH2 one, suggesting 
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that cleavage of the latter is more probable. These results are in clear agreement with the 
fragmentation patterns observed experimentally. 
The MS/MS spectra of [NO2-PLs+H]
+ ions (Figure III.1 A to C) also showed product 
ions arising from the combined loss of HNO2 and polar head group. These were the 
product ions formed by the neutral loss of 59+HNO2 and 183+HNO2 for NO2-PCs, 
43+HNO2 and 141+HNO2 for NO2-PEs and 87+HNO2 and 185+HNO2 for NO2-PSs, as 
confirmed by MS3 analysis (Supplementary Figures S-8 to S-10, Appendix A). We also 
observed combined loss of polar head and neutral losses due to the cleavage in the vicinity 
of the NO2 group for [M+H]
+ ions (Supplementary Figure S-10 and S-11, Appendix A). 
Overall, the typical fragmentation pattern reported in here is crucial to design targeted 
approaches for the identification of NO2-PL in complex biological samples. Moreover, 
these can be used to propose specific multiple reaction monitoring (MRM), precursor ions 
scan (PIS) or neutral loss scan (NLS), essential to detect and quantify nitrated 
phospholipids in the lipidome, as is resumed in Table III.1.  
 
Table III.1. Tandem MS fragment ions for diagnostic scan of NO2-PLs in positive and negative mode. 
 
Fragment Ion/Diagnostic Scan 
 Positive Mode [M+H]+ Negative Mode [M-H]- 
Nitro group (NO2) Neutral loss of 47 (-HNO2) Neutral loss of 47 (-HNO2) 
Head group   
Phosphatidylcholine Neutral loss of 59 u 
Neutral loss of 183 u 
-- 
-- 
Phosphatidylethanolamine Neutral loss of 43 u 
Neutral loss of 141 u 
-- 
-- 
Phosphatidylserine Neutral loss of 87 u Neutral loss of 87 u 
 Neutral loss of 185 u -- 
Nitrated Modifications   
[NO2-OA]+ Product ion 328 -- 
[NO2-LA]+ Product ion 326 -- 
[NO2-AA]+ Product ion 350 -- 
NO2-OARCOO- -- Product ion 326 
NO2-LARCOO- -- Product ion 324 
NO2-AARCOO- -- Product ion 348 
HNO2+Head Group   
Phosphatidylcholine Neutral loss of 106 u (HNO2+59) -- 
Neutral loss of 230 u (HNO2+183) -- 
Phosphatidylethanolamine Neutral loss of 90 u (HNO2+43) -- 
Neutral loss of 188 u (HNO2+141) -- 
Phosphatidylserine Neutral loss of 134 u (HNO2+87) Neutral loss of 134 u (HNO2+87) 
Neutral loss of 232 u (HNO2+185) -- 
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Identification of NO2-PL in Mitochondria 
 
Previously we have characterized the lipidome of cardiac mitochondria isolated from 
heart of an animal model of type 1 diabetes mellitus (T1DM) [156]. We observed an 
increase in the relative content of PC, and a decrease in the other classes of phospholipids 
(PI, SM and PG) in T1DM mitochondria in comparison with control group. Additionally, 
we detected higher amounts of carbonylated and nitrated proteins in T1DM mitochondria 
in comparison with control group [156]. In consequence, we decided to further investigate 
the presence of nitro phospholipids in the animal model of type 1 diabetes mellitus 
(T1DM), using the knowledge of the typical fragmentation pattern of NO2-PL reported in 
the previous section. It is worth noting that, in the previous report, we did not identify any 
NO2-PL.  
In this study, samples were analyzed by HILIC-LC-MS and MS/MS. The retention 
time (RT) observed for PC class was between RT 45 and 57 min and for PE was between 
RT 22 and 30 min, based on elution of internal standards (dMPC and dMPE, respectively) 
(Supplementary Figure S-12, Appendix A). The major PC molecular species identified for 
mitochondria of control and T1DM group, and their relative amount are shown in Figure 
III.3A. The LC-MS/MS spectra were also interpreted using the fragmentation pathway of 
NO2-PCs data. By doing so, we were able to identify nine NO2-PC species in T1DM 
cardiac mitochondria: at m/z 803.6 (NO2-PC 16:0/18:2); 805.7 (NO2-PC 16:0/18:1); 851.6 
(NO2-PC 18:2/20:4); 853.7 (NO2-PC 16:0/22:5, NO2-PC 18:0/20:5 and NO2-PC 
18:1/20:4); 855.7 (NO2-PC 18:0/20:4); 857.6 (NO2-PC 18:2/20:1); and 879.6 (NO2-PC 
18:0/22:6) (Figures 3B and Supplementary Figure S-13, Appendix A). Only NO2-PC 
18:2/20:1 was detected in the control samples, although with a small relative abundance. 
As an example, the LC–MS/MS spectra obtained for ions at m/z 805.7 (Figure III.4) 
allowed to confirm the presence of NO2-PC, based on typical fragmentation pattern namely 
loss of HNO2 and loss of HNO2+59 and HNO2+183.  
We calculated the ratio between the nitrated species and the corresponding non-
modified PC (Figure III.3C). It was found that the ratio of NO2-PC/non-modified PC was 
higher for PCs esterified with monounsaturated fatty acids such as for NO2-PC 34:1 (NO2-
PC 16:0/18:1) at m/z 805.7, NO2-PC 38:3 (NO2-PC 18:2/20:1) at m/z 857.6 and NO2-PC 
38:5 (NO2-PC 18:1/20:4) at m/z 853.7. This is in agreement with a recent report showing 
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that the increase in fatty acid length and in the unsaturation degree has a negative impact 
on the susceptibility towards NO2
+ driven nitration [5]. Using kinetic studies, authors 
reported that NO2-OA was formed faster compared to nitro-linoleic, nitro-arachidonic and 
nitro-docosahexaenoic acids. Interestingly, in our study, the non-modified PC molecular 
species (PC 16:0/18:1 at m/z 760.6 (POPC), PC 18:2/20:1 at m/z 812.7 (GLPC) and PC 
18:1/20:4 at m/z 808.6 (OAPC)) precursors of the NO2-PCs showing the higher percentage 
of conversion share the presence of one (mono)unsaturated fatty acyl chain in their 
composition.  
In this study, we were able to identify one nitrated PE species at m/z 837.5 (NO2-PE 
18:0/22:6) formed from nitration of PE 18:0/22:6 at m/z 792.5 (SDPE) bearing 
docosahexaenoic acid (Dha) as unsaturated fatty acyl chain (Supplementary Figure S-14, 
Appendix A). We have reported earlier the presence of PEs molecular species from cardiac 
mitochondria with high percentage of polyunsaturated fatty acids, mainly AA and Dha 
[156]. This could justify the observed lack of nitrated PEs in T1DM cardiac mitochondria. 
Interestingly, rat primary cardiomyocytes treated with the peroxynitrite donor 3-
morpholinosydnonimine (SIN-1) showed increased levels of Dha-NO2 when compared 
with NO2-AA (~3 fold) [5].  
The present results are significant as they highlight the presence of NO2-PCs and NO2-
PEs derivatives in biological samples, subjected to oxidative stress, allowing the 
quantification of the percentage of conversion of non-modified PL in NO2-PL. However, 
more research on this topic needs to be undertaken before the in vivo significance of 
phospholipid nitration is understood.  
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Figure III.3. A) Phosphatidylcholine (PC) molecular species profile observed for cardiac 
mitochondria of control group and type 1 diabetes mellitus (T1DM) group identified after 
LC-MS/MS analysis. B) NO2-PC molecular species identified after LC-MS/MS analysis 
for cardiac mitochondria of control group and for type 1 diabetes mellitus (T1DM) group. 
The results were expressed as relative percentage obtained by dividing the ratio between 
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the peak areas of each PC molecular specie and the PC internal standard (dMPC) and the 
total of all ratio. Values are means±standard deviation. *p<0.05, **p<0.01 and 
***p<0.0001, signiﬁcantly different from control group. C) Ratio between non-modified 
PC molecular species and NO2-PC in T1DM. The results were expressed as relative 
percentage determined by dividing the ratio between the peak areas of each NO2-PC 
molecular specie and the PC internal standard (dMPC) and the ratio between the peak areas 
of the correspondent non-modified PC molecular specie and the PC internal standard 
(dMPC). Values are means±standard deviation. **p<0.01 and ***p<0.0001, signiﬁcantly 
different from control group. 
 
 
Figure III.4. Reconstructed ion chromatogram (RIC) and HILIC-ESI-MS/MS spectrum of 
ions at m/z 805.7 ([M+H]+), retention time (RT) = 50.81 min, observed in mitochondria 
from T1DM heart. 
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III.1.1.3. Concluding Remarks 
 
In this study, we studied the in vitro formation of nitroalkenes derivatives of PCs, PEs 
and PSs after reaction with NO2BF4. Tandem mass spectra of the identified species (NO2-
PC, NO2-PE and NO2-PS) were acquired in order to determine the main fragmentation 
pathways of NO2-PLs. The fragmentation pattern observed in the MS/MS spectra of all 
PLs classes, showed product ions involving the neutral loss of HNO2, product ions formed 
by cleavage in the vicinity of the NO2 group and the presence of the nitrated fatty acyl 
chains.  
This approach allowed us to propose MS-based strategies that can allow simple, 
specific, rapid and sensitive analytical methodologies for the in vitro and in vivo detection 
and characterization of phospholipid nitration products. These approaches include specific 
tandem mass spectrometry modes such as MRM, PIS or NLS and can be used to identify 
and quantify NO2-PL in biological samples. On the basis of the typical fragmentation 
pattern observed for the NO2-PLs standards, we were able to identify ten nitrated 
derivatives of phospholipids, nine NO2-PCs and one NO2-PE, in cardiac mitochondria 
isolated from heart of a well-characterized animal model of type 1 diabetes mellitus. 
Nevertheless, more efforts are needed in order to test the propose scan modes and to 
extend the identification of nitrated PLs in other conditions. This will contribute for the 
understanding of nitration mechanisms in biological environments, and to establish the 
physiological relevance of NO2-PL species. 
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III.1. UNDERSTANDING THE NITROXIDATIVE STRESS-INDUCED 
MODIFICATIONS OF PHOSPHOLIPIDS 
 
 
III.1.2. PHOSPHOLIPID NITROXIDATION IN H9c2 MYOBLAST USING A 
LIPIDOMIC APPROACH 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The results and discussion presented in this section were integrally submitted as follow: 
Melo T, Domingues P, Ribeiro-Rodrigues TM, Girão H, Segundo MA, Domingues MRM (2016) 
Phospholipid nitroxidation in H9c2 Myoblast using a lipidomic approach. Free Radical Biology and 
Medicine, under revision. 
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III.1.2.1. Background and Aim of the Study 
 
Under nitroxidative stress conditions, lipids are prone to be modified by reaction with 
reactive nitrogen species (RNS) and different modifications were reported to occur in fatty 
acids. However, in the case of phospholipids (PL), studied under nitroxidative stress 
conditions, only nitroalkene derivatives of phosphatidylcholine (PC) and 
phosphatidylethanolamine (PE) were reported when using both in vitro biomimetic 
conditions and in vivo model system of type 1 diabetes mellitus. Therefore, in order to 
further explore other nitroxidative modifications of PL, a biomimetic model of 
nitroxidation combined with liquid chromatography mass spectrometry (MS) and MS/MS 
approaches were used to characterize the nitrated and nitroxidized derivatives of PCs and 
PEs.  
Results gathered with in vitro biomimetic models were validated by screening the 
nitrated and nitroxidized PL species in a cardiomyoblast cell line (H9c2), a suitable model 
for cardiac cells, in conditions of starvation and ischemia, to mimic the conditions to which 
cardiomyocytes are exposed during acute myocardial infarction. 
 
III.1.2.2. Results and Discussion 
 
Nitrated and nitroxidized modifications of PLs were induced by co-incubation of 
nitronium tetrafluoroborate (NO2BF4) with PC (POPC, PLPC and PAPC) and PEs (POPE, 
PLE and PAPE). These PL species were selected considering that PCs and PEs are the 
major constituents in membranes and, as reported for free fatty acids, different degree of 
unsaturation were chosen and this  can lead to different susceptibility to nitration [5]. 
The formation of nitrated and nitroxidized products of PLs was monitored by ESI-MS 
and LC-MS. These products were observed in positive-ion mode as [M+H]+ ions for PCs 
and PEs and negative-ion mode as [M-H]- ions for PEs (Supplementary Figures S-2 and S-
3, Appendix B). Analysis of the MS data revealed new ions observed at higher m/z values 
that the non-modified PLs, which are consistent with the formation of nitrated and 
nitroxidized products (Supplementary Tables S-1 and S-2; Figures S-2 and S-3, Appendix 
B). These ions were assigned as nitroso PL (NO-PL and (NO)2-PL) and nitro PL (NO2-PL 
and (NO2)2-PL). Products bearing concomitantly NO with NO2 groups (nitronitroso, 
(NO2)(NO)-PL), and products bearing one or two NO2 with hydroxy or hydroperoxy 
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moieties were also observed (Supplementary Tables S-1 and S-2, Appendix B). Weak 
signals attributed to the well-known oxidized derivatives of PCs and PEs, namely keto, 
hydroxy and hydroperoxy derivatives were also observed [173, 174]. Elemental 
composition and mass accuracy measurements supported the structural assignments that 
could be made with a high degree of confidence (Supplementary Tables S-3 and S-4, 
Appendix B).  
Typical fragmentation of nitrated and nitroxidized PL products was obtained 
performing reversed-phase LC-ESI-MS and LC/ESI-MS/MS, which allowed to confirm 
the proposed assignments, to identify specific fragmentation pattern that can be used for 
target lipidomics analysis of biological samples, and to unveil isomeric species.  
 
LC-MS and LC-MS/MS analysis of Nitrated Phospholipids 
 
Nitro PL derivatives (NO2-PL) showed typical fragmentation assigned as loss of 
HNO2 (-47 u) [175]. Nitroso derivatives, NO-PL and (NO)2-PL (Tables S1 and S2), 
showed product ions arising from the loss of one or two nitroxyl groups (31 u, HNO), thus 
confirming the presence of a NO group. The absence of fragment ions arising from loss of 
HNO2 (47 u) confirmed the proposed assignment and the nonexistence of a NO2 group 
linked to PL (Figure III.5; Supplementary Figures S-4 A, B and S-5, Appendix B).  
The LC-MS chromatogram of PL nitrated products with a mass shift of +45 u eluted in 
two distinct peaks (Supplementary Tables S-1 and S-2). The MS/MS data, obtained in each 
retention time, allowed to differentiate the isomeric nitrosohydroxy ((NO)O-PL) and the 
nitro derivatives (NO2-PL). As exemplified for POPE + 45u (Figure III.6; Supplementary 
Figures S-6 to S-8, Appendix B), the MS/MS spectrum of the nitrosohydroxy derivative 
(RT 31.3 min) showed the fragment ions arising from the neutral of HNO typical of the 
nitroso derivatives, but no fragment ions arising from the neutral loss of HNO2 were 
observed, while the isomer eluting at 44.0 min attributed to NO2-POPE only displayed the 
neutral loss of HNO2 [175]. Nitronitroso derivatives, (NO2)(NO)-PL (Figure III.7A; 
Supplementary Figures S-4 C, E and S-9, Tables S-1 and S-2, Appendix B) showed in their 
MS/MS spectra fragment ions arising from both neutral losses of HNO2 and HNO, while 
dinitro derivatives (NO2)2-PL showed fragment ions arising from from loss of one and two 
HNO2 (Figure III.7B; Supplementary Figure S-4 D, F and S-10; Tables S-1 and S-2, 
Appendix B). 
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The LC-MS/MS spectra of PL products that were simultaneously oxidized and 
nitrated, namely nitrohydroxy, nitrohydroperoxy, dinitrohydroxy and dinitrohydroperoxy, 
showed fragment ions arising from the neutral losses of one or two HNO2 depending on 
the presence of one or two NO2 moieties, but no fragment ions arising from the neutral loss 
of HNO could be observed (Figure III.7 C and D; Supplementary Figures S-11 to 17; 
Tables S-1 and S-2, Appendix B). MS/MS of hydroperoxy derivatives showed losses of 32 
u (O2) or 34 u (H2O2) (Figure III.7 C and D; Supplementary Figures S-11 to 17, Appendix 
B) [174, 176]. The above described reporter fragmentations are typical for MS/MS 
obtained both positive- ([M+H]+) and negative-ion mode ([M-H]-) ions.  
Besides the fragmentation patterns involving nitro and nitroso groups, the MS/MS data 
in positive mode ([M+H]+ precursor ions) from nitrated precursor ions also showed typical 
fragmentation involving PCs and PEs polar head group: fragment ions arising from neutral 
loss of 59 u and 183 u for PCs; and 43 u and 141 u for PEs. Moreover, ions arising from 
combined neutral losses of polar head groups and loss of HNO and HNO2 were also 
assigned (Table III.2). 
Fragmentation patterns involving nitrated fatty acids linked to PL could also be seen in 
MS/MS data, as summarized in Tables III.2 and S5. In positive mode, there were abundant 
product ions formed by loss of nitrated or nitroxidized sn-2 fatty acyl chains as acid or keto 
derivatives, and product ions corresponding to protonated modified fatty acids [NOn-
FA+On+H]
+, [NOn-FA+On-H2O+H]
+, and [NOn-FA+On -2H2O+H]
+, n=1-2. In negative 
mode, modified carboxylate anions, namely [NOn-FA+On-H]
-, [NOx-FA+Ox-H2O-H]
-, and 
[NOn-FA+On-2H2O-H]
- (n=1-2) ions were assigned both in the nitrated or nitroxidized 
products. 
 
Identification of nitrated and nitroxidized species of Phospholipids in Cardiomyoblasts  
 
The information on the typical fragmentation pattern observed in this study for the 
nitrated and nitroxidized PCs and PEs derivatives in biomimetic in vitro model system, 
was used to search for the nitroxidative PCs and PEs modifications in cardiomyoblasts 
(H9c2) under starvation or ischemia conditions, mimicking the acute myocardial infarction 
conditions [177]. Notably, the generation of NO2-FA was reported during 
ischemia/reperfusion [76] and heart ischemia preconditioning [77].  
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In our study, we have not identified any nitrated or nitroxidized PL products on cells 
under ischemia or control conditions. However, we identified nitrated and nitroxidized PCs 
and PEs species on H9c2 cells under starvation. The modified PCs we have identified were 
the following: one nitro derivative at m/z 805.8 (NO2-PC 16:0/18:1); two dinitro 
derivatives at m/z 822.9 ((NO2)2-PC 16:0/16:1) and 850.8 ((NO2)2-PC 16:0/18:1); one 
nitroso derivative at m/z 817.7 (NO-PC 18:0/18:1); one nitronitroso derivative at m/z 858.4 
((NO2)(NO)-PC 16:0/20:3); and one nitroxidized derivative at m/z 837.7 (NO2)(2O)-PC 
16:0/18:1 (Supplementary Figures S-19 and S-20, Appendix B).The relative amount of 
nitrated and nitroxidized PC molecular species and the ratio between the modified PCs 
molecular species and the corresponding non-modified PC were calculated and are shown 
in Figure III.8A to C. The modified PCs molecular species found to be present in higher 
relative amount was the nitro derivative (NO2-PC 16:0/18:1) followed by the dinitro 
derivatives ((NO2)2-PC 16:0/18:1 and ((NO2)2-PC 16:0/16:1). The nitroso derivative (NO-
PC 18:0/18:1) was the modified species with lower relative amount. In figure III.8C and D, 
the ratio of conversion, calculated by the ratio between nitrated and non-modified PL’s, is 
shown. The modified species with higher ratio of conversion were the nitro NO2-PC 
16:0/18:1 followed by the dinitro (NO2)2-PC 16:0/18:1 and nitronitroso (NO2)(NO)-PC 
16:0/20:3 derivatives, respectively (Figure III.8C). In the case of PE, we were able to 
identify two nitrated PE species: NO2-PE 34:1 and NO2-PE 36:1, at m/z 763.7 and 791.5, 
respectively (Supplementary Figures S-21 and S-22, Appendix B), and their percentage of 
conversion are shown in Supplementary Figure III.8D (Appendix B).  
Nitration seems to be favored in hydrophobic environment of biological membranes, 
where RNS easily diffuse, cross membranes and accumulate [48, 178, 179], being related 
with the formation of nitrated fatty acids [59]. As so, phospholipids in biomembranes are 
expected to be also a target for lipid nitration but these types of PL modifications are 
scarcely reported.  
In the present study, biomimetic models with PC and PE, the most abundant PL in 
membranes, were used to simulate nitroxidative stress conditions using NO2BF4, a salt of 
nitronium ion (NO2
+), recognized as a biomimetic agent of phospholipid [175] and fatty 
acid nitration [5, 9, 58]. Herein, we reported the fragmentation patterns of these nitrated 
species. This involved combined losses of HNO, HNO2, for single and multiple nitrated 
species, and also combined losses with fragmentation of polar head groups of PC and PE. 
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These fragmentation pathways can be used to pinpoint nitro and nitroxidized modifications 
of PL in biological samples. Results gathered in this study allow to identify specific 
fragmentation pathways for NO-PL, (NO)2-PL, NO2-PL, (NO2)2-PL, (NO2)(NO)-PL, 
(NO)O-PL, (NO2)O-PL, (NO2)(2O)-PL, (NO2)2O-PL and (NO2)2(2O)-PL species.  
 
 
 
 
Figure III.6. LC tandem mass spectra of isomers of nitroxidized and nitrated PE. LC-ESI-
MS/MS spectra of [M+H]+ ions at m/z 763.5 (POPE+NO+O) and 763.4 (POPE+NO2). 
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Table III.2. Typical neutral losses and product ions observed in tandem mass spectra that 
can be used for diagnostic scan of nitrated and nitroxidized PLs in positive- and negative-
ion mode. 
 
  
Mass shift to 
non-modified 
PLs 
Typical Neutral Losses (NL) for 
Diagnostic Scan in MS2 
Nitrated derivatives 
NO-PL Nitroso +29 -31 u  (HNO) 
NO2-PL Nitro +45 -47 u  (HNO2) 
(NO)2-PL Dinitroso +58 
-31 u  (HNO) 
-62 u  (2HNO) 
 (NO2)(NO)-PL Nitronitroso +74 
- 47 u  (HNO
2
 
-31 u  (HNO) 
(NO2)2-PL Dinitro +90 
- 47 u (HNO
2
) 
- 94 u (2HNO
2
) 
Nitroxidized derivatives 
 (NO)O-PL Nitrosohydroxy +45 
-18 u (H
2
O) 
-31 u (HNO) 
(NO2)O-PL Nitrohydroxy +61 
-18 u (H
2
O) 
- 47 u (HNO
2
) 
(NO2)(2O) Nitrohydroperoxy +77 
-18 u (H
2
O) 
- 32 u (O2) 
-47 u (HNO
2
) 
(NO2)2O-PL Dinitrohydroxy +106 
-18 u (H
2
O) 
-47 u (HNO
2
) 
-94 u (2HNO
2
) 
(NO2)2(2O)-PL Dinitrohydroperoxy +122 
-18 u (H
2
O) 
-32 u (O2) 
-47 u (HNO
2
) 
-94 u (2HNO
2
) 
Neutral losses of nitrated /and nitroxidized (-31 and -47 u) can be seen combined with the typical 
fragmentation of polar head of PLs [164]: PCs: NL+59 u (C3H9N) and NL+183 u (C5H14PO4N); PEs: 
NL+43 u (C2H5N) and NL+141 u (C2H8PO4N). 
 
The reported fragmentations proposed in this study were further validated by allowing 
to pinpoint nitrated and nitroxidized PL species in the lipidome of the cardiomyoblast 
H9c2 cell line under starvation, but not upon ischemia or control conditions. It is known 
previously that phospholipid profile changes as an adaptation/response mechanism to these 
pathophysiological conditions and can have a role in cell survival or cell death [177]. In the 
case of starvation, a decrease in the relative abundance of PC 34:1, and an increase in PS 
36:1 molecular species were observed, when comparing both with control and ischemia 
[177]. It was suggested that this could be associated with adaptive pathways related with 
cell recovery and survival, preventing the events that triggers apoptosis and cell death 
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[177]. Also, the decrease of PC 34:1 could be due to being modified by RNS, since the 
formation of their nitro derivatives was observed exclusively in starvation. 
In our study, the PL nitro derivatives showed higher relative abundance in comparison 
with nitroso or nitroxidized derivatives. In biological systems, it is reasonable to assume 
the formation of the nitro derivatives of lipids as the first step of nitration reactions. These 
products can further react with ROS or other RNS to generate the other products, such as 
nitroso, dinitro, nitronitroso and nitroxidized derivatives. Also, reaction of nitro derivatives 
with O2 can lead to the formation of a nitrohydroperoxide derivative, which can be further 
reduced to form the nitrohydroxy derivative [65]. These assumptions are also supported by 
the findings of Milic and co-authors [5] where, during both electrophilic (NO2
+) and free-
radical-mediated nitration of fatty acids, found that nitro derivatives do not represent the 
final products, but are prone to be further nitrated or oxidized leading to the formation of 
multiple nitrated, nitroso, nitronitroso and nitroxidized derivatives. 
Also, in our study, we were unable to observe the formation of NO2-PLs in ischemia 
simulating conditions. Interestingly, other authors have reported that endogenous 
generation of nitroalkene derivatives of fatty acids does not occur [76] or occurs in a very 
low extent, generating a minute amount of NO2-FA [77] in myocardial ischemia without 
reperfusion. In fact, we only observed nitrated PL species in starvation condition but not in 
ischemia. In spite of the biological effects of nitrated and nitroxidized PLs have not been 
reported and remain unknown, it is well recognized that nitroalkene derivatives of fatty 
acids have important biological signaling actions as anti-thrombotic [111], anti-
hypertensive [96, 97, 109] and anti-inflammatory agents [10, 11, 70, 94, 98, 100, 102, 105-
108]. Nitroxidized fatty acids have also been reported as anti-hypertensive agents [65]. 
It is well-known that nitro-fatty acids trigger their biological signaling events by post-
translational modifications (PTM) of key proteins such as PPARγ, NF-κB, Keap1-Nrf2, 
AT1 receptor, heme oxygense 1 (HO-1) [11, 76, 94, 96, 100, 105, 121, 180], regulating 
pivotal signaling pathways essential to ensure cellular homeostasis and provide protection 
to the cardiovascular system by affecting various biological processes namely reduction of 
vascular inflammation [76, 181] and platelets aggregation [111], enhancement of 
vasodilatation [111], stimulation of anti-inflammatory and antioxidant mechanisms [13]. 
For all of these reasons, an important modulatory role have been ascribed to NO2-FA in the 
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context of cardiovascular diseases [180], contributing to reduce the risk of atherosclerosis, 
myocardial infarction and stroke. 
Although nitroalkene derivatives of arachidonic acid (NO2-AA), linoleic acid (NO2-
LA) and oleic acid (NO2-OA) can be involved in PTM, NO2-OA seems to be a preferential 
player [11, 12]. Thus, it is conceivable that the main formation of NO2-PL derivatives 
bearing OA could have a critical role in cell survival associated with autophagy and 
starvation. Moreover, there is now sound evidence that NO2-OA may be an upstream 
signal-regulating species in autophagy [77, 138]. Indeed, NO2-OA has been reported to 
potently activate all PPAR isoforms, including peroxisome proliferator-activated receptor-
α (PPARα) and peroxisome proliferator-activated receptor-γ (PPARγ) [11, 94, 132]. 
PPARα is highly expressed in heart and cardiomyocytes [182-184], where upregulates the 
expression of many genes encoding enzymes of fatty acid transport, esterification, uptake, 
and utilization via β-oxidation [185]. Thus, its activation could be of remarkable 
importance in the adaptation to starvation conditions. PPARγ is involved in the regulation 
and maintenance of metabolic homeostasis [183, 185, 186] but has also been associated 
with anti-inflammatory pathways and regulation of inflammatory responses [182, 187, 
188]. PPARγ activation has an important role in the maintenance of normal heart function, 
[182, 189] reversed myocardial lipid accumulation, increased glucose oxidation, improved 
and restored myocardial heart function in a rat model of type 2 diabetes [186]. Nitro- and 
nitrohydroxy derivatives of fatty acids are physiologically relevant candidates as 
endogenous ligands of  PPARγ [78]. There are in vitro evidences that PPARγ activation is 
very sensitive to NO2-OA [133] leading to PPARγ-mediated anti-inflammatory actions 
[100, 102, 187, 190]. Therefore, it is plausible that the presence of NO2-PLs in 
cardiomyoblast H9c2 cells relates with PPARγ activation, which could sustain the 
resolution of myocardium infarction. 
Additionally, PPARγ is reported to protect cardiomyocytes from oxidative stress-
induced apoptosis, decreasing hydrogen peroxide (H2O2)-induced apoptosis in 
cardiomyocytes [188, 191, 192]. Upregulation of genes controlled by NF-κB transcription 
factor signaling pathways [193], which has been related with cardiomyocyte pro-
inflammatory cytokine release and apoptosis, and the induction of intracellular 
accumulation of Ca2+ in cardiomyocytes leading to heart dysfunction [194], together with 
being a precursor of hydroxyl radical are some of the adverse roles attributed to H2O2.  
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Activation of PPARγ by NO2-OA has already been associated with a concomitant 
downstream regulation of NF-κB [100]. Thus, the presence of the NO2-PLs could also be 
correlated with PPARγ activation, with anti-inflammatory and cardioprotective effects in 
H9c2 cardiomyoblast cells.  
Nevertheless, activation of PPARγ is not the only mechanism by which NO2-OA, and 
possibly NO2-PLs bearing NO2-OA, exerts their beneficial actions. NO2-OA also 
demonstrated to have a potent inhibitory effect on NF-κB activation and translocation to 
the nucleus by alkylation of the p65 subunit, thus modulating the release of pro-
inflammatory cytokines and inflammatory signaling [13, 76, 132, 181]. NO2-OA up-
regulates Nrf2 activity and expression by alkylation of the inhibitor protein keap1 [104, 
105, 122, 195]. NO2-OA is involved in heme oxygenase 1 (HO-1) expression and 
activation, which also mediates anti-inflammatory actions [13, 98, 104, 107]. NO2-OA can 
induce heat shock factor 1 (HSF1)- and HSF2-dependent activation of heat shock 
responsive genes [105] in order to regulate the heat shock response, which is a ordered 
response to metabolic dysregulation and exposure to inflammatory-derived reactive species 
[196]. The fact that NO2-OA being able to trigger the Keap1-Nrf2 pathway and the heat 
shock response is related to cellular adaptation and enhancement of cell survival [197]. In 
fact, NO2-FA has been suggested to an upstream signal for regulation of autophagy, thus 
confering cardioprotection [77, 138]. Autophagy is an adaptive survival response that aims 
to replenish the energy and “building blocks” required for cells survival when nutrients are 
scarce [198] being therefore a key mechanism to ensure the maintenance of the cardiac 
homeostasis under nutrients and oxygen deprivation conditions [199]. Under myocardial 
ischemia, where both oxygen and nutrient deprivation (starvation) occur simultaneously, 
there is an activation of autophagy, that according to its duration and extent can determine 
the cell fate, either survival or death [200, 201]. It is also established that in ischemic 
conditions, the activity of nitric oxide synthase (NOS) (mostly eNOS and nNOS) is 
reduced leading to reduced or diminished NO● generation and release [202]. Therefore, the 
low levels of NO● may not be enough to lead the generation of RNS able to induce 
nitration or nitroxidation of PLs. Thus, it is conceivable that the presence of NO2-FA 
esterified to PLs observed only in cardiomyoblasts under starvation may be also correlated 
with cardioprotective pathways. 
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III.1.2.3. Concluding Remarks  
 
In this study, by using a lipidomics approach, we have been able to identify and 
characterize nitroalkene derivatives of PLs (NO2-PLs) and other single and multiple 
nitrated species such as nitroso, dinitroso, dinitro and nitronitroso derivatives, together 
with nitroxidized species. 
The tandem mass spectrometry typical fragmentation pattern obtained for nitrated and 
nitroxidized phospholipid standards showed to be a valuable tool for the detection of the 
nitrated and nitroxidized derivatives of phospholipids (PCs and PEs) in vivo. 
In cardiomyoblasts subjected to starvation, but not in control or ischemia conditions, 
we were able to identified one NO2-PC, two (NO2)2-PCs, one (NO2)(NO)-PC, one NO-PC, 
one (NO2)(2O)-PC and two NO2-PEs. These products can have a role in cardioprotection 
by post-translational modifications of the key proteins, directly or after release of the 
nitrated/nitroxidized fatty acid moiety. These modifications of target proteins may initiate a 
cascade of signaling actions leading to the stimulation of anti-inflammatory and 
antioxidant pathways that can have an impact in reduction of the risk factors for onset and 
development of cardiovascular diseases. 
Although this study contributed to unveil the products that can be formed under 
nitroxidative conditions in vivo, it is very important to further identify these modified lipids  
and increase our knowledge regarding susceptibility to be modified, mechanism of  
formation, and, ultimately to understand their biological actions.  
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III.2. UNDERSTANDING THE BIOLOGICAL ACTIVITIES OF NITRATED AND 
NITROXIDIZED DERIVATIVES OF PHOSPHOLIPIDS 
 
Nitro-fatty acids (NO2-FA) and nitrohydroxy fatty acids ((NO2)O-FA) have been 
described to exerts important biological signaling actions namely as anti-inflammatory, 
anti-hypertensive, and inhibitors of  platelet aggregation – anti-thrombotic agents. Nitrated 
and nitroxidized phospholipids have been overlooked regarding both their 
identification/structural characterization and biological roles.  
In order to give new insights in the biological activities of nitrated phospholipids, the 
antioxidant and anti-inflammatory activities of nitrated/nitroxidized phosphatidylcholine 
products were evaluated using different antioxidant assays, well recognized as tools to 
establish the antioxidant status of compounds or extracts, and evaluating their anti-
inflammatory potential by measuring their effects on nitric oxide synthase expression in 
activated macrophages (Section III.2). 
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III.2. UNDERSTANDING THE BIOLOGICAL ACTIVITIES OF NITRATED AND 
NITROXIDIZED DERIVATIVES OF PHOSPHOLIPIDS 
 
 
III.2.1. NEW INSIGHTS IN ANTI-INFLAMMATORY AND ANTIOXIDANT 
PROPERTIES OF NITRATED PHOSPHOLIPIDS 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The results and discussion presented in this section were integrally under revision as follow: 
Melo T, Marques SS, Ferreira I, Cruz, MT, Domingues P, Segundo MA, Domingues MRM (2016) New 
Insights in Anti-inflammatory and Antioxidant Properties of Nitrated Phospholipids. Chemistry and Physics 
of Lipids, under revision. 
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III.2.1.1. Background and Aim of the Study 
 
The nitroalkene derivatives of unsaturated fatty acids (NO2-FA) have been widely 
studied regarding their identification, structural characterization and biological actions. 
NO2-FA could also be present endogenously esterified to phospholipids (PL), and NO2-
PLs were already identified in cardiac mitochondria from a well-characterized animal 
model of type 1 diabetes mellitus. However, the biological actions of NO2-PL have been 
overlooked.  
The aim of this study was to evaluate the anti-inflammatory and antioxidant potential 
of the nitrated/nitroxidized 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 
namely the nitroalkene derivative (NO2-POPC) that is the major product formed in vitro by 
incubation with nitronium tetraflouroborate (NO2BF4), in a well-recognized biomimetic 
model of nitroxidative stress. The antioxidant capacity was investigated through the 
evaluation of the radical scavenging capacity against 2,2-diphenyl-1-picrylhydrazyl radical 
(DPPH●), against 2,2’-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid radical cation 
(ABTS●+) and through the oxygen radical absorbance capacity (ORAC) assay. Anti-
inflammatory potential was assessed by evaluation the effects of nitrated POPC in the 
inducible nitric oxide synthase (iNOS) expression in RAW 264.7 macrophages activated 
by the Toll-like receptor 4 (TLR4) agonist lipopolysaccharide (LPS) in a well described in 
vitro model of inflammation. 
 
III.2.1.2. Results and Discussion 
 
Despite the mechanism of lipid nitration remains still under active investigation there  
are evidences concerning the formation and presence of NO2-FA as free and esterified  
species in vivo [7, 9, 67, 69, 175]. Moreover, although in vivo concentrations of NO2-FA 
are reported to range from the micromolar [11] to picomolar [9], during inflammatory 
conditions their levels have been shown to be greatly increased [71, 95]. These 
concentrations should be higher enough to allow NO2-FA to exert biological actions 
namely as antioxidant and anti-inflammatory agents partially by counteracting the pro-
inflammatory effects [16]. The biological actions described for NO2-FA are based on their 
ability to potently regulate the expression of key inflammatory proteins [11, 94, 100, 117, 
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127, 128] and phase II antioxidant enzymes [70, 105, 107]. Inspired by the lack of 
knowledge concerning the anti-inflammatory and antioxidant potential of NO2-FA 
esterified to phospholipids, we evaluated the anti-inflammatory and antioxidant capacity of 
a nitrated POPC. Nitrated POPC, whose nitroalkene derivative (NO2-POPC) is the major 
product formed after biomimetic nitration, was chosen as a model system due to the high 
prevalence of phosphatidylcholine in mammalian cellular membranes and lipoproteins. In 
fact, POPC and oleic acid are, respectively, one of the major PC species and the most 
abundant monounsaturated fatty acid found in biological systems [68]. Besides, nitro-oleic 
acid is the most abundant nitroalkene derivative found in human plasma [10, 68] and NO2-
POPC was one of the major nitrated phospholipid specie recently detected in vivo [175]. 
Three common assays were used for measuring the antioxidant activity: DPPH● assay, 
Trolox equivalent antioxidant capacity assay (with ABTS●+ radical cation) and ORAC 
assay. These assays are well recognized as instrumental tools to establish the antioxidant 
status of candidate compounds or extracts in vitro [205]. These methods differ in terms of 
their assay principles and experimental conditions, therefore, it is indispensable to consider 
all assays for the fully elucidation of the antioxidant capacity profile of a given compound 
or extract as no single method has the ability to accurately reflect the multiple mechanisms 
of antioxidant actions. The anti-inflammatory capacity of the nitrated POPC was assessed 
through evaluation of iNOS expression on LPS-stimulated RAW 264.7 macrophages. LPS 
is a TLR4 agonist able to evoke a pro-inflammatory profile in macrophages [163]. In all 
experiments, non-modified POPC was used as a control.    
 
Antiradical Activity: ABTS●+ and DPPH● Assay 
 
The blue-green ABTS●+ radical can be reduced either by an antioxidant compound or a 
mixture by electron or hydrogen atom transfer, while the purple chromogen DPPH● radical 
can be reduced through electron transfer to the corresponding pale yellow hydrazine [203].  
The scavenging capacity of non-modified POPC and nitrated POPC (125, 150 and 250 
µg/mL in ethanol) was evaluated by monitoring the absorbance decrease at 734 nm 
(ABTS●+) and 517 nm (DPPH●) during 120 min. Firstly, we assessed the amount (in 
percentage) of ABTS●+ (Supplementary Figure S-1A to A2, Appendix C) and DPPH● 
radical (Supplementary Figure S-1B to B2, Appendix C) that remained in solution 
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throughout the reaction time. In the presence of the non-modified POPC, only a very 
slightly decreased in the percentage of both ABTS●+ and DPPH● radical remaining was 
observed after 120 min of reaction as summarized in Table III.3. Thereby lower ability to 
scavenge the ABTS●+ and DPPH● radicals can be attributed to non-modified POPC. These 
findings also allowed us to establish that both radicals are highly stable and not decayed by 
itself during the reaction time. In the presence of nitrated POPC, a marked decrease of the 
ABTS●+ radical remaining was found (Supplementary Figure S-1A to A2, Appendix C). 
The ability of nitrated POPC to reduce the ABTS●+ radical was concentration dependent, in 
spite of the response seems to be not linear. The percentage of inhibition of ABTS●+ radical 
obtained in the presence of non-modified POPC (control; white bar) and nitrated POPC 
(black bar, P<0.0001) was calculated and is shown in Figure III.9A and S2 A. In the 
presence of non-modified POPC the percentage of inhibition was found at basal levels thus 
the amount of ABTS●+ radical remaining was high, as reported above. For nitrated POPC, 
the percentage of inhibition was higher and enhanced by the increase of concentration 
(Figure III.9A). The IC50 value after 120 min of reaction was 124±2 µg/mL. Nitrated 
POPC also exhibits ability to reduce the DPPH● radical since the percentage of DPPH● 
radical remaining decreased during the reaction time (Supplementary Figure S-1B to B2, 
Appendix C). This ability seems to be dose-dependent since higher concentrations of 
nitrated POPC are reflected in a higher ability to reduce the DPPH● radical (Table III.3). 
Figure III.9B and Supplementary Figure S-2B (Appendix C) show the percentage of 
inhibition of DPPH● radical obtained in the presence of non-modified POPC (control; 
white bar) and nitrated POPC (black bar, P<0.0001). However, in comparison with the 
ABTS●+ assay, the decrease in the percentage of the remaining radical was lower and not 
allowed to achieve the 50% inhibition of DPPH● radical (Figure III.9B and Supplementary 
Figure S-2B, Appendix C). For this reason, we were not able to calculate the IC50 value 
for DPPH● assay. Instead, we calculate the IC20 value after 120 min of reaction, which 
was 225±4µg/mL. The obtained TE values were 152±9 µmol Trolox/g lipid for ABTS●+ 
assay and 86±6 µmol Trolox/g lipid for DPPH● assay.  
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Figure III.9.  (A) Percentage of inhibition of ABTS●+ (A) and DPPH● radicals (B) 
obtained in the presence of non-modified POPC and nitrated POPC (125, 150 and 250 
µg/mL) after 120 min of reaction. Values were the means±SD. ***, signiﬁcantly different 
from control group (P<0.0001). 
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Table III.3. Amount of the residual ABTS●+ and DPPH●
 
radicals after 120 min of reaction 
in the presence of non-modified POPC and nitrated POPC at the three concentrations 
tested (125, 150 and 250 µg/mL) prepared in ethanol. The results were expressed as 
percentage of ABTS●+ and DPPH● remaining. 
 
[Non-modified POPC] 
(µg/mL) 
%ABTS 
Remaining 
[Nitrated POPC] 
(µg/mL) 
%ABTS 
Remaining 
125 95.1±2.1 125 60.5±3.3 
150 95.7±2.0 150 47.9±4.8 
250 94.5±2.4 250 21.5±1.0 
[Non-modified POPC] 
(µg/mL) 
%DPPH 
Remaining 
[Nitrated POPC] 
(µg/mL) 
%DPPH 
Remaining 
125 95.3±1.0 125 86.3±0.3 
150 93.9±0.4 150 80.0±2.4 
250 91.8±0.8 250 74.3±1.0 
 
These results indicate a higher reactivity of nitrated POPC in aqueous media (ABTS●+ 
assay) than in ethanolic media (DPPH● assay). Trolox is a fast acting antioxidant in both 
assays and, this apparent difference in TE values result from kinetic differences. As 
observed in Supplementary Figure S-1 (Appendix C), ABTS●+ consumption reaches its 
end-point but this is not verified in DPPH● assay. 
As reported above, previous published work [85] evaluated the radical scavenging 
capacity against DPPH● radical of two synthetic isomers of nitroalkene derivative of 
linoleic acid (NO2-LA). Manini et al [85] found the 9-NO2-LA isomer to be more prone to 
H-atom loss and thereby a higher decay of DPPH● radical absorbance was observed. 
However, the absorbance decay in the presence of 10-NO2-LA and non-modified linoleic 
acid was in the same order of magnitude of decay observed for nitrated POPC and non-
modified POPC, respectively. Another key feature was the concentrations of both NO2-FA 
and DPPH● radical solution. The concentration of NO2-FA used in the study of Manini et 
al [85] was 7.7 mmol/L while the concentrations used in our study for non-modified and 
nitrated POPC were undoubtedly lower (between 0.1 and 0.3 mmol/L). Regarding the 
DPPH● radical solution, they used 100 µmol/L while we used 250 µmol/L. Based on the 
results displayed by Manini et al [85] we performed some calculations in order to establish 
the amount of DPPH● radical consumed after 60 min of reaction (Supplementary Figure S-
2 and Table S-1, Appendix C). The percentage of DPPH● radical consumed was 
approximately 15.5%, 28.3% and 88% for non-modified linoleic acid, 10-NO2-LA and 9-
NO2-LA, respectively. This corresponds to approximately 15.5, 28.3 and 88 µmol/L of 
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DPPH● radical consumed. Considering the final fatty acid concentration used in their 
experiments (7.7 mmol/L), the amount of DPPH● radical consumed was, respectively, 7.2, 
11.3 and 35.0 µmol DPPH● radical/g of non-modified linoleic acid, 10-NO2-LA and 9-
NO2-LA [85]. In our work, the amount of DPPH
● radical consumed was 74 µmol DPPH● 
radical/g of nitrated POPC, within a similar order of magnitude. 
The DPPH● and ABTS●+ assays are widely used for screening and routine 
determinations of radical scavenging activity of antioxidants candidates and mixtures due 
to their stability, availability and technical simplicity. Nevertheless, these assays have been 
criticized as the DPPH● and ABTS●+ radicals are non-physiological radicals and thus not 
representative of biomolecules and not even found in any biological system [203]. In this 
way, we also performed the ORAC assay that is based in a biologically relevant radical 
source (peroxyl radicals) associated with physiological disturbance [203, 204]. 
 
ORAC Assay 
 
The ORAC assay is based on the inhibition of the peroxyl radical (ROO●)-induced 
oxidation through hydrogen atom donation. Peroxyl radicals are produced in a time-
dependent manner during the thermal decomposition of 2,2’-azobis-(2- 
methylpropionamidine) dihydrochloride (AAPH), and react with a fluorescent probe 
(usually fluorescein) inducing its oxidation and quenching the fluorescent signal. In the 
presence of a compound with chain-breaking antioxidant properties, the elimination of the 
peroxyl radicals occurs, and fluorescein is protected from oxidation and therefore the 
fluorescent signal is maintained until antioxidant depletion. Peroxyl radicals are formed in 
vivo during oxidation of biomolecules particularly during lipid peroxidation and are 
themselves capable of propagate the oxidation reactions bringing harmful effects [204]. 
Thus, ORAC assay has been widely used to measure the antioxidant capacity since this 
assay is considered one of the most relevant to define the antioxidant level in a biological 
system [205].  
The ability of non-modified POPC and nitrated mixtures of this lipid (0.75, 2.5 and 10 
µg/mL) to protect fluorescein from peroxyl radical induced-oxidation was assessed and 
compared with the fluorescence decrease for blank sample (fluorescein and AAPH). Both 
non-modified and nitrated POPC confer higher lag time and higher AUC values when 
compared to blank (tcalc values between -33.13 and -5.626, ttab = 2.074,  = 22, p = 0.05), 
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which indicates that the presence of both lipid samples retard fluorescein oxidation (Figure 
III.10). Non-modified POPC bears oleic acid in its composition. Indeed, oleic acid was 
already described to be able to protect PC12 rat cells against nanoparticle-induced 
oxidative stress enhancing cell survival [206]. However, for the ABTS●+ and DPPH● 
assays no antioxidant activity was observed for non-modified POPC. Thereby, the 
inhibition of ROO● radicals should occur through a different mechanism from the free 
radical scavenging. A possible explanation could be the reaction of ROO● radicals with the 
double bond present in the oleic fatty acyl chain of POPC in a radical mechanism since 
POPC is susceptible to be oxidized [174, 207].  
 
 
 
Figure III.10. ORAC profile of I) non-modified POPC and II) nitrated POPC at 0.75 (a), 
2.5 (b) and 10 (c) µg/mL. Control experiment (dashed line) corresponds to fluorescein (70 
nM) + AAPH (12 mM). 
 
Considering non-modified and nitrated POPC, non-significant differences in the AUC 
values were attained (|tcalc| < 1.797, ttab = 2.145,  = 14, p = 0.05), with slightly larger AUC 
values for nitrated POPC (Table III.4). Moreover, significant differences in the lag time 
values were observed between non-modified and nitrated POPC when higher 
concentrations (2.5 and 10 µg/mL) were analyzed showing concentration dependent 
behavior (|tcalc| was 4.503 (2.5 µg/mL) and 16.358 (10 µg/mL), ttab = 2.145,  = 14, p = 
0.05). These results indicate that nitrated POPC reacts faster than non-nitrated POPC with 
peroxyl radicals, thus providing a more relevant initial protection against fluorescein 
oxidation. Nevertheless, the total protection (based on AUC values) did not differ 
significantly for non-modified and nitrated POPC. Indeed, the obtained TE values for the 
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highest lipid concentration were 1.03 ± 0.22 and 1.30 ± 0.16 mmol trolox/g lipid for non-
modified and nitrated POPC, respectively. 
 
Table III.4. Lag time and area under the curve (AUC) values for non-modified and 
nitrated POPC. 
 
Concentration 
(µg/mL) 
Non-modified POPC Nitrated-POPC 
Lag time 
(min) 
AUC 
Lag time 
(min) 
AUC 
0.75 13.6 ± 1.7 45.5 ± 4.5 13.8 ± 2.2 45.5 ± 7.1 
2.5 14.9 ± 2.7 61.0 ± 5.6 22.1 ± 3.7 67.1 ± 7.8 
10 23.7 ± 3.0 113 ± 24 51.7 ± 3.8 129 ± 16 
Blank experiment: Lag time = 5.62 ± 1.44 min, AUC = 30.8 ± 2.9. 
 
Taken together, the results obtained using these three common assays suggest that 
nitrated POPC has antioxidant potential. Its actions could be associated either to hydrogen- 
or electron-donation to radicals. The results obtained for ORAC assay could be quite 
important regarding that peroxyl radicals are formed in vivo bringing harmful effects[204].  
 
Anti-Inflammatory Activity 
 
Previous studies have reported that several anti-inflammatory drugs have shown an 
antioxidant and/or radical scavenging mechanism as part of their activity [208-211]. 
Additionally, considering that antioxidants and free radical scavengers present concomitant 
anti-inﬂammatory actions [212], we also investigate the anti-inflammatory capacity of the 
nitrated POPC. In our study, we investigated and compared the anti-inflammatory capacity 
of the non-modified POPC and a nitrated mixture of POPC on LPS-stimulated RAW 264.7 
macrophages through the evaluation of their effects in iNOS expression. The expression of 
this enzyme is strongly increased under inflammatory conditions and inhibition of its 
intracellular levels is often used to disclose the anti-inflammatory potential of several 
drugs. In a first approach, and before testing the anti-inflammatory potential of nitrated 
POPC, we performed the MTT assay in order to select concentrations devoid of toxicity to 
macrophages. For that, macrophages were incubated with several concentrations of non-
modified POPC and nitrated POPC. The in vitro cytotoxic effect of non-modified POPC 
(light grey bar) and nitrated POPC (dark grey bar) on macrophages viability was 
represented as percentage of control (non-stimulated cells; white bar), as shown in Figure 
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III.11. A cytotoxic effect was observed using concentrations of 15 and 30 μg/mL for 
nitrated POPC. Subsequently, for the further experiments concentrations of 7.5 μg/mL for 
both non-modified POPC and nitrated POPC we selected. 
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Figure III.11. Cell viability (% of the control) of Raw 264.7 cells incubated with non-
modified POPC (light grey bar; 7.5, 15 and 30 μg/mL) or nitrated POPC (light grey bar; 
7.5, 15 and 30 μg/mL) for 1 h, and later activated with LPS for 24 h. Results are expressed 
as a percentage of MTT reduction by control cells maintained in culture medium. Data 
represent mean ± SD of three independent assays. 
 
In order to investigate the effects of nitrated POPC in iNOS expression on LPS-
activated macrophages (Raw 264.7 cells), western blotting analysis was performed using a 
specific antibody against iNOS. Macrophages were incubated with LPS in the absence and 
the presence of 7.5 μg/mL of non-modified POPC or nitrated POPC. As shown in Figure 
III.12, non-stimulated cells (control; white bar) expressed low levels of iNOS protein. The 
iNOS expression is increased after stimulation with LPS for 24 h (black bar). The presence 
of nitrated POPC inhibited the expression of iNOS in LPS-activated macrophages in 
20.2% (dark grey bar; p<0.05). 
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Figure III.12. Effect of non-modified POPC and nitrated POPC (7.5 µg/ml) on iNOS 
expression in raw 264.6 cells. Raw 264.6 cells (0.6x106 cells) were incubated for 24h in 
culture medium in the absence (control; white bar) or in the presence of LPS (1 µg/mL; 
black bar) or in the presence of LPS plus non-modified POPC (light grey bar) or nitrated 
POPC (dark grey bar). Data are mean ± SD values from three independent 
experiments.*p<0.05: LPS vs Nitrated POPC+LPS. 
 
The results obtained in this work for nitrated POPC are somewhat in agreement with 
previous published work concerning the NO2-FA. In a previous study, Ferreira et al [71] 
demonstrated that macrophage (J774.1 cells) inflammatory responses evoked by LPS 1 
µg/mL were suppressed in the presence of NO2-cLA (50 µmol/L) and NO2-LA (20 
µmol/L) namely through the inhibition of iNOS expression. Both nitroalkene derivatives 
down-regulate the NOS2 expression, however NO2-LA demonstrated more potent 
inhibitory effects. Likewise, Trostchansky et al [10] demonstrated that, in activated 
macrophages, NO2-AA also exert protective anti-inflammatory actions through the down-
regulation of iNOS expression and diminishing the secretion of pro-inflammatory 
cytokines. The ability of NO2-FA and NO2-POPC to attenuate the iNOS expression during 
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macrophage activation should account for the resolution of inflammation, limiting the 
putative deleterious effects of pro-inflammatory stimuli.  
NO2-FA has been reported as a promising pharmacological tool to prevent and 
modulate inflammatory diseases associated with oxidative and nitroxidative stress 
conditions. The potential beneficial actions of the administration of NO2-FA have been 
evaluated in vivo using murine models of several diseases and pathologies including 
diabetes and metabolic syndrome [135], nephropathy [101], ischemia-reperfusion injury 
[76, 77, 101], cardiovascular disease [96, 111], pulmonary inflammation [98, 102] and 
chronic inflammatory disease [100]. However, further studies are necessary to determine 
whether NO2-FA supplementation would exert protective actions in human diseases, and to 
evaluate their potential toxicity when administrated for longer periods of time. The nitrated 
derivatives of POPC also demonstrated to be promising candidates as antioxidant and anti-
inflammatory agents using in vitro model systems. These findings could be of utmost 
importance since the identification of nitrated derivatives of phospholipids was previously 
reported in vivo [175]. Besides, free NO2-FA found endogenously can arise from nitrated 
phospholipids, and NO2-PLs could be the first species to be formed in vivo. Nevertheless, 
future work may contemplate the elucidation of the biological properties of other nitrated 
phospholipids and the effects of specific nitrated products. The mechanisms underlying 
their antioxidant and anti-inflammatory actions namely the effects in the expression of 
antioxidant enzymes, in inhibition of pro-inflammatory signaling pathways and the effect 
of nitrated phospholipids on other key players of the inflammatory response, for instance 
cytokines, constitute key points that should be considered for further investigation. The 
effects of supplementation in human disease and their toxicity should also be evaluated for 
nitrated derivatives of phospholipids. This is an important topic since diet could contribute 
to increase the levels of NO2-FA, and perhaps NO2-PL, in tissues and plasma directly or 
through elevation of their endogenous generation. 
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III.2.1.3. Concluding Remarks 
 
This study highlights for the first time the potential biological actions of nitrated 
phospholipids. Nitrated POPC revealed potential as anti-inflammatory and antioxidant 
agents, showing ability to reduce ABTS●+ and DPPH● radicals and quench the ROO● 
radicals in ORAC assay in a concentration-dependent way. The inhibition of iNOS 
expression in LPS-activated macrophages seems to be one of the molecular mechanisms 
accounting for their anti-inflammatory properties. The biological relevance of these 
findings needs to be deeply explored and validated in in vivo models.  
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III.3. UNDERSTANDING THE CROSS REACTION BETWEEN NITRATED AND 
NITROXIDIZED DERIVATIVES OF PHOSPHOLIPIDS AND PROTEINS  
 
III.3.1. MODIFICATION OF VIMENTIN BY NITRATED/NITROXIDIZED 
PRODUCTS OF POPC 
 
The predominant molecular mechanism associated to NO2-FA biological signaling 
actions is based on their electrophilic nature and reactivity toward proteins. NO2-FAs 
interact with key target proteins inducing post-translational modifications that change 
protein structure and function leading to antioxidant and anti-inflammatory signaling 
effects. However, once again work focused on biological actions of nitrated phospholipids 
mediated by their adduction with key proteins remains undisclosed. Additionally, the 
structures and mechanisms involved in the formation of these adducts are far to be 
elucidated. 
Aiming to contribute to knowledge regarding the ability of nitrated phospholipids to 
interact with target proteins, and the structures and mechanisms involved in the formation 
of the correspondent adducts, nitrated/nitroxidized phosphatidylcholine was incubated with 
well-known protein targets of electrophilic lipids, namely vimentin, using in vitro gel-
based competition assays. Their interactions were evaluated using western blotting. It 
effects in the organization of vimentin network was also evaluated in SW13 adrenal 
carcinoma cell line expressing defined vimentin constructs using confocal microscopy 
(Section III.3.1). 
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III.3.1.1. Background and aim of the study 
 
Nitrated and nitroxidized PLs were already identified in cardiac mitochondria from an 
animal model of type 1 diabetes and in cardiomyoblast cell line (H9c2) under starvation. 
However, the biological roles of these products still poorly explored. Nevertheless, as 
reported for nitro-fatty acids (NO2-FA), nitro derivatives of PLs (NO2-PLs) may also be 
able to interact with key proteins. Vimentin is an intermediate filament protein that 
possesses a single cysteine residue (Cys328), target for modifications by electrophiles.  
In this study, the vimentin interactions with non-modified 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine (POPC) and nitrated POPC, namely the nitroalkene derivative 
(NO2-POPC) that is the major product formed in vitro after biomimetic nitration of POPC 
with nitronium tetraflouroborate (NO2BF4), were assessed using an in vitro gel-based 
competition method. The effects of non-modified POPC and nitrated POPC in vimentin 
network organization were also evaluated using the human adrenal tumor SW13 cell line.  
 
III.3.1.2. Results and discussion 
 
Vimentin is the major intermediate filament protein expressed in mesenchymal cells 
where it forms the vimentin cytoskeletal network [213]. In cells, vimentin particles fuse 
into elongated structures known as squiggles that further assembly into intermediate 
filaments [214] which can further undergo polymerization [215-217]. This coiled coil 
protein is involved in physiological and pathological processes, such as embryogenesis, 
wound healing, autoimmune diseases, epithelial mesenchymal transition and therefore 
cancer cell dissemination and metastasis, among others.  
Vimentin has been shown to play a number of critical functions. In spite of being a 
dynamic protein which provides flexibility to the cells, vimentin network whose robust 
filaments extended from the nuclear periphery to the cell membrane have important 
structural roles conferring mechanical resistance to cells and contributing to the 
maintenance of cell shape, architecture and integrity. Vimentin is the support for the 
correct anchorage of the position and function of cellular organelles in the cytosol such as 
nucleus, endoplasmic reticulum, and mitochondria where vimentin is usually attached to 
[218]. Besides, vimentin network promote the interaction with, regulation and organization 
of a number of proteins involved in attachment/adhesion, migration, and cell signaling 
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[219, 220]; promote a bidirectional cross-talk with other cytoskeletal structures and 
stabilize the cytoskeletal interactions [221, 222]. So, vimentin network play key roles in 
maintenance of cell homeostasis [221, 222]. Vimentin is also involved in the control of the 
transport of low-density lipoproteins-derived cholesterol from the lysosome to the site of 
the esterification. In cells with modified vimentin, the transport of LDL inside the cells is 
blocked and cells store a much lower amount of LDL. This is remarkably important in 
adrenal cells which rely on cholesteryl esters derived from LDL [223]. Vimentin also plays 
a role in aggresome formation, where it forms a cage surrounding a core of misfolded 
aggregated protein [224], which is formed when the protein-degradation system of cells 
(proteosomal degradation) is overloaded. Vimentin has another role as a mediator of the 
innate immune response. 
In spite of its complete structural characterization remains undone, it is known that 
vimentin (55 kDa) possesses a single cysteine residue, Cys328. The highly conserved 
cysteine 328 residues is essential for vimentin stability, dynamics and correct function, 
being a requisite for optimal vimentin performance in network organization and expansion, 
organelle distribution and aggresome formation. Nevertheless, Cys328 is also considered 
as a noteworthy sensor for oxidative stress [225] being a target for numerous non-
enzymatic oxidative modifications by several thiol-reactive compounds including 
glutathionylation, carbonylation, and nitrosylation [226-229]. Modifications of cys328 by 
different oxidants or electrophiles makes this modified vimentin not able to keep up with 
non-modified vimentin’s demanding roles. Vimentin performance in network expansion, 
organization, and functions became compromised namely in achieving the appropriate 
distribution of cytoplasmic organelles, in formation of aggresomes upon inhibition of 
proteosomal degradation or extensive oxidative damage. However, these modifications 
may also be involved in regulation of response of vimentin network to oxidants and 
electrophiles under stress conditions [225, 230].  
Since vimentin is a target for various electrophilic lipids [225], in this study we have 
explored the ability of vimentin to bind non-modified POPC and nitrated POPC (Figure 
III.13). Nitrated POPC was obtained after reaction between POPC and NO2BF4, previously 
reported [175], and the nitroalkene derivatives of POPC (NO2-POPC), with electrophilic 
properties, were the major nitrated products identified (Figure III.13).  
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Figure III.13. Representative structure of the phospholipids used in this study. POPC, 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (16:0/18:1). The structures of the two 
nitro derivatives of POPC (NO2-POPC isomers), previously identified [175] are also 
presented: the 9-NO2-POPC (nitro group in carbon 9, NO2 in C9) e o 10-NO2-POPC (nitro 
group in carbon 10, NO2 in C10). *, specify the carbons susceptible to Michael addition. 
 
We first performed a competition gel-based assay, as previously described in the work 
of Zorrilla and co-authors [231], based on the ability of compounds interacting with a 
given protein to shield its modifications by biotinylated iodoacetamide. In the presence of 
nitrated POPC de percentage of biotinylated iodoacetamide (Iac-B) binding to vimentin 
(21.9%) was significantly lower in comparison with POPC control (Figure III.14). Thus, 
incubation with nitrated POPC prevented vimentin modifications by Iac-B. This may point 
out a common site for electrophilic addition. In fact, the vimentin’s Cys328 may be the 
common target for nitrated POPC-covalently binding. 
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Figure III.14. Competition binding assay to evaluate the ability of non-modified POPC 
and nitrated POPC for binding to vimentin. Vimentin was pre-incubated with either 
100 µmol/L non-modified POPC, nitrated POPC or vehicle (DMSO) for 4 h at room 
temperature before the addition of 20 µmol/L Iac-B and continued incubation for more 
30 min at room temperature. Incorporation of non-modified POPC and nitrated POPC as 
well as the vimentin levels were obtained by western blotting. The graph presents results of 
three independent experiments performed in three different days (mean±SD, **p<0.01). 
 
In order to obtain further support and to assess the functional effects of the interaction 
between nitrated POPC and vimentin, we explored the effects of non-modified POPC and 
nitrated POPC on cells expressing vimentin. We used the adrenal carcinoma cell line 
SW13/cl.2, a vimentin deficient cell model devoid of cytosolic intermediate filaments, 
which was previously stably transfected with several vimentin constructs using different 
plasmid-transfection strategies, as described in [225].  
In the first place we used SW13/cl.2 cells stably transfected with bicistronic vectors 
coding for vimentin wt or C328S mutant and the red fluorescent protein RFP as a marker 
of transfection as separate products (RFP//vimentin wt or C328S). In these cells, both 
vimentin constructs form an extended radial network. Incubation of RFP//vimentin wt – 
expressing cells with 10 µmol/L nitrated POPC for 6h led to changes in vimentin filaments 
organization. A clear condensation of filaments at the cell periphery instead of the normal 
distribution was observed in 50.8% of cells. In the presence of 10 µmol/L non-modified 
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POPC, 98% of RFP//vimentin wt –expressing cells displayed the typical radial dispersion 
of vimentin filaments. However, for RFP//vimentin C328S – expressing cells, the effect of 
nitrated POPC was attenuated, and only in 34.7% of cells the vimentin filaments 
arrangement was changed. For RFP//vimentin C328S – expressing cells treated 10 µmol/L 
non-modified POPC, the majority of cells (96%) displayed the typical radial dispersion of 
vimentin filaments. Thus, RFP//vimentin C328S – expressing cells seem to be protected 
against the nitrated POPC-induced vimentin condensed filaments rearrangement at the cell 
periphery (Figure III.15). This may suggest that Cys328 has a key role in organization of 
vimentin filament network and in rearrangement of this network induced by nitrated 
POPC.  These results are in agreement with the previously reported [225]. Treatment of 
RFP//vimentin wt – expressing cells with various electrophiles, such as HNE and diamide, 
was shown to induce modifications in vimentin cytoskeleton namely vimentin 
condensation in a higher proportion in comparison with C328-expressing cells.  
 
 
 
Figure III.15. Evaluation of effects of non-modified POPC and nitrated POPC in vimentin 
network in SW13 cells stably transfected with RFP//vimentin wt or C328S plasmids. Cells 
were treated with 10 µmol/L non-modified POPC or nitrated POPC for 6h, fixed and 
processed for immunofluorescence of vimentin. Inserts show overlays with RFP 
fluorescence as a control of transfection. Scale bar, 20 µm. The proportion of cells with 
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normal versus condensed vimentin was evaluated (mean±SD of two experiments, 
**p<0.01, ***p<0.001). 
 
We next used a different cellular model, namely, SW13/cl.2 cells stably transfected 
with constructs expressing the green fluorescent protein fused to vimentin wt or C328S 
mutant (GFP-vimentin wt or C328S). These cells are characterized by the formation of 
filamentous structures with two free ends consistent with vimentin squiggles or short 
vimentin filaments in the case of wt, but only bright vimentin dots in the case of GFP-
vimentin C328S, which is not competent for the formation of squiggles (not used in this 
work). The GFP-vimentin wt cells were treated with vehicle (DMSO), 10 or 30 µmol/L 
non-modified POPC, 10 or 30 µmol/L nitrated POPC, or 10 or 30 µmol/L GSNO (used as 
NO● generator). Before being treated, cells were observed in vivo by confocal microscopy. 
After the treatments, cells were also immediately observed and followed during the 75 min 
of treatment. After 75 min of incubation, cells were fixed and processed for 
immunofluorescence. DSMO and 30 µmol/L non-modified POPC-treated cells displayed 
the short vimentin filaments (Figure III.16). For 10 µmol/L nitrated POPC-treated cells, a 
mix of cells showing vimentin filaments together with vimentin dots was observed. A 
small number of cells with rounded shape were also observed. Treatment with 30 µmol/L 
nitrated POPC also led to a disassembly of short filaments into dots. In fact, a great number 
of cells showing vimentin dots were observed. The aspect of dots mimics the distribution 
vimentin in of GFP-vimentin C328S cells. For cells treated with GSNO, no significant 
alterations were observed in vimentin filaments. All of these observations were similar in 
live cells before being fixed for immunofluorescence. Besides, an increased number of 
cells with rounded shape were observed, which may be related with the loss of cellular 
adhesion. In fact, we observed that cells treated with 30 µmol/L nitrated POPC seems to be 
in lower number after the immunofluorescence protocol, suggesting that cells could be lost 
during the experimental procedure due to the loss of cellular adhesion induced by 
treatment with 30 µmol/L nitrated POPC (Figure III.16).  
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Figure III.16. Evaluation of effects of non-modified POPC and nitrated POPC in vimentin 
network in SW13 cells stably transfected with GFP-vimentin wt. Cells were treated with 
vehicle (DMSO), non-modified POPC (30 µmol/L) or nitrated POPC (10 or 30 µmol/L) 
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for 75 min. After that, cells were fixed and processed for immunofluorescence of vimentin. 
Scale bar, 20 µm. These images are representative of two experiments. Panels at the right 
shows enlarged areas of the images. 
 
III.3.1.3. Concluding Remarks 
In summary, Cys328 of vimentin seems to be a key residue for interaction with 
nitrated products of POPC, namely the NO2-POPC derivative, which has a nitro group with 
electrophilic potential and ability to interact with Cys328 of vimentin leading to the 
formation of lipid-protein adducts. Nevertheless, these are preliminary results that need to 
be deeply explored. In fact, further studies based on MS approaches are needed to 
characterize vimentin-NO2-POPC adducts and confirm the location of adduction.  
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Lipids are privileged targets of reactive nitrogen species (RNS) under nitrative and 
nitroxidative stress conditions associated with disease. Nitro-fatty acids (NO2-FA) have 
been the most reported products of the reaction between lipids and RNS, and have already 
been detected in vivo in plasma, urine and tissues, and are considered anti-inflammatory, 
anti-hypertensive, and anti-thrombotic agents. Although RNS can accumulate in the 
hydrophobic milieu of membranes, where phospholipids are abundant rather than free 
fatty, there is a lack of knowledge in what concern possible phospholipid (PL) 
nitration/nitroxidation and their putative biological roles. Having this in mind, the 
proposed aim of this thesis was to give some insights on the development of mass 
spectrometry strategies to identify nitrated/nitroxidized PL, and to search for their potential 
as anti-inflammatory and antioxidants agents together with their putative roles in post-
translational modifications (PTM) of proteins. 
To achieve the proposed aim, we used in vitro biomimetic model of nitroxidative 
stress conditions using pure PL standards and NO2BF4, and mass spectrometry (MS) 
analysis. Nitro derivatives of PL (NO2-PL) were successfully identified by MS-based 
approaches (MS and MS/MS) also combined with liquid chromatography. The specific 
fragmentation pathways were assigned as the loss of HNO2 and the formation of nitrated 
phospholipids as positive and negative ions. Interestingly, loss of HNO2 was reported to be 
a typical neutral loss of nitro-fatty acids, and thus can be a general reporter neutral loss to 
nitro lipids. In addition, other forms of nitration and nitroxidation of phospholipids were 
also considered, and new mass spectrometry approaches were developed to identify by MS 
and MS/MS the nitroso, dinitroso, dinitro, nitronitroso and nitroxidized PL derivatives. 
Typical fragmentation pathways of nitrated and nitroxidized PL identified included the loss 
of HNO and HNO2 for nitroso and nitro derivatives, respectively; the combined losses of 
HNO (or HNO2) and polar head groups of PLs; and product ions corresponding to the 
modified fatty acyl chains ([NOn-FA+On+H]
+ and [NOn-FA+On-H]
- ions (n=1-2)). 
Using the defined fragmentation approaches, NO2-PL were detected in this work and 
for the first time, both in biomimetic systems, in vitro in cell cultures, and in vivo in heart 
mitochondria from an animal model of type 1 diabetes mellitus. These results corroborate 
that besides the formation of NO2-FA in vivo, our hypothesis of the chemical feasibility of 
nitration of phospholipids was confirmed, and their formation in biological conditions was 
also corroborated. Furthermore, NO2-PL and the other modified PL were also detected in 
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cardiomyoblast H9c2 cells under starvation but not in ischemia or control revealing that 
modification of PL by RNS is a process dependent on other factors than their putative 
reactivity, and that can mirror the production of nitric oxide (NO●) and modulation of 
expression or activity of nitric oxide synthase (NOS). 
These results highlight the importance of the PL nitration/nitroxidation and give the 
suggestion that, similarly as NO2-FA, NO2-PL or other nitrated/nitroxidized PL products, 
can be formed and can possess important biological roles, and beneficial health effects 
namely as cardioprotectors in cardiovascular diseases (CVD). This field of research needs 
to be explored considering that the biological role of nitrated lipids in CVD seems to be a 
join effect of cardioprotection, vasodilation and anti-inflammatory effects, among other. It 
is evident that future work is need in this field, either detecting nitrated PL in different 
pathological conditions, using a lipidomic approach, and to evaluate their biological 
effects. 
Thus in this thesis, we also evaluate the potential of the nitrated/nitroxidized products 
of 1-plamitoyl-2-oleoyl-phosphatidylcholine (POPC) in immune/inflammatory response 
and as antioxidant agents. Nitrated/nitroxidized products of POPC revealed anti-
inflammatory properties by decreasing the expression of the inducible nitric oxide synthase 
(iNOS) induced by LPS stimulation in macrophages (Raw 264.7). They also showed 
antioxidant properties, namely as scavenging agents, by reducing the ABTS●+, DPPH● and 
peroxyl radicals. These findings highlight the potential role of nitrated/nitroxidized PLs as 
possible beneficial players in inflammatory and oxidative stress-related disorders. 
Moreover, it was reported that NO2-FA exerts their modulatory effects by the 
interaction with key proteins, forming intramolecular linkages by Michael addition with 
thiols group of cysteines or even with other amino acids, such as histidine. 
Nitrated/nitroxidized products of POPC, namely NO2-POPC which is the major products 
formed, were incubated with vimentin, a protein that has a reactive cysteine able to from 
covalent adducts with other electrophilic lipids, and the results showed the ability of NO2-
POPC to interact with vimentin, demonstrating that similar with NO2-FA, NO2-PL are also 
very prone to protein PTM, and thus could exert similar signaling actions. 
Overall, NO2-PL and other nitrated/nitroxidized derivatives can be generated under 
biological conditions and can be considered lipid mediators during inflammatory and 
oxidative stress-related disorders, with signaling and modulatory properties that can be 
CHAPTER IV. GENERAL CONCLUDING REMARKS 
 
125 
important in diseases. Nevertheless, further research must be done in order to get more 
insights regarding the structural modifications and properties of nitrated/nitroxidized PL 
namely under nitroxidative stress conditions. 
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SUPPLEMTARY FIGURES 
 
 
Figure S-1. Representative structure of the phospholipids used in this study. POPC, 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine (16:0/18:1); PLPC, 1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphocholine 
(16:0/18:2); PAPC, 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine (16:0/20:4). POPE, 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (16:0/18:1); PLPE, 1-palmitoyl-2-linoleoyl-sn-
glycero-3-phosphoethanolamine (16:0/18:2); PAPE, 1-palmitoyl-2-arachidonoyl-sn-glycero-3-
phosphoethanolamine (16:0/20:4). POPS, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoserine (16:0/18:1); 
PLPS, 1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphoserine (16:0/18:2); PAPS, 1-palmitoyl-2-arachidonoyl-
sn-glycero-3-phosphoserine (16:0/20:4). 
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Figure S-2. ESI-MS/MS spectra of [M+NO2+H]+ and [M+NO2+OAc]- molecular ions of: A) POPC 
([POPC+NO2+H]+; A1, [POPC+NO2+OAc]-); B) PLPC ( [PLPC+NO2+H]+; B1, [PLPC+NO2+OAc]-) and; 
C) PAPC ( [PAPC+NO2+H]+; C1, [PAPC+NO2+OAc]-). Product ions indicating the presence of a NO2 group 
are labeled with (♦). 
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Figure S-3. ESI-MS/MS spectra of [M+NO2+H]+ and [M+NO2-H]- molecular ions of: A) POPE 
([POPE+NO2+H]+; A1, [POPE+NO2-H]-); B) PLPE ([PLPE+NO2+H]+; B1, [PLPE+NO2-H]-) and; C) PAPE 
([PAPE+NO2+H]+; C1, [PAPE+NO2-H]-). Product ions indicating the presence of a NO2 group are labeled 
with (♦). 
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Figure S-4. ESI-MS/MS spectra of [M+NO2-H]- and [M+NO2+H]+ molecular ions of: A) POPS 
([POPS+NO2-H]-; A1, [POPS+NO2+H]+); B) PLPS ( [PLPS+NO2-H]-; B1, [PLPS+NO2+H]+) and; C) PAPS 
([PAPS+NO2-H]-; C1, [PLPS+NO2+H]+). Product ions indicating the presence of a NO2 group are labeled 
with (♦). 
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Figure S-5. MS3 spectra of [M+NO2-H]- and [M+NO2+H]+ ions of oleic acid ([NO2-OA-H]- ions at m/z 
326.1; [NO2-OA+H]+ ions at m/z 328.2), linoleic acid ([NO2-LA-H]- ions at m/z 324.3; [NO2-LA+H]+ ions at 
m/z 326.2) and arachidonic acid ([NO2-AA-H]- ions at m/z 348.2; ([NO2-AA+H]+ ions at m/z 350.2). Product 
ions indicating the presence of a NO2 group are labeled with (♦).  
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Two major fragmentation pathways were proposed for the two distinct isomers NO2-
OA-PL. In the MS3 of the NO2-OACOO
-, the 9-NO2-OA isomer gives specific signals at 
m/z 156.9 (C8H13O3
-; loss of C10H19ON) and 168.0 (C9H14O2N
-; loss of C9H18O2), while 
10-NO2-OA was assigned based on product ions at m/z 124.9 (C8H13O
-; loss of 
C10H19O3N) and 198.0 (C10H16O3N
-; loss of) (Figure S-6 A and S-11). For NO2-LA-PL, 9-
NO2-LA was assigned based on product ions at m/z 156.9 (C8H13O3
-; loss of C10H19ON), 
m/z 168.0 (C9H14O2N
-; loss of C9H16O2) and m/z 209.9 (C11H16O3N
-; loss of C7H17O), 10- 
NO2-LA at m/z 124.7 (C8H13O
-; loss of C10H17ON), m/z 182.1 (C10H16O2N
-; loss of 
C8H14O2) and m/z 238.1 (C13H20O3N
-; loss of C5H10O), 13- NO2-LA at m/z 185.1 
(C10H17O3
-; loss of C8H13ON) and 208.9 (C12H17O3
-; loss of C6H13ON). Low abundant 
product ions observed at m/z 195.1 (C11H15O3
-; loss of C7H15ON) along with ions at m/z 
156.9 (C8H13O3
-; loss of C10H19ON) can be assigned as 12- NO2-LA (Figure S-6 B and S-
11). For NO2-AA-PL, 14-NO2-AA was assigned based on product ions at m/z 165.3 
(C10H13O2
-; loss of C10H17O2N), 195.2 (C11H15O3
-; loss of C9H15ON) and 177.2 (C11H13O2
-; 
loss of C9H17O2N) while 15-NO2-AA was assigned based on product ions at m/z 191.3 
(C12H15O2
-; loss of C8H15O2N), 147.2 (C11H15
-; loss of C9H15O4N), 205.3 (C13H17O2
-; loss 
of C7H13O2N), 195.2 (C11H15O3
-; loss of C9H15ON) and 177.2 (C11H13O2
-; loss of 
C9H17O2N). For 11- and 12-NO2-AA assignment, product ions were observed at m/z 155.2 
(C8H11O3
-; loss of C12H19ON) (Figure S-6 C and S-11).  
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Figure S-6. Fragmentation products observed in the MS3 spectra of the [M-H]- ions of NO2-FA and 
proposed structural information for each nitroalkene isomer identified. 
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Figure S-7. Lowest energy conformations of the NO2 and NH2 protonated structures (top and 
bottom, respectively), obtained at the B3LYP/6-31G++** level, alongside the Wiberg bond indices 
of selected bonds discussed in the text. Color code - red: oxygen; blue: nitrogen; orange: 
phosphorus; gray: carbon; white: hydrogen. 
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Figure S-10. MS3 spectra of [M+NO2-HNO2-H]- (m/z 758.2), [M+NO2-C3H5NO2-H]- (m/z 718.3), [M+NO2-
C3H5NO2-H2O-H]- (m/z 700.4), [M+NO2-C3H5NO2-HNO2-H]- (m/z 671.3), [M+NO2-C3H5NO2-C8H16O-H]- 
(m/z 590.2), [M+NO2-C3H5NO2-C10H19NO-H]- (m/z 549.2), [M+NO2-C3H5NO2-R1C=C=O-H]- (m/z 480.1), 
[M+NO2-C3H5NO2-R1COOH-H]- ions (m/z 462.1) of POPS. R’2COOH and R’2C=C=O correspond to the acid 
and ketene derivative of NO2-FA, respectively. 
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Figure S-12. HILIC-LC-MS chromatogram obtained for cardiac mitochondria of type 1 diabetes mellitus 
(T1DM) group with identification of retention time for phosphatidylethanolamine (PE) and nitrated PE 
(NO2-PE) elution, and phosphatidylcholine (PC) and nitrated PC (NO2-PC) elution. Reconstructed ion 
chromatogram (RIC) of ions at m/z 636.4 ([dMPE+H]+), RT = 26.49 min, and ions at m/z 678.5  
([dMPC+H]+), RT = 55.15 min. 
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Figure S-13. HILIC-ESI-MS/MS spectra of ions at m/z 855.7 and 857.6 ([M+H]+) observed in mitochondria 
from T1DM heart. 
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Figure S-14. A) Phosphatidylethanolamine (PE) molecular species profile observed for cardiac mitochondria 
of control group and type 1 diabetes mellitus (T1DM) group identified after LC-MS/MS analysis. B) NO2-PE 
molecular species identified after LC-MS/MS analysis for cardiac mitochondria of control group and for type 
1 diabetes mellitus (T1DM) group. The results were expressed as percentage obtained by dividing the ratio 
between the peak areas of each PE molecular specie and the PE internal standard (dMPE) and the total of all 
ratio. C) Ratio between non-modified PE molecular species and NO2-PE in T1DM. The results were 
expressed as percentage determined by dividing the ratio between the peak areas of each NO2-PE molecular 
specie and the PE internal standard (dMPE) and the ratio between the peak areas of the correspondent non-
modified PE molecular specie and the PE internal standard (dMPE). Values are means±standard deviation. 
*p<0.05, **p<0.01 and ***p<0.0001, signiﬁcantly different from control group. 
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SUPPLEMETARY TABLES 
 
Table S-1. Summary of the nitroalkene products observed in the ESI-MS spectra, both in the positive- 
([M+H]+ ions for all PLs) and negative-ion mode ([M-H]- ions for PEs and PSs and [M+OAc+NO2]- ions for 
PCs), after reaction of each phospholipid class with NO2BF4 with the identiﬁcation and the indication of the 
respective m/z values. POPC, PC16:0/18:1; PLPC, PC16:0/18:2; PAPC, PC16:0/20:4; POPE, PE16:0/18:1; 
PLPE, PE16:0/18:2; PAPE, PE16:0/20:4; POPS, PS16:0/18:1; PLPS, PS16:0/18:2; PAPS, PS16:0/20:4. 
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Table S-2. Formula, calculated and observed mass and mass error of the NO2-PLs derivatives formed due to 
reaction between NO2BF4 and each PL observed in the ESI-MS spectra. Data was acquired in the Q-TOF2 
mass spectrometer, and lock mass was done in the [M+H+non-modified PL]+. POPC, PC16:0/18:1; PLPC, 
PC16:0/18:2; PAPC, PC16:0/20:4; POPE, PE16:0/18:1; PLPE, PE16:0/18:2; PAPE, PE16:0/20:4; POPS, 
PS16:0/18:1; PLPS, PS16:0/18:2; PAPS, PS16:0/20:4. 
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Table S-3. Summary of the major fragmentation pathways observed in the ESI-MS spectra, in the positive-
ion mode ([M+NO2+H]+ ions) after reaction of each phospholipid class with NO2BF4 with the identiﬁcation 
and the indication of the respective m/z values. POPC, PC16:0/18:1; PLPC, PC16:0/18:2; PAPC, 
PC16:0/20:4; POPE, PE16:0/18:1; PLPE, PE16:0/18:2; PAPE, PE16:0/20:4; POPS, PS16:0/18:1; PLPS, 
PS16:0/18:2; PAPS, PS16:0/20:4. 
Typical neutral losses  and product ions observed for NO2-PL in positive-ion mode 
Neutral 
Losses 
Proposed 
Identification 
[POPC+NO2+H]
+ [PLPC+NO2+H]
+ [PAPC+NO2+H]
+ 
  805.75 803.58 827.75 
18 u  -H2O 787.63 785.54 809.58 
47 u  -HNO2 758.70 756.46 780.58 
59 u -C3H9N 746.52 744.34 768.67 
106 u 
(59+47) 
-(C3H9N+HNO2) 699.62 697.42 721.50 
183 u -C5H14PO4N 622.55 620.55 644.58 
230 u 
(183+47) 
-(C5H14PO4N+HNO2) 575.54 573.56 597.67 
238 u  -R1C=C=O 567.62 565.42 589.33 
256 u  -R1COOH 549.57 547.35 571.50 
Product Ions 
[NO2-FA+H]
+ 328.26 326.41 350.33 
[NO2-FA-H2O+H]
+ 310.27 308.35 332.25 
[NO2-FA-2H2O+H]
+ 292.30 290.26 314.17 
[NO2-FA-NO2+H]
+ 281.26 279.26 303.25 
 
 
Neutral 
Losses 
Proposed 
Identification 
[POPE+NO2+H]
+ [PLPE+NO2+H]
+ [PAPE+NO2+H]
+ 
  763.62 761.48 785.61 
18 u  -H2O 745.50 743.51 767.51 
43 u -C2H5N 720.41 718.38 742.51 
47 u  -HNO2 716.51 714.63 738.47 
90 u 
(43+47) 
-(C2H5N+HNO2) 673.44 671.60 695.52 
141 u -C2H8PO4N 622.51 620.47 644.51 
188 u 
(141+47) 
-(C2H8PO4N+HNO2) 575.44 573.44 597.57 
238 u  -R1C=C=O 525.37 523.33 547.36 
256 u  -R1COOH 507.44 505.48 529.47 
Product Ions 
[NO2-FA+H]
+ 328.31 326.42 350.36 
[NO2-FA-H2O+H]
+ 310.30 308.38 332.33 
[NO2-FA-2H2O+H]
+ 292.41 290.24 314.27 
[NO2-FA-NO2+H]
+ 281.21 279.26 303.35 
 
 
Neutral 
Losses 
Proposed 
Identification 
[POPS+NO2+H]
+ [PLPS+NO2+H]
+ [PAPS+NO2+H]
+ 
  807.31 805.74 829.58 
18 u  -H2O 789.28 787.36 811.50 
47 u  -HNO2 760.52 758.46 782.68 
87 u  -C3H5NO2 720.26 718.46 742.56 
134 u 
(87+47) 
-(C3H5NO2+HNO2) 673.60 671.53 695.50 
185 u -C3H8PO6N 622.52 620.42 644.56 
232 u 
(185+47) 
-(C3H8PO6N+HNO2) 575.43 573.43 597.32 
238 u  -R1C=C=O 569.15 567.44 591.63 
256 u  -R1COOH 551.57 549.40 573.46 
Product Ions 
[NO2-FA+H]
+ 328.22 326.36 350.48 
[NO2-FA-H2O+H]
+ 310.24 308.29 332.37 
[NO2-FA-2H2O+H]
+ 292.33 290.47 314.23 
[NO2-FA-NO2+H]
+ 281.18 279.20 303.20 
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SUPPLEMTARY FIGURES 
 
 
Figure S-1. Structure of the phosphatidylcholines (PCs) and phosphatidylethanolamines 
(PEs) used in this study. POPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine; PLPC, 
1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphocholine; PAPC, 1-palmitoyl-2-arachidonoyl-
sn-glycero-3-phosphocholine. POPE, 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphoethanolamine; PLPE, 1-palmitoyl-2-linoleoyl-sn-glycero-3- phosphoethanolamine; 
PAPE, 1-palmitoyl-2-arachidonoyl-sn-glycero-3- phosphoethanolamine.  
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Figure S-2. ESI-MS spectra of POPC (A), PLPC (B) and PAPC (C) in positive-ion mode 
after incubation with NO2BF4.  
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Figure S-4. LC-ESI-MS/MS spectra of [M+H]+ ions at m/z 787.6 (PLPC+NO), 811.6 
(PAPC+NO), 832.7 (PLPC+NO2+NO), 850.5 (POPC+2NO2), 856.4 (PAPC+NO2+NO), 
and 872.6 (PAPC+2NO2). 
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Figure S-5. LC-ESI-MS/MS spectra of [M-H]- ions at m/z 743.5 (PLPE+NO), 767.3 
(PAPE+NO), 796.4 (PAPE+2NO). LC-ESI-MS/MS spectra of [M+H]+ ions at m/z 745.6 
(PLPE+NO), 769.5 (PAPE+NO), and 798.7 (PAPE+2NO). 
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Figure S-6. LC-ESI-MS/MS spectra of [M+H]+ ions at m/z 805.5 (POPC+NO2), 805.6 
(POPC+NO+O), 803.5 (PLPC+NO2), 803.5 (PLPC+NO+O), 827.8 (PAPC+NO2), 827.7 
(PAPC+NO+O). 
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Figure S-8. LC-ESI-MS/MS spectra of [M-H]- ions at m/z 761.5 (POPE+NO2), 761.4 
(POPE+NO+O), 759.5 (PLPE+NO2), 759.4 (PLPE+NO+O), 783.5 (PAPE+NO2) and 
783.4 (PAPE+NO+O). 
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Figure S-9. LC-ESI-MS/MS spectra of [M-H]- ions at m/z 790.4 (POPE+NO2+NO), 788.4 
(PLPE+NO2+NO), and 812.4 (PAPE+NO2+NO). LC-ESI-MS/MS spectra of [M+H]
+ ions 
at m/z 792.3 (POPE+NO2+NO), 790.4 (PLPE+NO2+NO), and 814.5 (PAPE+NO2+NO). 
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Figure S-10. LC-ESI-MS/MS spectra of [M-H]- ions at m/z 806.4  (POPE+2NO2), 804.6 
(PLPE+2NO2), and 828.4 (PAPE+2NO2). LC-ESI-MS/MS spectra of [M+H]
+ ions at m/z 
808.5 (POPE+2NO2), 806.5 (PLPE+2NO2), and 830.5 (PAPE+2NO2). 
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Figure S-11. LC-ESI-MS/MS spectra of [M+H]+ ions at m/z 819.5 (PLPC+NO2+O), 821.7 
(POPC+NO2+O), 835.6 (PLPC+NO2+2O), 859.6 (PLPC+NO2+2O), 864.6 
(PLPC+2NO2+O), 866.5(POPC+2NO2+O), and 888.6 (PLPC+2NO2+O). 
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Figure S-18. Reconstructed ion chromatogram (RIC) of [M+H]+ ion of the non-modified 
PC molecular species identified in H9c2 cardiomyoblast cells under starvation conditions. 
IS, internal standard. 
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Figure S-19. Reconstructed ion chromatogram (RIC) of [M+H]+ ions of the nitrated PC 
molecular species (m/z 805 NO2-PC 16:0/18:1, m/z 822 (NO2)2-PC 16:0/16:1, m/z 817 NO-
PC 18:0/18:1, m/z 850 (NO2)2-PC 16:0/18:1 and m/z 858 NO2NO-PC 16:0/20:3) and 
nitroxidized PC molecular species (m/z 837.7 NO2OOH-PC 16:0/18:1) identified in H9c2 
cardiomyoblast cells under starvation condition.  
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Tandem mass spectra of ions at m/z 805.8 (NO2-PC 16:0/18:1) showed neutral losses 
of 47 u (HNO2, m/z 758.4) and combined losses of HNO2 plus the polar head (m/z 699.8 
(neutral loss of 106, corresponding to 59 u (C3H9N) + 47 u) and 575.5, neutral loss of 230, 
corresponding to 183 u (C5H15O4NP) + 47 u). For ions m/z 822.9 ((NO2)2-PC 16:0/16:1) 
and 850.8 ((NO2)2-PC 16:0/18:1), their tandem mass spectra showed ions formed as a 
result of neutral losses of 47 u (775.7 and 803.4, respectively) and 94 u (m/z 728.5 and 
756.7, respectively). Also, combined losses of 47 u and polar head were observed (-106 u 
(59+47): m/z 716.6 and 744.5, respectively; -230 (183+47): m/z 592.4 and 620.4, 
respectively). The nitronitroso derivative at m/z 858.4 (NO2NO-PC 16:0/20:3) displayed 
neutral losses of 31 u (m/z 786.5), 47 u (m/z 790.7), 90 u (m/z 768.7), 106 u (m/z 753.0), 
214 u (644.5). Nitrohydroxy derivative (m/z 837.7 (NO2OOH-PC 16:0/18:1) showed 
neutral losses of 32 u (m/z 805.6), 47 u (m/z 790.7) and 106 u (m/z 731.6). tandem mass 
spectra of nitroso derivative m/z 817.7 (NO-PC 18:0/18:1) showed neutral losses of 31 u 
(m/z 786.5). 
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Figure S-21. Reconstructed ion chromatogram (RIC) of the protonated molecular ions 
[M+H]+ of the non-modified (m/z 718 and 746) and nitrated and nitroxidized PE molecular 
species (m/z 763 NO2-PE 16:0/18:1 and m/z 791 NO2-PE 18:0/18:1) identified in H9c2 
cardiomyoblast cells under starvation condition. IS, internal standard. 
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Figure S-22. HILIC-ESI-MS/MS spectra of [M+H]+ ions at m/z 763 (NO2-PE 16:0/18:1) 
and m/z 791 (NO2-PE 18:0/18:1) observed in H9c2 cardiomyoblast cells under starvation 
condition. 
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SUPPLEMTARY TABLES 
 
Table S1. Summary of the main nitrated and nitroxidized products observed in the positive 
ESI-MS spectra as [M+H]+ ions of each PC after reaction with NO2BF4 with the 
identiﬁcation and the indication of the respective m/z values. The corresponding retention 
time (RT) is also shown. 
 
 
 POPC PLPC PAPC 
 [M+H]
+
 [M+H]
+
 [M+H]
+
 
 m/z
(RT)
 m/z
(RT)
 m/z
(RT)
 
Non-modified 760.59 758.57 782.57 
Nitration Derivatives 
NO-PL +29, Nitroso 789.58(35.1) 787.56(20.8) 811.56(26.4) 
NO2-PL +45, Nitro 805.57(44.8) 803.56(39.3) 827.56(43.0) 
(NO)2-PL +58, Dinitroso -- -- 840.55(11.6) 
(NO)(NO)2-PL  +74, Nitronitroso 834.56(27.4) 832.55(18.5) 856.56(21.0) 
(NO2)2-PL +90, Dinitro 850.56(39.0) 848.54(32.6) 872.54(35.3) 
Nitration and Oxidation derivatives 
(NO)O-PL +45, Nitrosohydroxy 805.57(31.1) 803.56(25.1) 827.56(21.1) 
(NO2)O-PL +61, Nitrohydroxy  821.57(29.4) 819.55(31.6) 843.55(21.0) 
(NO2)(2O)-PL +77, Nitrohydroperoxy  837.56(22.6) 835.54(24.8) 859.54(21.5)
 
(NO2)2O-PL +106, Dinitrohydroxy  866.55(25.7) 864.54(34.2) 888.53(18.8)
 
(NO2)2(2O)-PL +122, Dinitrohydroxy  882.55(22.4) 880.53(24.6) 904.53(14.0) 
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Table S2. Summary of the main nitrated and nitroxidized products observed both in the 
positive-ion mode as [M+H]+ ions and negative-ion mode as [M-H]- ions ESI-MS spectra 
from each PE, with the identiﬁcation and the indication of the respective m/z values. The 
corresponding retention time (RT) is also shown. 
 
 POPE PLPE PAPE 
 [M+H]
+
 [M-H]
-
 [M+H]
+
 [M-H]
-
 [M+H]
+
 [M-H]
-
 
 m/z(RT) m/z(RT) m/z(RT) m/z(RT) m/z(RT) m/z(RT) 
Non-modified 718.54 716.53 716.52 714.52 740.52 738.52 
Nitration Derivatives 
NO-PL +29, Nitroso 747.53(35.4) 745.51(31.2) 745.51(20.7) 743.50(19.7) 769.51(26.7) 767.50(27.4) 
NO2-PL +45, Nitro 763.52(44.0) 761.51(43.8) 761.51(39.6) 759.49(39.0) 785.51(37.8) 783.49(38.3) 
(NO)2-PL +58, Dinitroso -- -- -- -- 798.50(9.8) 796.49(9.3) 
(NO)(NO2)-PL +74, Nitronitroso 792.51(26.5) 790.50(25.9) 790.50(19.1) 788.48(18.3) 814.50(21.9) 812.48(22.8) 
(NO2)2-PL +90, Dinitro 808.51(40.2) 806.49(38.5) 806.49(34.1) 804.48(32.4) 830.49(35.1) 828.48(36.0) 
Nitration and Oxidation derivatives 
(NO)O-PL +45, Nitrosohydroxy 763.52(31.3) 761.51(30.7) 761.51(24.5) 759.49(23.7) 785.51(21.6) 783.49(22.0) 
(NO2)O-PL +61, Nitrohydroxy  779.52(29.6) 777.50(27.5) 777.50(32.2) 775.49(30.9) 801.50(21.3) 799.49(21.4) 
(NO2)2O-PL 
+77, 
Nitrohydroperoxy  
795.51
(24.6)
 793.50
(25.5)
 793.50
(25.0)
 791.48
(25.9)
 817.50
(18.9)
 815.48
(19.8)
 
(NO2)2O-PL +106, Dinitrohydroxy  824.50(25.4) 822.49(25.2) 822.49(33.4) 820.47(33.2) 846.49(14.4) 844.47(15.3) 
(NO2)22O-PL 
+122, 
Dinitrohydroperoxy  
840.50
(23.4)
 838.48
(24.6)
 838.48
(23.9)
 836.47
(25.1)
 862.48
(11.7)
 860.47
(12.6)
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Table S3. Formula, calculated and observed mass and mass error of the nitrated and 
nitroxidized derivatives formed due to reaction between NO2BF4 and each PC observed in 
the ESI-MS spectra. Data was acquired in the Q-TOF2 mass spectrometer, and lock mass 
was done in the [M+H+non-modified PL]+. POPC, PC16:0/18:1; PLPC, PC16:0/18:2; 
PAPC, PC16:0/20:4. 
 
 
 
 
PC nitration 
products 
Observed 
Mass (Da) 
Calculated 
Mass (Da) 
Error 
(mDa) 
Error 
(ppm) 
Predicted Formula 
[M+H]+ 
[POPC+14u+H]+ 774.5656 774.5649 0.7 0.9 C42H81NO9P 
[POPC+16u+H]+ 776.5845 776.5805 -2.9 -3.8 C42H83NO9P 
[POPC+29u+H]+ 789.5742 789.5758 -1.6 -2 C42H82N2O9P 
[POPC+32u+H]+ 792.5739 792.5755 -1.6 -2 C42H83NO10P 
[POPC+45u+H]+ 805.5695 805.5707 -1.2 -1.5 C42H82N2O10P 
[POPC+58u+H]+ 818.5673 818.5660 1.3 1.6 C42H81N3O10P 
[POPC+61u+H]+ 821.5695 821.5656 3.9 4.7 C42H82N2O11P 
[POPC+74u+H]+ 834.5615 834.5609 0.6 0.7 C42H81N3O11P 
[POPC+77u+H]+ 837.5561 837.5605 -4.4 -5.3 C42H82N2O12P 
[POPC+90u+H]+ 850.5589 850.5558 3.1 3.7 C42H81N3O12P 
[POPC+106u+H]+ 866.5500 866.5507 -0.7 -0.8 C42H81N3O13P 
[POPC+122u+H]+ 882.5458 882.5456 0.2 0.2 C42H81N3O14P 
[PLPC+14u+H]+ 772.5483 772.5492 -0.9 -1.2 C42H79NO9P 
[PLPC+16u+H]+ 774.5647 774.5649 -0.2 -0.3 C42H81NO9P 
[PLPC+29u+H]+ 787.5597 787.5601 -0.4 -0.6 C42H80N2O9P 
[PLPC+32u+H]+ 790.5631 790.5598 3.3 4.2 C42H81NO10P 
[PLPC+45u+H]+ 803.5565 803.5551 1.4 1.8 C42H80N2O10P 
[PLPC+58u+H]+ 816.5518 816.5503 1.5 1.8 C42H79N3O10P 
[PLPC+61u+H]+ 819.5507 819.5500 0.7 0.9 C42H80N2O11P 
[PLPC+74u+H]+ 832.5466 832.5452 1.4 1.7 C42H79N3O11P 
[PLPC+77u+H]+ 835.5397 835.5449 -5.2 -6.2 C42H80N2O12P 
[PLPC+90u+H]+ 848.5435 848.5401 3.4 4 C42H79N3O12P 
[PLPC+106u+H]+ 864.5383 864.5351 3.2 3.8 C42H79N3O13P 
[PLPC+122u+H]+ 880.5309 880.5300 0.9 1.1 C42H79N3O14P 
[PAPC+14u+H]+ 796.5513 796.5492 2.1 2.6 C44H79NO9P 
[PAPC+16u+H]+ 798.5676 798.5649 2.7 3.4 C44H81NO9P 
[PAPC+29u+H]+ 811.5589 811.5601 -1.2 -1.5 C44H80N2O9P 
[PAPC+32u+H]+ 814.5583 814.5598 -1.5 -1.9 C44H81NO10P 
[PAPC+45u+H]+ 827.5578 827.5551 2.7 3.3 C44H80N2O10P 
[PAPC+58u+H]+ 840.5457 840.5503 -4.6 -5.5 C44H79N3O10P 
[PAPC+61u+H]+ 843.5463 843.5500 -3.7 -4.4 C44H80N2O11P 
[PAPC+74u+H]+ 856.5450 856.5452 -0.2 -0.3 C44H79N3O11P 
[PAPC+77u+H]+ 859.5413 859.5449 -3.6 -4.2 C44H80N2O12P 
[PAPC+90u+H]+ 872.5424 872.5401 2.3 2.6 C44H79N3O12P 
[PAPC+106u+H]+ 888.5349 888.5351 -0.2 -0.2 C44H79N3O13P 
[PAPC+122u+H]+ 904.5302 904.5300 0.2 0.3 C44H79N3O14P 
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Table S4. Formula, calculated and observed mass and mass error of the nitrated and 
nitroxidized derivatives formed due to reaction between NO2BF4 and each PE observed in 
the ESI-MS spectra. Data was acquired in the Q-TOF2 mass spectrometer, and lock mass 
was done in the [M+H+non-modified PL]+. POPE, PE16:0/18:1; PLPE, PE16:0/18:2; 
PAPE, PE16:0/20:4. 
 
PE nitration 
products 
Observed 
Mass (Da) 
Calculated 
Mass (Da) 
Error 
(mDa) 
Error 
(ppm) 
Predicted Formula 
[M+H]+ 
[POPE+14u+H]+ 732.5200 732.5179 2.1 2.8 C39H75NO9P  
[POPE+16u+H]+ 734.5327 734.5336 -0.9 -1.2 C39H77NO9P 
[POPE+29u+H]+ 747.5297 747.5288 0.9 1.1 C39H76N2O9P 
[POPE+32u+H]+ 750.5278 750.5285 -0.7 -0.9 C39H77NO10P  
[POPE+45u+H]+ 763.5236 763.5238 -0.2 -0.2 C39H76N2O10P 
[POPE+58u+H]+ 776.5193 776.5190 0.3 0.4 C39H75N3O10P 
[POPE+61u+H]+ 779.5203 779.5187 1.6 2.1 C39H76N2O11P 
[POPE+74u+H]+ 792.5135 792.5139 -0.4 -0.5 C39H75N3O11P 
[POPE+77u+H]+ 795.5125 795.5136 -1.1 -1.4 C39H76N2O12P 
[POPE+90u+H]+ 808.5076 808.5088 -1.2 -1.5 C39H75N3O12P 
[POPE+106u+H]+ 824.5029 824.5038 -0.9 -1 C39H75N3O13P  
[POPE+122u+H]+ 840.4999 840.4987 1.2 1.5 C39H75N3O14P  
[PLPE+14u+H]+ 730.5004 730.5023 -1.9 -2.6 C39H73NO9P  
[PLPE+16u+H]+ 732.5170 732.5179 -0.9 -1.3 C39H75NO9P  
[PLPE+29u+H]+ 745.5125 745.5132 -0.7 -0.9 C39H74N2O9P 
[PLPE+32u+H]+ 748.5142 748.5129 1.3 1.8 C39H75NO10P  
[PLPE+45u+H]+ 761.5087 761.5081 0.6 0.8 C39H74N2O10P 
[PLPE+58u+H]+ 774.5037 774.5034 0.3 0.4 C39H73N3O10P 
[PLPE+61u+H]+ 777.5052 777.5030 2.2 2.8 C39H74N2O11P 
[PLPE+74u+H]+ 790.5005 790.4983 2.2 2.8 C39H73N3O11P 
[PLPE+77u+H]+ 793.4970 793.4979 -0.9 -1.2 C39H74N2O12P 
[PLPE+90u+H]+ 806.4915 806.4932 -1.7 -2.1 C39H73N3O12P 
[PLPE+106u+H]+ 822.4863 822.4881 -1.8 -2.2 C39H73N3O13P  
[PLPE+122u+H]+ 838.4841 838.4830 1.1 1.3 C39H73N3O14P  
[PAPE+14u+H]+ 754.5019 754.5023 -0.4 -0.5 C41H73NO9P  
[PAPE+16u+H]+ 756.5192 756.5179 1.3 1.7 C41H75NO9P 
[PAPE+29u+H]+ 769.5146 769.5132 1.4 1.8 C41H74N2O9P 
[PAPE+32u+H]+ 772.5115 772.5129 -1.4 -1.8 C41H75NO10P  
[PAPE+45u+H]+ 785.5090 785.5081 0.9 1.1 C41H74N2O10P 
[PAPE+59u+H]+ 798.5049 798.5034 1.5 1.9 C41H73N3O10P 
[PAPE+61u+H]+ 801.5023 801.5030 -0.7 -0.9 C41H74N2O11P 
[PAPE+74u+H]+ 814.4969 814.4983 -1.4 -1.7 C41H73N3O11P 
[PAPE+77u+H]+ 817.4977 817.4979 -0.2 -0.3 C41H74N2O12P 
[PAPE+90u+H]+ 830.4920 830.4932 -1.2 -1.4 C41H73N3O12P 
[PAPE+106u+H]+ 846.4893 846.4881 1.2 1.4 C41H73N3O13P  
[PAPE+122u+H]+ 862.4813 862.4830 -1.7 -2 C41H73N3O14P  
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Table S5. Typical modified carboxylate cations and anions of each fatty acids of each 
nitrated and nitroxidized PL molecular species observed in tandem mass spectra that can 
be used for diagnostic scan of nitrated and nitroxidized PLs in positive- and negative-ion 
mode. 
 
Typical modified carboxylate cations and anions observed in MS2 
 Oleic Acid Linoleic Acid Arachidonic Acid 
 [R’COOH+H]
+
 R’COO
-
 [R’COOH+H]
+
 R’COO
-
 [R’COOH+H]
+
 R’COO
-
 
Nitrated derivatives 
Nitroso 312.3 310.2 310.2 308.2 334.2 332.2 
Nitro 328.2 326.2 326.3 324.2 350.2 348.2 
Dinitroso -- -- -- -- 363.2 361.2 
Nitronitroso 357.2 355.2 355.2 353.2 379.2 377.2 
Dinitro 373.2 371.2 371.2 369.2 395.2 393.2 
Nitroxidized derivatives 
Nitrosohydroxy 328.2 326.2 326.3 324.2 350.2 348.2 
Nitrohydroxy 344.2 342.2 342.2 340.2 366.2 364.2 
Nitrohydroperoxy 360.2 358.2 358.2 356.2 382.2 380.2 
Dinitrohydroxy 389.2 387.2 387.2 385.2 411.2 409.2 
Dinitrohydroperoxy 405.2 403.2 403.2 401.2 427.2 425.2 
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SUPPLEMTARY FIGURES 
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Figure S-2.  (A) Percentage of inhibition of ABTS●+ (A) and DPPH● radicals (B) obtained in the presence of 
non-modified POPC and nitrated POPC (125, 150 and 250 µg/mL) after 60 min of reaction. Values were the 
means±SD. ***, signiﬁcantly different from control group (P<0.0001). 
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SUPPLEMTARY TABLES 
 
Table S-1. Amount of the residual ABTS●+ and DPPH● radicals after 60 min of reaction in the presence of 
non-modified POPC and nitrated POPC at the three concentrations tested (125, 150 and 250 µg/mL) prepared 
in ethanol. The results were expressed as percentage of ABTS●+ and DPPH● remaining. 
[Non-modified 
POPC] (µg/mL) 
%ABTS 
Remaining 
[Nitrated POPC] 
(µg/mL) 
%ABTS 
Remaining 
125 98.1±0.9 125 71.9±2.5 
150 98.4±0.7 150 61.8±3.8 
250 97.7±1.2 250 39.0±2.5 
[Non-modified 
POPC] (µg/mL) 
%DPPH 
Remaining 
[Nitrated POPC] 
(µg/mL) 
%DPPH 
Remaining 
125 98.0±0.9 125 92.3±2.2 
150 96.8±1.1 150 88.9±2.5 
250 97.5±0.5 250 85.2±2.2 
 
 
 
